AU2015203662A1 - Induction of flocculation in photosynthetic organisms - Google Patents
Induction of flocculation in photosynthetic organisms Download PDFInfo
- Publication number
- AU2015203662A1 AU2015203662A1 AU2015203662A AU2015203662A AU2015203662A1 AU 2015203662 A1 AU2015203662 A1 AU 2015203662A1 AU 2015203662 A AU2015203662 A AU 2015203662A AU 2015203662 A AU2015203662 A AU 2015203662A AU 2015203662 A1 AU2015203662 A1 AU 2015203662A1
- Authority
- AU
- Australia
- Prior art keywords
- organism
- flocculation
- protein
- lectin
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000243 photosynthetic effect Effects 0.000 title claims abstract description 78
- 238000005189 flocculation Methods 0.000 title abstract description 219
- 230000016615 flocculation Effects 0.000 title abstract description 218
- 230000006698 induction Effects 0.000 title description 9
- 210000004027 cell Anatomy 0.000 claims description 204
- 108090000623 proteins and genes Proteins 0.000 claims description 165
- 102000004169 proteins and genes Human genes 0.000 claims description 119
- 239000002523 lectin Substances 0.000 claims description 106
- 102000004856 Lectins Human genes 0.000 claims description 94
- 108090001090 Lectins Proteins 0.000 claims description 94
- 230000002792 vascular Effects 0.000 claims description 34
- 108020001507 fusion proteins Proteins 0.000 claims description 27
- 102000037865 fusion proteins Human genes 0.000 claims description 27
- 102000023852 carbohydrate binding proteins Human genes 0.000 claims description 19
- 241000195633 Dunaliella salina Species 0.000 claims description 18
- 150000001720 carbohydrates Chemical class 0.000 claims description 16
- 210000000170 cell membrane Anatomy 0.000 claims description 16
- 210000002421 cell wall Anatomy 0.000 claims description 14
- 241000195632 Dunaliella tertiolecta Species 0.000 claims description 13
- -1 E-selection Proteins 0.000 claims description 13
- 239000000427 antigen Substances 0.000 claims description 13
- 241000195597 Chlamydomonas reinhardtii Species 0.000 claims description 12
- 108091007433 antigens Proteins 0.000 claims description 11
- 102000036639 antigens Human genes 0.000 claims description 11
- 108010038196 saccharide-binding proteins Proteins 0.000 claims description 10
- 241000195585 Chlamydomonas Species 0.000 claims description 9
- 241000168517 Haematococcus lacustris Species 0.000 claims description 9
- 241000195634 Dunaliella Species 0.000 claims description 8
- 241000195663 Scenedesmus Species 0.000 claims description 8
- 108010029176 Sialic Acid Binding Ig-like Lectin 1 Proteins 0.000 claims description 8
- 102100032855 Sialoadhesin Human genes 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 7
- 108090000342 C-Type Lectins Proteins 0.000 claims description 6
- 102000003930 C-Type Lectins Human genes 0.000 claims description 6
- 102100028681 C-type lectin domain family 4 member K Human genes 0.000 claims description 5
- 101710183165 C-type lectin domain family 4 member K Proteins 0.000 claims description 5
- 102100040839 C-type lectin domain family 6 member A Human genes 0.000 claims description 5
- 101710125370 C-type lectin domain family 6 member A Proteins 0.000 claims description 5
- 101100256850 Drosophila melanogaster EndoA gene Proteins 0.000 claims description 5
- 108010046569 Galectins Proteins 0.000 claims description 5
- 102000007563 Galectins Human genes 0.000 claims description 5
- 101000863880 Homo sapiens Sialic acid-binding Ig-like lectin 6 Proteins 0.000 claims description 5
- 101000863882 Homo sapiens Sialic acid-binding Ig-like lectin 7 Proteins 0.000 claims description 5
- 101000863883 Homo sapiens Sialic acid-binding Ig-like lectin 9 Proteins 0.000 claims description 5
- 108010092694 L-Selectin Proteins 0.000 claims description 5
- 102000016551 L-selectin Human genes 0.000 claims description 5
- 102100024621 Layilin Human genes 0.000 claims description 5
- 101710147757 Layilin Proteins 0.000 claims description 5
- 102100033486 Lymphocyte antigen 75 Human genes 0.000 claims description 5
- 101710157884 Lymphocyte antigen 75 Proteins 0.000 claims description 5
- 108010031099 Mannose Receptor Proteins 0.000 claims description 5
- 102000017099 Myelin-Associated Glycoprotein Human genes 0.000 claims description 5
- 108010013731 Myelin-Associated Glycoprotein Proteins 0.000 claims description 5
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 5
- 108010035766 P-Selectin Proteins 0.000 claims description 5
- 108010043045 Phospholipase A2 Receptors Proteins 0.000 claims description 5
- 102000004050 Phospholipase A2 Receptors Human genes 0.000 claims description 5
- 108010029180 Sialic Acid Binding Ig-like Lectin 3 Proteins 0.000 claims description 5
- 102100029957 Sialic acid-binding Ig-like lectin 5 Human genes 0.000 claims description 5
- 101710110535 Sialic acid-binding Ig-like lectin 5 Proteins 0.000 claims description 5
- 102100029947 Sialic acid-binding Ig-like lectin 6 Human genes 0.000 claims description 5
- 102100029946 Sialic acid-binding Ig-like lectin 7 Human genes 0.000 claims description 5
- 102100029965 Sialic acid-binding Ig-like lectin 9 Human genes 0.000 claims description 5
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 4
- 101710159429 C-type lectin domain family 10 member A Proteins 0.000 claims description 4
- 102100028668 C-type lectin domain family 4 member C Human genes 0.000 claims description 4
- 102100040840 C-type lectin domain family 7 member A Human genes 0.000 claims description 4
- 101000766907 Homo sapiens C-type lectin domain family 4 member C Proteins 0.000 claims description 4
- 101000863884 Homo sapiens Sialic acid-binding Ig-like lectin 8 Proteins 0.000 claims description 4
- 102100032966 Myomegalin Human genes 0.000 claims description 4
- 108010029157 Sialic Acid Binding Ig-like Lectin 2 Proteins 0.000 claims description 4
- 102100027164 Sialic acid-binding Ig-like lectin 10 Human genes 0.000 claims description 4
- 101710143293 Sialic acid-binding Ig-like lectin 10 Proteins 0.000 claims description 4
- 102100029964 Sialic acid-binding Ig-like lectin 8 Human genes 0.000 claims description 4
- 108010025838 dectin 1 Proteins 0.000 claims description 4
- 101710183446 C-type lectin domain family 4 member E Proteins 0.000 claims description 3
- 102000008212 P-Selectin Human genes 0.000 claims description 3
- 241001231664 Dunaliella viridis Species 0.000 claims 1
- 241000095509 Sympagurus dimorphus Species 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 81
- 238000004519 manufacturing process Methods 0.000 abstract description 24
- 230000003311 flocculating effect Effects 0.000 abstract description 13
- 239000000203 mixture Substances 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 230000028327 secretion Effects 0.000 abstract description 5
- 239000012528 membrane Substances 0.000 description 87
- 239000013598 vector Substances 0.000 description 60
- 230000014509 gene expression Effects 0.000 description 56
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 48
- 241000196324 Embryophyta Species 0.000 description 47
- 239000003656 tris buffered saline Substances 0.000 description 44
- 108020004414 DNA Proteins 0.000 description 43
- 239000000872 buffer Substances 0.000 description 38
- 239000007788 liquid Substances 0.000 description 38
- 150000007523 nucleic acids Chemical class 0.000 description 37
- 102000039446 nucleic acids Human genes 0.000 description 36
- 108020004707 nucleic acids Proteins 0.000 description 36
- 241000195493 Cryptophyta Species 0.000 description 33
- 230000009466 transformation Effects 0.000 description 33
- 230000004927 fusion Effects 0.000 description 31
- 230000001131 transforming effect Effects 0.000 description 31
- 230000001105 regulatory effect Effects 0.000 description 30
- 239000003550 marker Substances 0.000 description 25
- 229910052757 nitrogen Inorganic materials 0.000 description 24
- 241000894006 Bacteria Species 0.000 description 23
- 210000003763 chloroplast Anatomy 0.000 description 23
- 230000012010 growth Effects 0.000 description 23
- 238000004520 electroporation Methods 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 241001269524 Dura Species 0.000 description 19
- 230000000903 blocking effect Effects 0.000 description 19
- 239000008394 flocculating agent Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 17
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 17
- 241000723792 Tobacco etch virus Species 0.000 description 17
- 229920002401 polyacrylamide Polymers 0.000 description 17
- 239000006228 supernatant Substances 0.000 description 17
- 102000003992 Peroxidases Human genes 0.000 description 16
- 230000001086 cytosolic effect Effects 0.000 description 16
- 230000001939 inductive effect Effects 0.000 description 16
- 108040007629 peroxidase activity proteins Proteins 0.000 description 16
- 108010006654 Bleomycin Proteins 0.000 description 15
- 239000002033 PVDF binder Substances 0.000 description 15
- 238000013459 approach Methods 0.000 description 15
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 15
- 229960001561 bleomycin Drugs 0.000 description 15
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 15
- 239000000499 gel Substances 0.000 description 15
- 239000002245 particle Substances 0.000 description 15
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 15
- 241000588724 Escherichia coli Species 0.000 description 14
- 239000000910 agglutinin Substances 0.000 description 14
- 239000011324 bead Substances 0.000 description 14
- 235000015097 nutrients Nutrition 0.000 description 14
- 239000008188 pellet Substances 0.000 description 14
- 108091033319 polynucleotide Proteins 0.000 description 14
- 102000040430 polynucleotide Human genes 0.000 description 14
- 239000002157 polynucleotide Substances 0.000 description 14
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 108020005345 3' Untranslated Regions Proteins 0.000 description 13
- 108020003589 5' Untranslated Regions Proteins 0.000 description 13
- 108091005804 Peptidases Proteins 0.000 description 13
- 239000004365 Protease Substances 0.000 description 13
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 13
- 229930006000 Sucrose Natural products 0.000 description 13
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 13
- 108700019146 Transgenes Proteins 0.000 description 13
- 238000003776 cleavage reaction Methods 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- 229920001184 polypeptide Polymers 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 13
- 230000007017 scission Effects 0.000 description 13
- 241000894007 species Species 0.000 description 13
- 239000005720 sucrose Substances 0.000 description 13
- 230000008685 targeting Effects 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 235000014633 carbohydrates Nutrition 0.000 description 12
- 238000005119 centrifugation Methods 0.000 description 12
- 108020004705 Codon Proteins 0.000 description 11
- 108700010070 Codon Usage Proteins 0.000 description 11
- 244000043158 Lens esculenta Species 0.000 description 11
- 241000264606 Tetradesmus dimorphus Species 0.000 description 11
- 229910052799 carbon Inorganic materials 0.000 description 11
- 238000003306 harvesting Methods 0.000 description 11
- 229910052751 metal Inorganic materials 0.000 description 11
- 239000002184 metal Substances 0.000 description 11
- 241000195628 Chlorophyta Species 0.000 description 10
- 241000237369 Helix pomatia Species 0.000 description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 description 10
- 238000004113 cell culture Methods 0.000 description 10
- 238000010276 construction Methods 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 10
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 10
- 238000010369 molecular cloning Methods 0.000 description 10
- 210000002706 plastid Anatomy 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 241000235058 Komagataella pastoris Species 0.000 description 9
- 229920001213 Polysorbate 20 Polymers 0.000 description 9
- 108010076504 Protein Sorting Signals Proteins 0.000 description 9
- 108091008400 carbohydrate binding proteins Proteins 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 9
- 230000013011 mating Effects 0.000 description 9
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 9
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- 238000001262 western blot Methods 0.000 description 9
- 108091026890 Coding region Proteins 0.000 description 8
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 8
- 102000018697 Membrane Proteins Human genes 0.000 description 8
- 108010052285 Membrane Proteins Proteins 0.000 description 8
- 239000012722 SDS sample buffer Substances 0.000 description 8
- 238000004873 anchoring Methods 0.000 description 8
- 108010083912 bleomycin N-acetyltransferase Proteins 0.000 description 8
- 239000003638 chemical reducing agent Substances 0.000 description 8
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 8
- 235000003642 hunger Nutrition 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 238000002955 isolation Methods 0.000 description 8
- 229930027917 kanamycin Natural products 0.000 description 8
- 229960000318 kanamycin Drugs 0.000 description 8
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 8
- 229930182823 kanamycin A Natural products 0.000 description 8
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 230000037351 starvation Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000000844 transformation Methods 0.000 description 8
- 101710186708 Agglutinin Proteins 0.000 description 7
- 241000192700 Cyanobacteria Species 0.000 description 7
- 101710146024 Horcolin Proteins 0.000 description 7
- 101710189395 Lectin Proteins 0.000 description 7
- 101710179758 Mannose-specific lectin Proteins 0.000 description 7
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 7
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 210000004940 nucleus Anatomy 0.000 description 7
- 238000000751 protein extraction Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 101100033183 Acidithiobacillus ferrooxidans cbbS2 gene Proteins 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 108091029865 Exogenous DNA Proteins 0.000 description 6
- 102000003886 Glycoproteins Human genes 0.000 description 6
- 108090000288 Glycoproteins Proteins 0.000 description 6
- 108090000913 Nitrate Reductases Proteins 0.000 description 6
- 240000002657 Thymus vulgaris Species 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 230000029553 photosynthesis Effects 0.000 description 6
- 238000010672 photosynthesis Methods 0.000 description 6
- 238000004064 recycling Methods 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 238000004062 sedimentation Methods 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 241001300028 Pomatias Species 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 5
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 238000009630 liquid culture Methods 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 210000001938 protoplast Anatomy 0.000 description 5
- 238000010561 standard procedure Methods 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 101150089023 FASLG gene Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 239000000020 Nitrocellulose Substances 0.000 description 4
- 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 description 4
- 101710204410 Scaffold protein Proteins 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 229920001220 nitrocellulos Polymers 0.000 description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 102000007469 Actins Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 101710163595 Chaperone protein DnaK Proteins 0.000 description 3
- 241000701022 Cytomegalovirus Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000199914 Dinophyceae Species 0.000 description 3
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 3
- 101710178376 Heat shock 70 kDa protein Proteins 0.000 description 3
- 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- 239000006137 Luria-Bertani broth Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 101710160107 Outer membrane protein A Proteins 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 108010022394 Threonine synthase Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 102000004419 dihydrofolate reductase Human genes 0.000 description 3
- 238000001823 molecular biology technique Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 230000018612 quorum sensing Effects 0.000 description 3
- 239000013535 sea water Substances 0.000 description 3
- 230000004960 subcellular localization Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- QRBLKGHRWFGINE-UGWAGOLRSA-N 2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2s,3r,4r,5s)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)- Chemical compound N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(C)=O)NC(=O)C(C)C(O)C(C)NC(=O)C(C(O[C@H]1[C@@]([C@@H](O)[C@H](O)[C@H](CO)O1)(C)O[C@H]1[C@@H]([C@](O)([C@@H](O)C(CO)O1)C(N)=O)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C QRBLKGHRWFGINE-UGWAGOLRSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 241000206761 Bacillariophyta Species 0.000 description 2
- 101000870242 Bacillus phage Nf Tail knob protein gp9 Proteins 0.000 description 2
- 241000461044 Careproctus reinhardti Species 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 241001147674 Chlorarachniophyceae Species 0.000 description 2
- 241001672700 Erycina crista-galli Species 0.000 description 2
- 241000195623 Euglenida Species 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 241000828585 Gari Species 0.000 description 2
- 241001517276 Glaucocystophyceae Species 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 239000005562 Glyphosate Substances 0.000 description 2
- 241000206759 Haptophyceae Species 0.000 description 2
- 101001001500 Homo sapiens Phosphatidylinositol N-acetylglucosaminyltransferase subunit H Proteins 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 102100023472 P-selectin Human genes 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- LTQCLFMNABRKSH-UHFFFAOYSA-N Phleomycin Natural products N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(O)C)NC(=O)C(C)C(O)C(C)NC(=O)C(C(OC1C(C(O)C(O)C(CO)O1)OC1C(C(OC(N)=O)C(O)C(CO)O1)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C LTQCLFMNABRKSH-UHFFFAOYSA-N 0.000 description 2
- 108010035235 Phleomycins Proteins 0.000 description 2
- 102100036162 Phosphatidylinositol N-acetylglucosaminyltransferase subunit H Human genes 0.000 description 2
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 2
- 241000206572 Rhodophyta Species 0.000 description 2
- 241000714474 Rous sarcoma virus Species 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 229940100389 Sulfonylurea Drugs 0.000 description 2
- 108020005038 Terminator Codon Proteins 0.000 description 2
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical group C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 230000009918 complex formation Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical compound NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000003495 flagella Anatomy 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229930004094 glycosylphosphatidylinositol Natural products 0.000 description 2
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 2
- 229940097068 glyphosate Drugs 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 238000002823 phage display Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- 235000010333 potassium nitrate Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 239000013605 shuttle vector Substances 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 108010000700 Acetolactate synthase Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241001465318 Aspergillus terreus Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 241000713826 Avian leukosis virus Species 0.000 description 1
- 108700023313 Bacteriophage Receptors Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 244000045232 Canavalia ensiformis Species 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108020004998 Chloroplast DNA Proteins 0.000 description 1
- 241000206751 Chrysophyceae Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241001464430 Cyanobacterium Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 101000802895 Dendroaspis angusticeps Fasciculin-1 Proteins 0.000 description 1
- 101000802894 Dendroaspis angusticeps Fasciculin-2 Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000224472 Eustigmatophyceae Species 0.000 description 1
- 101150018234 Fas3 gene Proteins 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- SNVFDPHQAOXWJZ-UHFFFAOYSA-N Furcelleran Chemical compound CCOC(=O)C1=C(C)NC(C=2C=CC=CC=2)=C(C(=O)OCC=2C=CC=CC=2)C1C#CC1=CC=CC=C1 SNVFDPHQAOXWJZ-UHFFFAOYSA-N 0.000 description 1
- 241000027294 Fusi Species 0.000 description 1
- 102100024637 Galectin-10 Human genes 0.000 description 1
- 102100039555 Galectin-7 Human genes 0.000 description 1
- 101001011019 Gallus gallus Gallinacin-10 Proteins 0.000 description 1
- 101001011021 Gallus gallus Gallinacin-12 Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 102100031001 Hepatoma-derived growth factor-related protein 2 Human genes 0.000 description 1
- 101710161030 Hepatoma-derived growth factor-related protein 2 Proteins 0.000 description 1
- 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
- 101000608772 Homo sapiens Galectin-7 Proteins 0.000 description 1
- 101001011906 Homo sapiens Matrix metalloproteinase-14 Proteins 0.000 description 1
- 101001038341 Homo sapiens Serine/threonine-protein kinase LMTK3 Proteins 0.000 description 1
- 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 1
- 108091006975 Iron transporters Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- BVARSKHQNMUXIB-WOUBZNJSSA-N L-idopyranose 6-monomycolate Chemical compound CCCCCCCCCCCCCCCCCC\C=C/CCCCCCCC\C=C/CCCCCCCCCCCCCCCCCCC[C@@H](O)[C@@H](CCCCCCCC)C(=O)OC[C@@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O BVARSKHQNMUXIB-WOUBZNJSSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 101710197067 Lectin 5 Proteins 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 description 1
- 102100030216 Matrix metalloproteinase-14 Human genes 0.000 description 1
- 101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
- 241000713333 Mouse mammary tumor virus Species 0.000 description 1
- 101150054907 Mrps12 gene Proteins 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 108010079246 OMPA outer membrane proteins Proteins 0.000 description 1
- 229940122060 Ornithine decarboxylase inhibitor Drugs 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101710091688 Patatin Proteins 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 102100026918 Phospholipase A2 Human genes 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- 102100035362 Phosphomannomutase 2 Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 229920001715 Porphyran Polymers 0.000 description 1
- 241000192142 Proteobacteria Species 0.000 description 1
- 108020001991 Protoporphyrinogen Oxidase Proteins 0.000 description 1
- 102000005135 Protoporphyrinogen oxidase Human genes 0.000 description 1
- 241001518925 Raphidophyceae Species 0.000 description 1
- 101100177329 Rattus norvegicus Hdgfl3 gene Proteins 0.000 description 1
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
- 101100000443 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ACC1 gene Proteins 0.000 description 1
- 101100395581 Schizosaccharomyces pombe (strain 972 / ATCC 24843) hrp3 gene Proteins 0.000 description 1
- 101100199945 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rps1201 gene Proteins 0.000 description 1
- 102100040291 Serine/threonine-protein kinase LMTK3 Human genes 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000192707 Synechococcus Species 0.000 description 1
- 241000192584 Synechocystis Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 101710090861 Treponemal membrane protein A Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 1
- 108010073429 Type V Secretion Systems Proteins 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 241000206764 Xanthophyceae Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 108010084455 Zeocin Proteins 0.000 description 1
- 101150067314 aadA gene Proteins 0.000 description 1
- ATPYWZKDGYKXIM-UHFFFAOYSA-N acetic acid phosphoric acid Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.OP(O)(O)=O ATPYWZKDGYKXIM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000000089 arabinosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)CO1)* 0.000 description 1
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 108010060641 flavanone synthetase Proteins 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000008195 galaktosides Chemical group 0.000 description 1
- 235000003869 genetically modified organism Nutrition 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 102000035122 glycosylated proteins Human genes 0.000 description 1
- 108091005608 glycosylated proteins Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 210000003783 haploid cell Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 101150113423 hisD gene Proteins 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 230000014726 immortalization of host cell Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 108010083942 mannopine synthase Proteins 0.000 description 1
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 238000001216 nucleic acid method Methods 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 235000021232 nutrient availability Nutrition 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 239000002818 ornithine decarboxylase inhibitor Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
- 229940067626 phosphatidylinositols Drugs 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 101150075980 psbA gene Proteins 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 101150015537 rps12 gene Proteins 0.000 description 1
- 101150098466 rpsL gene Proteins 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- XGRLSUFHELJJAB-JGSYTFBMSA-M sodium;[(2r)-2-hydroxy-3-[(z)-octadec-9-enoyl]oxypropyl] hydrogen phosphate Chemical group [Na+].CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)([O-])=O XGRLSUFHELJJAB-JGSYTFBMSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 101150081616 trpB gene Proteins 0.000 description 1
- 101150111232 trpB-1 gene Proteins 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention provides compositions and methods for producing flocculation moieties in photosynthetic organisms. The photosynthetic organisms are genetically modified to effect production, secretion, or both, of the flocculation moieties. Also provided are methods of flocculating organisms.
Description
P/00101i1 Regulation 3.2 AUSTRALIA Patents Act 1990 COMPLETE SPECIFICATION STANDARD PATENT Invention Title: Induction of flocculation in photosynthetic organisms The following statement is a full description of this invention, including the best method of performing it known to us: 1001143232 INDUCTION OF FLOCCULATION IN PHOTOSYNTHETIC ORGANISMS CROSS REFERENCES TO RELATED APPLICATIONS 10001] This application claims the benefit of United States Provisional Application Number 61/076,430, filed June 27, 2008, the entire contents of which are incorporated herein by reference for all purposes. This application is 5 a divisional of Australian patent application no. 2009261966, the entire disclosure of which is incorporated herein by reference. BACKGROUND [0001A] Reference to any prior art in the specification is not, and should not be taken as, an 10 acknowledgment or any form of suggestion that this prior art forms part of the common general knowledge in Australia or any other jurisdiction or that this prior art could reasonably be expected to be ascertained, understood and regarded as relevant by a person skilled in the art. 100021 Algae are unicellular organisms, producing oxygen by photosynthesis. One group, the microalgae, are useful for biotechnology applications for many reasons, including their high growth rate and tolerance to varying 15 environmental conditions. The use of microalgae in a variety of industrial processes for commercially important products is known and/or has been suggested. For example, microalgae have uses in the production of nutritional supplements, pharmaceuticals, natural dyes, a food source for fish and crustaceans, biological control of agricultural pests, production of oxygen and removal of nitrogen, phosphorus and toxic substances in sewage treatment, and pollution controls, such as biodegradation of plastics or uptake of carbon dioxide. 20 10003] Microalgae, like other organisms, contain lipids and fatty acids as membrane components, storage products, metabolites and sources of energy. Some algal strains, diatoms, and cyanobacteria have been found to contain proportionally high levels of lipids (over 30%). Microalgal strains with high oil or lipid content are of great interest in the search for a sustainable feedstock for the production of biofuels. 100041 Some wild-type algae are suitable for use in various industrial applications. However, it is 25 recognized that by modification of algae to improve particular characteristics useful for the aforementioned applications, the relevant processes are more likely to be commercially viable. To this end, algal strains can be developed which have improved characteristics over wild-type strains. Such developments have been made by traditional techniques of screening and mutation and selection. Further, recombinant DNA technologies have been widely suggested for algae. Such approaches may increase the economic validity of production of commercially 30 valuable products. [00051 For the production of some commercial products of interest, organisms producing the products may be grown in liquid environments. It is sometimes beneficial to remove the organisms from the liquid environments. One method of removing organisms is to flocculate or aggregate the organisms to facilitate removal. Flocculants or flocculating agents promote flocculation by causing colloids and other suspended particles (e.g., 35 cells) in liquids to aggregate, forming a floc. Flocculants are used in water treatment processes to improve the sedimentation of small particles. For example, a flocculant may be used in swimming pool or drinking water filtration to aid removal of microscopic particles which would otherwise cause the water to be cloudy and which would be difficult to remove by filtration alone. 1A 1001143232 [00061 Many flocculants are multivalent cations such as aluminium, iron, calcium or magnesium. These positively charged molecules interact with negatively charged particles and molecules to reduce the barriers to aggregation. In addition, many of these chemicals, under appropriate pH and other conditions such as temperature and salinity, react with water to form insoluble hydroxides which, upon precipitating, link together to form long 5 chains or meshes, physically trapping small particles into the larger floc. [0007] Flocculation of microalgae using chemical flocculants is known. Long-chain polymer flocculants, such as modified polyacrylamides, are manufactured and sold by the flocculant producing business. These can be supplied in dry or liquid form for use in the flocculation process. The most common liquid polyacrylamide, for example, is supplied as an emulsion with 10-40 % actives and the rest is a carrier fluid, surfactants and latex. 100081 Use of chemical flocculants, however, has multiple drawbacks. For instance, use in water treatment and other processes require subsequent removal of flocculants. The addition and removal of flocculants adds to the cost of commercial production of a product of interest, thus decreasing the economic feasibility of production. SUMMARY 100091 One aspect of the present disclosure provides for vectors comprising a nucleic acid encoding a flocculating moiety and a regulatory element linked to express the flocculating moiety in the nucleus of a photosynthetic organism. The flocculating moieties employed in this invention may comprise carbohydrate binding proteins, antibodies binding to a cell surface antigen of C. reinhardtii, D. salina, D. tertiolecta, or H. pluvialis, lectin, FhuA protein, pbS protein, or other proteins that form a tight protein-protein pairing where the pairing leads to flocculation of microalgae. The regulatory elements utilized in the vectors may comprise a constitutive promoter, light-inducible promoter, quorum sensitive promoter, temperature-sensitive promoter, or nitrogen-starvation responsive promoter. The vectors disclosed herein may also contain nucleic acids capable of targeting the flocculation moiety to the cell surface and to anchor a portion of the flocculation moiety to be tightly bound on the cell surface. The vectors are utilized to transform non vascular photosynthetic organisms, such as microalgae, for flocculation. Tn certain cases, the anchoring moiety can be optional as secreting the flocculation moiety into the culture, depending on the property of a flocculation moiety, is preferable method for flocculation. 100101 Another aspect provides methods of flocculation utilizing non-vascular photosynthetic organisms. Examples of non-vascular photosynthetic organisms are C. reinhardii, D. salina, D.tertiolecta, S. dimorphus, or H. pluvialis. The flocculation methods may comprise creating two distinctly different photosynthetic organisms by transforming with different flocculation moieties and causing flocculation by allowing the two flocculation moieties to interact each other. Examples of flocculation moieties comprise protein-protein interaction between FhuA and pb5, interactions between mating-type specific agglutinins, an antibody-antigen pairing, and other proteins capable of recognizing each other as a pair and form a stable protein-protein complex. Examples of methods for the induction of flocculation of non-vascular photosynthetic organisms are changing light condition, culture density, culture temperature, or nutrient availability; adding lectin, protein, heavy metal, cationic or chemical flocculant in the culture; or attaching the aforementioned flocculation agents to a solid support. 100111 Another aspect provides methods to recycle the culture liquid from a liquid environment. Non-vascular photosynthetic organisms can be cultured in a media with defined media known in the art, such as min-70, M-medium, or TAP medium. After flocculation, it is often possible and economically beneficial to recycle the liquid portion of the culture, Disclosed herein are methods to enable the recycling of the liquid comprising growing microorganisms encoding a flocculation moiety; contacting the organism with flocculating moiety and thereby flocculating the organism; and removing the aggregated microorganism from the liquid environment. 100121 One particular aspect provides a method for flocculating a non-vascular photosynthetic organism comprising expressing an exogenous nucleic acid encoding a first flocculation moiety on the external surface of a non-vascular photosynthetic organism and contacting the organism with a second flocculation moiety. The organism can be a member of the genus Chlamydononas, Dunaliella, Scenedesmus or Henatococcus, for example C. reinhardii, D. 2 sa/ina, D.aertiolecta, S. dimorphus or H. pluvialis, although members of other genera may be used. The first flocculation moiety can be a carbohydrate binding protein such as a lectin and in particular a c-type lectin. Other non limiting examples of carbohydrate binding proteins include CD-SIGN, dectin-1, dectin-2, HECL, langerin, layilin, mince, MMOL, E-selection, P-selectin, L-selectin, DEC-205, Endo 180, mannose receptor, phospholipase A2 receptor, sialoadhesin (siglec-1), siglcc-2, siglec-3, siglec-4, siglec-5, siglec-6, siglec-7, siglcc-8, siglec-9, siglec-l0, siglec-l 1, and galectins. In other embodiments, the first flocculation moiety may be a univalent, monvalent or polyvalent antibody, for example an scFv antibody, that binds to an antigen on the surface of an organism of interest. Examples of such organisms include members of the genus Chlamydomonas, Dunaliella, Scenedesinus or Hemalococcus, such as C. reinhardii, D. salina, D.tertiolecta, S. dimorphus or H. pluvialis. Some embodiments may also include the use of a second flocculation moiety. The second flocculation moiety may be on the surface of a solid support or on the surface of a second organism, which may or may not be a non-vascular photosynthetic organism. When the second flocculation moiety is expressed on the surface of a second organism, the second flocculation moiety may be naturally occurring or may be the result of expression of an exogenous nucleotide sequence. In some embodiments, the first and second organisms are the same species, while in other embodiments, the first and second organisms a-e of different strains, different genera or different kingdoms. For example, in one embodiment the first and second organism are both algae while in another embodiment one organism is an alga while the other is a bacterium or yeast. When the second flocculation moiety is on the surface of a second organism or solid support, the method further comprises combining the first organism with the second organism, with the solid support, or both. [00131 Another aspect provides a non-vascular photosynthetic organism comprising an exogenous protein on the organism's external cell surface, such as a cell membrane or cell wall; the exogenous protein comprising one member of a binding pair. The exogenous protein can be an antibody such as a single chain variable fragment (scFv) antibody or a carbohydrate binding protein such as a lectin, for example a c-type lectin. In other embodiments the exogenous protein is an antigen which is the target of an antibody, and in one embodiment an antibody specific to that antigen. In some embodiments the exogenous protein is a fusion or chimeric protein in which part of the protein serves to anchor the protein to the cell surface. The non-vascular photosynthetic organism may be an alga, for example a green alga, more particularly a member of the genus Chlanydomonas, Dunaliella, Scenedesmus or Hematococcus and more particularly one of C. reinhardii, D. salina. D.tertiolecta, S. dimorphus or H. phuvialis. In one embodiment, the non-vascular photosynthetic organism is a halophile such as D. salina or D.tertiolecta. In still other embodiments, the carbohydrate binding protein is at least one of CD-SIGN, dectin-1, dectin-2, HECL, langerin, layilin, mince, MMGL, E-selection, P selectin, L-selectin, DEC-205, Endo 180, mannose receptor, phospholipase A2 receptor, sialoadhesin (siglec-l), siglec 2, siglec-3, siglec-4, siglec-5, siglec-6, siglec-7, siglec-8, siglec-9, siglec-10, siglec-l 1, or galectins. 100141 Yet another aspect provides a flocculation method comprising transforming a first non-vascular photosynthetic organism with a nucleic acid encoding a first flocculation moiety, transforming a second organism, which may or may not be a non-vascular photosynthetic organism, with a nucleic acid encoding a second flocculation moiety or a protein necessary for the production of a second flocculation moiety that interacts with the first flocculation moiety, expressing the first and second flocculation moieties and contacting the two moieties such that flocculation occurs. The two organisms may be of the same or different genera, the same or different species or the same or different kingdoms. For example, the organisms may be the same species of algae, different species of algae, or an alga and a bacterium or yeast. The first organism, the second organism or both can be members of the genus Chlanrydoians, Dunaliella. 3 Scenedesmus or Hematococcus such that one or both of the organisms can be C. reinhardil, D. salina, D.fertiolecta. S. dimorphus or H. pluvialis. The first or second flocculation moieties can be antibodies, carbohydrate binding proteins or mating-type specific agglutinins. [00151 Still another aspect provides a vector comprising an isolated nucleic acid encoding a flocculation moiety, a regulatory element for expressing the flocculation moiety in the photosynthetic organism, for example in the nucleus, and a targeting element that allows the flocculating moiety to be directed to the surface of the organism or be secreted by the organism. The flocculation moiety can be an antibody or any of the carbohydrate binding proteins described herein. Specific examples of flocculation moieties include antibodies, lectins, FhuA protein and pb5 protein. When the nucleic acid encodes an antibody, it may be to an antigen of the surface of a member of the genus Chlamydomonas. Dunaliella, Scenedesmus or Henatococcus, for example, C. reinhardili, D. salina, D.tertiolecta, S. dimorphus or H. pluvialis. In certain embodiments, the vector further comprises a nucleic acid encoding an anchoring element that anchors the flocculation moiety to the surface of the organism. 100161 Still another aspect provides a host cell comprising any of the preceding vectors. The host cell may or may not be a non-vascular photosynthetic organism. In some embodiments, the host cell is a member of the genus Chlamydomonas. Dunaliella, Scenedesmus or Hiematococcus, for example C. reinhardii. D. salina, D.tertiolecta S. dinorphus or i-. p/uvialis. In another embodiment, the host cell is a bacterium or a yeast. 100171 Yet another method provides a method for recycling liquid, such as water or a water based growth medium, comprising growing a non-vascular photosynthetic organism comprising an exogenous nucleic acid encoding a flocculation moiety in a liquid environment, contacting the organism with a second flocculation moiety that binds directly or indirectly to the first flocculation moiety resulting in flocculation of the organism and separating at least a portion of the liquid in the liquid environment from the organism. The first and second flocculation moieties can be any of the moieties described herein, including, but not limited to, antibodies, carbohydrate binding proteins, carbohydrates, heavy metal flocculants, chemical flocculants, cationic flocculants, and mating type agglutinins. The second flocculation moiety may be attached to the surface of a second organism, which may or may not be a non-vascular photosynthetic organism, or may. be attached to a solid support. [0018] Still another aspect provides a method of flocculating a non-vascular photosynthetic organism comprising contacting the non-vascular photosynthetic organism with a second organism comprising an exogenous nucleic acid encoding an antibody that binds to an antigen on the surface of the non-vascular photosynthetic organism thereby causing flocculation. In one embodiment, the antibody is expressed on the surface of the second organism. In another embodiment, the antibody is a single chain variable fragment (scFv) antibody. In still another embodiment, the exogenous nucleic acid encodes a fusion or chimeric protein that comprises the antibody and an anchoring component that anchors the antibody to the external surface of the cell membrane or cell wall of the second organism. In one embodiment, the second organism is a bacterium, while in another embodiment, the second organism is a yeast. The non-vascular photosynthetic organism may a green alga for example a member of the genus Chlamydononas, Dunaliella. Scenedesmus or Hematococcus and more particularly C. reinhardfil. D. salina. D.tertiolecta. S. dimorphus or H. pluvialis. [00191 Another aspect provides a method of flocculating a non-vascular photosynthetic organism comprising contacting the non-vascular photosynthetic organism with a second organism comprising an exogenous nucleic acid encoding a flocculation moiety that binds to a surface component of the non-vascular photosynthetic organism thereby 4 causing flocculation of the non-vascular photosynthetic organism. The flocculation moiety can be secreted by the second organism, expressed on the surface of the second organism, or both. The second organism can be a yeast, a bacterium, a non-photosynthetic alga or a photosynthetic alga. In some embodiments, the second organism is E. coli or P. pastoris. The carbohydrate moiety can be at least one of the members of the group selected from CD-SIGN, dectin I, dectin-2, HIECL, langerin, layilin, mincle, MMGL, E-selection, P-selectin, L-selectin, DEC-205, Endo 180, mannose receptor, phospholipase A2 receptor, sialoadhesin (siglec-l), siglec-2, siglec-3, siglec-4, siglec-5, siglec-6, siglec-7, siglec-8, siglec-9, siglec-10, siglec-l I, and galectins, In particular embodiments, the carbohydrate binding protein is a lectin, for example, a c-type lectin. 100201 In any of the embodiments described herein, an exogenous nucleic acid encoding a flocculation moiety, for example an antibody or a carbohydrate binding protein, may further comprise one or more regulatory elements such as a promoter. Promoters may be constitutive or inducible. Inducible promoters include, but are not limited to light inducible promoters, quorum-sensitive promoters, temperature-sensitive promoters or nitrogen sensitive promoters. 100211 It should be understood that, unless stated otherwise, when reference is made to the expression or presence of a flocculation moiety on the surface of an organism or solid support such reference refers to the external surface of the organism or solid support, that is the surface facing the environment in which the organism to be flocculated is present. INCORPORATION BY REFERENCE 100221 All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference, BRIEF DESCRIPTION OF THE DRAWINGS 100231 The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which: [00241 FIGURE I illustrates various constructs used in the present disclosure [00251 FIGURE 2 is a flow chart of flocculation by lectin. Perform Q.C.; performing quality control of the large scale growth including growth rate, pH of the media, and screening for strain contamination. N; alternative work flow for conditions unsatisfactory to move forward to the next step, 100261 FIGURE 3 is a flow chart of flocculation induced by an anti-Fus I antibody. [00271 FIGURE 4 is a flow chart of flocculation induced by the expression of FhuA and pb5. 100281 FIGURE 5 is a flow chart of flocculation induced by genes regulated by nitrogen starvation in genetically modified Chiamydonionas reinhardlii, 100291 FIGURE 6 shows the activity of recombinant lectins produced in E. coli, A-D arc Chlamydononas reinhardfli where A and C are negative controls and B and D are in the presence of FITC-conjugated lectins from -I. pomatia and T. vulgaris, respectively. E-H is Scenedesnus dinorphus where E and G are negative controls and F and H are in the presence of FITC-conjugated lectins from H. ponatia and T. vulgaris, respectively. f00301 FIGURE 7 shows the insertion of a LppOmpA-lectin fusion protein in the cell membrane of E. coli. 5 100311 FIGURE 8 shows the effect of p-autotransporter L. culinaris lectin fusion protein on sedimentation of S. dimorphus. [00321 FIGURE 9 shows a western blot showing proper insertion of a LppOmpA-scFv5 fusion in the plasma membrane of E. coli. 100331 FIGURE 10 shows a western blot of secreted lectins in Pichiapastoris. Representative examples labeled I (H. pomatia lectin) and 2 (L. culinaris lectin) show protein secretion into the growth medium [0034] FIGURE 1 shows the expression of scaffold lectin fusion proteins in P. pastoris: (1) Pirlb-H. pomatia lectin, (2) Pirlb-L. culinaris lectin, and (3) Pirla- T vulgaris lectin. 10035) FIGURE 12 shows insertion of a Pirla-lectin fusion protein into the membrane of P. pavtoris. 100361 FIGURE 13 shows expression of FasI-lectin fusions. Band 1: FasI-L. culinaris lectin; Band 2: FasI-truncated L culinaris lectin; Band 3: FasI -E. cristagalli lectin. 100371 FIGURE 14 shows a western blot describing the subcellular localization of FasI-lectin fusion proteins. WT: 21gr; Control: Cytosolic enzyme; 1: Fasl -L. culinaris lectin fusion; 2: Fasl -L. culinaris truncated lectin fusion: 3: Fast T. E.cristagalli lectin fusion 10038] FIGURE 15 shows the effect of the presence of the FasI-T. vulgaris lectin fusion protein construct on settling. 100391 FIGURE 16 shows whole cell expression of GPI-lectin proteins in C. reinhardiii. /: GPI-H. pomalia lectin fusion; 2: GP I-L. culinaris truncated lectin fusion. 100401 FIGURE 17 shows a western blot describing the subcellular localization of GPl-lectin fusion proteins. WT: 21gr; Control: Cytosolic enzyme; GPI-H. pomatia lectin. 100411 FIG U RE 18 shows the effect of the presence of the GPI- Hpomatia lectin construct on settling. 100421 FIGURE 19 shows a western blot showing expression of a scFv5-FasI fusion protein in C. reinhardii. I: The fusion protein is shown here. The higher band is the residual intact fusion with the bleomycin protein. 100431 FIGURE 20 shows a western blot describing the subcellular localization of FasI fusion proteins. WT: 21gr; Control: Cytosolic enzyme; scFv5-FasI fusion. There is scFv5-FasI protein localizing to the membrane fraction. (arrow). 100441 FIGURE 21 shows N03 induced expression of H. pomalia lectin in C. reinhardtii. Lane 1: Time 0, TAP; Lane 2: Time 12 hours, TAP; Lane 3: Time 24 hours, TAP; Lane 4: Time 12 hours, TAP -NH 4 CI + 7.4 mM KNO 3 ; Lane 5: Time 24 hours, TAP-NH 4 CI + 7.4 mM KNG 3 Lane 6: Control. [00451 FIGURE 22 shows flocculation of two C. reinhardtii strains following nitrogen deprivation. [0046] FIGURE 23 shows flocculation of two C. reinhardtii strains following minimization of nitrogen. DETAILED DESCRIPTION 10047) The disclosure herein provides novel approaches to initiating flocculation in photosynthetic organisms, and particularly in non-vascular photosynthetic organisms (NVPO). Growth of photosynthetic organisms, particularly single-celled organisms such as microalgae or cyanobacteria, for industrial or agricultural purposes often involves harvesting the cells of the organisms from liquid environments. Currently, much of this harvesting is performed by centrifugation, belt-press processing, adding chemical flocculants to the liquid environment or some combination of methods. Traditional methods of flocculation may lead to additional costs (e.g., cost of the flocculant, cost for removal 6 of the flocculant from the liquid and/or organisms, etc.) and other problems (e.g., pollution, product purification, etc.). The present disclosure provides novel compositions, host cells and methods for flocculating photosynthetic organisms which can overcome the detriments of traditional flocculation methodologies. 100481 The present disclosure takes advantage of strong molecular interactions between different molecules, for example, antibodies and antigens, proteins and carbohydrates, protein-protein binding pairs, etc. Flocculation pairs (two component complexes) or flocculation complexes (more than two component complexes) may be utilized. In some instances, one member of a flocculation pair or complex will be naturally expressed on an organism which will be flocculated, but the level of production may be genetically enhanced. In other instances, one member of a flocculation pair or complex will be recombinantly expressed on an organism to be flocculated. The organism is then contacted with the second (and/or subsequent) flocculation moiety to induce flocculation. The second or subsequent flocculation moieties may be added extrinsically (e.g., on a solid phase such as a bead or sieve), expressed on a separate organism (which may be the same or different species as the first organism) which is then contacted with the first organism, or expressed on the same organism (e.g., under control of an inducible regulatory element). [00491 One approach utilized involves genetic manipulation of a photosynthetic organism (e.g., an NVPO) to express one or more flocculation moieties. Genetic manipulation may involve transient or integrative transformation of a photosynthetic organism (e.g., Chlamydomonas reinhardii, Dunaliella salina, Dunaliella tertiolecta, Scenedesmus dinorphus, Hemalococcus pluvalis) or a non-photosynthetic organism (e.g. E. colt) with a nucleic acid encoding a flocculation moiety. In some instances, the flocculation moiety is a protein capable of binding to another protein, a carbohydrate or another molecule of interest. For example, C. reinhardtii may be transformed with a gene encoding a C. reinhardii-cell surface protein fused to an antibody, such that expression of the antibody on the surface of the cell will cause flocculation of the transformed cells or any other target organisms. Antibodies have been produced in C. reinhardWii chloroplasts, but such expression does not yield antibody on the surface of the cell, See, e.g., Mayfield et al., PNAS 100(2):438-42 (2003). Alternatively the antibody can be expressed on the surface of a non-photosynthetic organism. In one embodiment, the non-photosynthetic organism is a prokaryote such as a bacterium. In another embodiment, the non-photosynthetic organism is a eukaryote, for example a fungi, and more particularly a yeast, The cell surface antibodies on the surface of the non-photosynthetic organism then bind to multiple photosynthetic organisms'resulting in flocculation. Host Cells [0050] The present disclosure also contemplates a host cell transformed with one or more of the nucleic acids described herein. In certain embodiments, the host cell is photosynthetic, In some cases, the host cell is photosynthetic and non-vascular. In other cases, the host cell is photosynthetic and vascular. In still other cases the host cell is non photosynthetic. The host cell can be eukaryotic or prokaryotic. Some host cells may be transformed with multiple genes encoding one or more flocculation moieties. For example, a single transformed cell may contain exogenous nucleic acids encoding one, two, three or more proteins or subunits thereof. For example, an alga such as C. reinhardril , a bacterium such as E. coli or a cyanobacterium, or a yeast such as Pichia pastoris, may be transformed with a gene encoding an antibody which recognizes a cell-surface protein of the organism to be flocculated, where the antibody is produced as a fusion protein or in two or more subunits which are assembled internally. The organism to be flocculated may be the same or different as the organism expressing the surface protein. Constructs may contain multiple copies of 7 the same gene, and/or multiple genes encoding the same protein, and/or multiple genes with mutations in one or more parts of the coding sequences. [00511 The host cell is transfected with a vector described herein (e.g., a vector comprising one or more flocculation moiety encoding genes). The vector may contain a plastid promoter or a nuclear promoter for transforming the nucleus or a chloroplast or other plastid of the host cell. The vector may also encode a fusion protein or agent that selectively targets the vector product to nucleus or the chloroplast or other plastid. Transfection of a host cell can occur using any method known in the art. 100521 A host organism is an organism comprising a host cell. In certain embodiments, the host organism is photosynthetic. A photosynthetic organism is one that naturally photosynthesizes (has a plastid) or that is genetically engineered or otherwise modified to be photosynthetic. In some instances, a photosynthetic organism may be transformed with a construct which renders all or part of the photosynthetic apparatus inoperable. In some instances it is non-vascular and photosynthetic. The host cell can be prokaryotic. Examples of some photosynthetic prdkaryotic organisms of the present invention include, but are not limited to cyanobacteria (e.g., Synechococcus, Synechocystis, Athrospira). The host organism can be unicellular or multicellular. In several embodiments, the host organism is eukaryotic (e.g. green algae). Examples of organisms contemplated herein include, but are not limited to, rhodophyta, chlorophyta, heterokontophyta, tribophyta, glaucophyta, chlorarachniophytes, euglenoids, haptophyta, cryptomonads, dinoflagellata, and phytoplankton. In other embodiments the host organism is non-photosynthetic. Non-photosynthetic host organisms include bacteria and yeast. Examples of suitable bacterial host organisms can be found in the phylum proteobacteria and include, but are not limited to Escherichia coli. Examples of suitable yeast organism can be found in the phylum Ascomycota and include, but are not limited to Pichia pastoris and Saccharomyces cerevisiae. [00531 A host organism may be grown under conditions which permit photosynthesis, however, this is not a requirement (e.g., a host organism may be grown in the absence of light). In some instances, the host organism may be genetically modified in such a way that photosynthetic capability is diminished and/or destroyed. In growth conditions where a host organism is not capable of photosynthesis (e.g., because of the absence of light and/or genetic modification), typically, the organism will be provided with the necessary nutrients to support growth in the absence of photosynthesis. For example, a culture medium in (or on) which an organism is grown, may be supplemented with any required nutrient, including an organic carbon source, nitrogen source, phosphorous source, vitamins, metals, lipids, nucleic acids, micronutrients, or an organism-specific requirement. Organic carbon sources include any source of carbon which the host organism is able to metabolize including, but not limited to, acetate, simple carbohydrates (e.g., glucose, sucrose, lactose), complex carbohydrates (e.g., starch, glycogen), proteins, and lipids. One of skill in the art will recognize that not all organisms will be able to sufficiently metabolize a particular nutrient and that nutrient mixtures may need to be modified from one organism to another in order to provide the appropriate nutrient mix. [00541 A host organism can be grown on land, e.g., in ponds, aqueducts, landfills, or in closed or partially closed bioreactor systems. The host organisms can also be grown directly in water, e.g., oceans, seas, lakes, rivers, reservoirs, etc. In embodiments where algae are mass-cultured, the algae can be grown in high density photobioreactors. Methods of mass-culturing algae are known in the art. For example, algae can be grown in high density photobioreactors (see, e.g., Lee et al, Biotech. Bioengineering 44; 1161-1167, 1994) and other biorcactors (such as those for sewage and waste water treatments) (e.g., Sawayama et al, Appl. Micro. Biotech., 41:729-731, 1994). Additionally, algae may be mass 8 cultured to remove heavy metals (e.g., Wilkinson, Biotech. Leters, 11:861-864, 1989), hydrogen (e.g., U.S. Patent Application Publication No. 20030162273), and pharmaceutical compounds f0055] An exemplary group of organisms are the green algae. One example, Ch/amydomonas, is a genus of unicellular green algae (Chlorophyta). These algae are found in soil, fresh water, oceans, and even in snow on mountaintops. Algae in this genus have a cell wall, a chloroplast, and two anterior flagella allowing mobility in liquid environments. More than 500 different species of Chlanydomonas have been described. (00561 The most widely used laboratory species is C. reinhardtii. Cells of this species are haploid, and can grow on a simple medium of inorganic salts, using photosynthesis to provide energy. They can also grow in total darkness if acetate is provided as a carbon source. When deprived of nitrogen, C. reinhardiji cells can differentiate into isogametes. Two distinct mating types, designated mt+ and mit-, exist. These fuse sexually, thereby generating a thick walled zygote which forms a hard outer wall that protects it from various environmental conditions. The controlled expression of mating type agglutinins can be used to aid in flocculation. When restored to nitrogen culture medium in the presence of light and water, the diploid zygospore undergoes meiosis and releases four haploid cells that resume the vegetative life cycle. In mitotic growth the cells double as fast as every eight hours. C. reinhardili cells can grow under a wide array of conditions. While a dedicated, temperature-controlled space can result in optimal growth, C. reinhardrii can be readily grown at room temperature under standard fluorescent lights. The cells can be synchronized by placing them on a light-dark cycle and depriving them of acetate. 100571 The nuclear genetics of C. reinhardil! is well established. There are a large number of mutants that have been characterized and the C reinhardtili center (www.chlamy.org) maintains an extensive collection of mutants, as well as annotated genomic sequences of Chlamydomonas species. A large number of chloroplast mutants as well as several mitochondrial mutants have been developed in C. reinhardli. (00581 The term "plant" is used broadly herein to refer to a eukaryotic organism containing plastids, particularly chloroplasts, and includes any such organism at any stage of development, or to part of a plant, including a plant cutting, a plant cell, a plant cell culture, a plant organ, a plant seed, and a plantlet. A plant cell is the structural and physiological unit of the plant, comprising a protoplast and a cell wall, A plant cell can be in the form of an isolated single cell or a cultured cell, or can be part of higher organized unit, for example, a plant tissue, plant organ, or plant, Thus, a plant cell can be a protoplast, a gamete producing cell, or a cell or collection of cells that can regenerate into a whole plant. As such, a seed, which comprises multiple plant cells and is capable of regenerating into a whole plant, is considered plant cell for purposes of this disclosure. A plant tissue or plant organ can be a seed, protoplast, callus, or any other groups of plant cells that is organized into a structural or functional unit. Particularly useful parts of a plant include harvestable parts and parts useful for propagation of progeny plants. A harvestable part of a plant can be any useful part of a plant, for example, flowers, pollen, seedlings, tubers, leaves, stems, fruit, seeds, roots, and the like. A part of a plant useful for propagation includes, for example, seeds, fruits, cuttings, seedlings, tubers, rootstocks, and the like, Vectors 100591 The vectors described herein may be capable of stable transformation of multiple photosynthetic organisms, including, but not limited to, photosynthetic bacteria (including cyanobacteria), cyanophyta, prochlorophyta, rhodophyta, chlorophyta, heterokontophyta, tribophyta, glaucophyta, chlorarachniophytes, euglenophyta, cuglenoids, haptophyta. chrysophyta, cryptophyta, cryptomonads, dinophyta, dinoflagellata, pyrmnesiophyta, bacillariophyta, 9 xanthophyta, eustigmatophyta, raphidophyta, phaeophyta, and phytoplankton. Other vectors are capable of stable transformation of C reinhardtii, D. salina, D. tertiolecta. S. dimorphus or-H. plvalis. Still other vectors are capable of stable transformation of non-photosynthetic organisms such as yeast and bacteria. Vectors for stable transformation of bacteria and yeast are well known in the art and can be obtained from commercial vendors. Expression vectors can be engineered to produce heterologous and/or homologous protein(s) of interest (e.g., antibodies, mating type agglutinins, etc.). Such vectors are useful for recombinantly producing the protein of interest. Such vectors are also useful to modify the natural phenotype of host cells (e.g., expressing a flocculation moiety). 100601 An expression cassette can be constructed in an appropriate vector. In some instances, the cassette is designed to express one or more protein-coding sequences in a host cell. Such vectors can be constructed using standard techniques known in the art, In a typical expression cassette, the promoter or regulatory element is positioned on the 5' or upstream side of a coding sequence whose expression is desired. In other cassettes, a coding sequence may be flanked by sequences which allow for expression upon insertion into a target genome (e.g., nuclear or plastid). For example, a nucleic acid encoding a flocculation moiety may be inserted into a nuclear genome of a host cell, such that the flocculation moiety expression is controlled by a naturally occurring regulatory element, In the present disclosure, any regulatory element which provides expression under appropriate conditions such that the mRNA or protein product is expressed to a level sufficient to produce flocculation of the transformed NVPO can be used. 100611 One or more additional protein coding sequences can be operatively fused downstream or 3' of a promoter. Coding sequences for single proteins can be used, as well as coding sequences for fusions of two or more proteins. Coding sequences may also contain additional elements that would allow the expressed proteins to be targeted to the cell surface and either be anchored on the cell surface or be secreted to the environment. A selectable marker is also employed in the design of the vector for efficient selection for green algae transformed by the vector. Both a selectable marker and another sequence which one desires to introduce may be introduced fused to and downstream of a single promoter. Alternatively, two protein coding sequences can be introduced, each under the control of a promoter. [00621 A regulatory element, as the term is used herein, broadly refers to a nucleotide sequence that regulates the transcription or translation of a polynucleotide or the localization of a polypeptide to which it is operatively linked. A regulatory element may be native or foreign to the nucleotide sequence encoding the polypeptide. Such elements include, but are not limited to, a ribosome binding site (RBS), a leader, a polyadenylation sequence, a pro-peptide sequence, a promoter, a signal peptide sequence, and a transcription terminator, an enhancer, an initiation (start) codon, a splicing signal for intron excision and maintenance of a correct reading frame, a STOP codon, an amber or ochre codon, and/or an internal ribosome entry site (]RES). Typically, a regulatory element includes a promoter and transcriptional and translational stop signals. Elements may be provided with linkers for the purpose of introducing specific restriction sites facilitating ligation of the control sequences with the coding region of the nucleotide sequence encoding a polypeptide. In some instances, such vectors include promoters. Additionally, a cell compartmentalization signal (i.e., a sequence that targets a polypepride to the cytosol, nucleus, chloroplast membrane or cell membrane). Such signals are well known in the art and have been widely reported (see, e.g., U.S. Pat. No, 5,776,689). Promoters useful for the present invention may come from any source (e.g., viral, bacterial, fungal, protist, animal). The promoters contemplated herein can be specific to photosynthetic organisms, non-vascular photosynthetic organisms, vascular photosynthetic organisms (e.g., algae, flowering plants), yeast and bacteria. As used herein, the term "non-vascular photosynthetic organism," refers to any macroscopic or microscopic organism, including, but not 10 limited to, algae, cyanobacteria and photosynthetic bacteria, which do not have a vascular system such as that found in higher plants. In some instances, the nucleic acids above are inserted into a vector that comprises a promoter of a photosynthetic organism, e.g., algae. The promoter can be a promoter for expression in the nucleus or in a chloroplast and/or other plastid. Examples of promoters contemplated for insertion with any of the nucleic acids herein into the chloroplast include those disclosed in US Application No. 2004/0014174. Promoters suitable for use in bacteria, include but are not limited to, promoters from Simian Virus 40 (SV40), Mouse Mammary Tumor Virus (MMTV) promoter, the HIV Long Terminal Repeat (LTR) promoter, Moloney virus, ALV, Cytomegalovirus (CMV) such as the CMV inmediate early promoter, Epstein Barr Virus (EBV), and Rous Sarcoma Virus (RSV). The promoter can be a constitutive promoter or an inducible promoter. A promoter typically includes necessary nucleic acid sequences near the start site of transcription, (e.g., a TATA element). [0063] To construct the vector, the upstream DNA sequences of a gene expressed under control of a suitable promoter may be restriction mapped and areas important for the expression of the protein characterized. The exact location of the start codon of the gene is determined and, making use of this information and the restriction map, a vector may be designed for expression of a heterologous protein by removing the region responsible for encoding the gene's protein but leaving the upstream region found to contain the genetic material responsible for control of the gene's expression. A synthetic oligonucleotide is preferably inserted in the location where the protein sequence once was, such that any additional gene could be cloned in using restriction endonuclease sites in the synthetic oligonucleotide (i.e., a multicloning site). An unrelated gene (or coding sequence) inserted at this site would then be under the control of an extant start codon and upstream regulatory region that will drive expression of the foreign (i.e., not normally present) protein encoded by this gene. Once the gene for the foreign protein is put into a cloning vector, it can be introduced into the host organism using any of several methods, some of which might be particular to the host organism. Variations on these methods are described in the general literature. Manipulation of conditions to optimize transformation for a particular host is within the skill of the art. [00641 Regarding the type of plasmid used for the insertion of the various DNA expression cassette, any convenient plasmid may be employed. The plasmids, or vectors, may include such vectors as pUC or its derivatives, pBR322, pBluescript, or pGEM. Other vectors included pPIC3.5K, pPIC9K and pAO815 available from Invitrogen (Carlsbad, CA USA). A particular plasmid is chosen based on the nature of the markers, availability of convenient restriction sites, copy number and the like. The DNA sequence encoding the polypeptide of interest may be synthetic, naturally derived, or any combination thereof. Depending upon the nature of the DNA sequence of interest, it may be desirable to synthesize the sequence with codons preferred in NVPO. The DNA sequence encoding the polypeptide of interest may be a structural gene or a portion thereof which provides for a desired expression product. The gene may be any gene, whether native, mutant of the native, or foreign to the host. The term foreign is intended to denote a gene not endogenous to the host cell, but may include indigenous sequences, such as viral sequences and bacterial sequences which are naturally associated with the NVPO. (00651 A vector utilized can also contain one or more additional nucleotide sequences that confer desirable characteristics on the vector, including, for example, sequences such as cloning sites that facilitate manipulation of the vector, regulatory elements that direct replication of the vector or transcription of nucleotide sequences contain therein, sequences that encode a selectable marker, and the like. As such, the vector can contain, for example, one or more cloning sites such as a multiple cloning sites, which can, but need not, be positioned such that a heterologous 11 polynucleotide can be inserted into the vector and operatively linked to a desired element. The vector also can contain a prokaryote origin of replication (ori), for example, an E. coli ori or a cosmid ori, thus allowing passage of the vector in a prokaryote host cell, as well as in a plant chloroplast, as desired. Such features, combined with appropriate selectable markers, allows for the vector to be "shuttled" between the target host cell and the bacterial and/or yeast cell. The ability to passage a shuttle vector in a secondary host may allow for more convenient manipulation of the features of the vector. For example, a reaction mixture containing the vector and putative inserted polynucleotides of interest can be transformed into prokaryote host cells such as E. coli, amplified and collected using routine methods, and examined to identify vectors containing an insert or construct of interest. If desired, the vector can be further manipulated, for example, by performing site directed mutagenesis of the inserted polynucleotide, then again amplifying and selecting vectors having a mutated polynucleotide of interest. A shuttle vector then can be introduced into plant cell chloroplasts, wherein a polypeptide of interest can be expressed and, if desired, isolated. 100661 A vector or other recombinant nucleic acid molecule may include a nucleotide sequence encoding a reporter polypeptide or other selectable marker, The term "selectable marker" refers to a polynucleotide (or encoded polypeptide) that confers a detectable phenotype. A reporter generally encodes a detectable polypeptide, for example, a green fluorescent protein or an enzyme such as luciferase, which, when contacted with an appropriate agent (a particular wavelength of light or luciferin, respectively) generates a signal that can be detected by eye or using appropriate instrumentation (Giacomin, Plant Sci, 16:59-72, 1996; Scikantha, J. Bacteriol. 178:121, 1996; Gerdes, FEBS Left. 389:44-47, 1996; see, also, Jefferson, EMBO J. 6:3901-3907, 1997, fl-glucuronidase). A selectable marker generally is a molecule that, when present or expressed in a cell, provides a selective advantage (or disadvantage) to the cell containing the marker, for example, the ability to grow in the presence of an agent that otherwise would kill the cell, 100671 A selectable marker can provide a means to obtain prokaryotic cells or plant cells or both that express the marker and, therefore, can be useful as a component of a vector (see, for example, Bock, supra, 200 1). Examples of selectable markers include, but are not limited to, those that confer antimetabolite resistance, for example, dihydrofolate reductase, which confers resistance to methotrexate (Reiss, Plant Physiol. (Life Sci. Adv.) 13:143-149, 1994); neomycin phosphotransferase, which confers resistance to the aminoglycosides neomycin, kanamycin and paromycin (Herrera Estrella, EMBO J. 2:987-995, 1983), hygro, which confers resistance to hygromycin (Marsh, Gene 32:481-485, 1984), trpB, which allows cells to utilize indole in place of tryptophan; hisD, which allows cells to utilize histinol in place of histidine (Hartman, Proc. Nall. Acad. Sci., USA 85:8047, 1988); mannose-6-phosphate isomerase which allows cells to utilize mannose (WO 94/20627); omithine decarboxylase, which confers resistance to the ornithine decarboxylase inhibitor, 2-(difluoromethyl)-DL-ornithine (DFMO; McConlogue, 1987, In: Current Communications in Molecular Biology, Cold Spring Harbor Laboratory ed.); and deaminase from Aspergillus terreus, which confers resistance to Blasticidin S (Tamura, Biosci. Biotechnol. Biochem. 59:2336-2338, 1995). Additional selectable markers include those that confer herbicide resistance, for example, phosphinothricin acetyltransferase gene, which confers resistance to phosphinothricin (White et al., NucL. Acids Res. 18:1062, 1990; Spencer et al., Theor. Apple. Genet. 79:625-631, 1990), a mutant EPSPV-synthase, which confers glyphosate resistance (Hinchee et al., BioTechnology 91:915-922, 1998), a mutant acetolactate synthase, which confers imidazolione or sulfonylurea resistance (Lee et al., EMBO J. 7:1241-1248, 1988), a mutant psbA, which confers resistance to atrazine (Smeda et al., Plant Physiol. 103:911-917, 1993), or a mutant protoporphyrinogen oxidase (see U.S. Pat. No. 5,767,373), or other markers conferring resistance to an herbicide such as glufosinate. Selectable markers include polynucleotides that confer dihydrofolate reductase (DHFR) or 12 neomycin resistance for eukaryotic cells and tetracycline; ampicillin resistance for prokaryotes such as E. coil; and bleomycin, gentamycin, glyphosate, hygromycin, kanamycin, methotrexate, phleomycin, phosphinotricin, spectinomycin, streptomycin, sulfonamide and sulfonylurea resistance in plants (see, for example, Maliga et al., Methods in Plant Molecular Biology, Cold Spring Harbor Laboratory Press, 1995, page 39). 100681 One or more codons of an encoding polynucleotide can be biased to reflect the preferred codon usage of the host cell, or an organelle thereof (e.g. chloroplasts). Most amino acids are encoded by two or more different (degenerate) codons, and it is well recognized that various organisms utilize certain codons in preference to others. The codon bias of C. reinhardtii has-been reported (See U.S. Application 2004/0014174) as has codon bias in bacteria and yeast (See e.g. Gene 18:199-209 (1982); FEBS Lett, 285:165-169 (1991); J. Biol. Chem., 257:3026-3031 (1982)). [00691 The term "biased," when used in reference to a codon, means that the sequence of a codon in a polynucleotide has been changed such that the codon is one that is used preferentially in the target which the bias is for, e.g., alga cells, chloroplasts, bacteria or yeast. A polynucleotide that is biased for a particular codon usage can be synthesized de novo, or can be genetically modified using routine recombinant DNA techniques, for example, by a site directed mutagenesis method, to change one or more codons such that they are biased for chloroplast codon usage. Codon bias can be variously skewed in different plants, including, for example, in alga as compared to tobacco. Generally, the codon bias selected reflects codon usage of the plant (or organelle therein) which is being transformed with the nucleic acids of the present invention. For example, where C, reinhardtii is the host, the chloroplast codon usage may be biased to reflect nuclear or chloroplast codon usage (e.g., about 74.6% AT bias in the third codon position for sequences targeting the chloroplast). Alternatively, when bacteria or yeast are used as the host organism, codon usage may be biased for those organisms. 100701 Disclosed herein are vectors employed in various flocculation methods. These vectors or plasmids may comprise regulatory elements recognized by the gene-transcription machinery of the host organism used, including for nuclear or plastid genes, coding sequences operably linked to the regulatory elements, selection markers allowing the selection for host cells transformed by the vector, and other elements allowing the vector to be stably integrated into the nuclear or plastid genome of a host organism. Examples of regulatory elements include, but are not limited to, constitutive promoters, light-inducible promoters, quorum-sensing promoters, temperature-sensitive promoters, or nitrogen-starvation responsive promoters. An example of light-inducible promoter is described in U.S. Patent No. 6858429. Examples of flocculation moieties which may be encoded by polynucleotides used in the present disclosure include, but are not limited to, FhuA, pb5, Chlamydomonas male gamete agglutinin (mt+), Chlamydomonas female gamete agglutinin (mt-), lectin, carbohydrate binding proteins, antibodies (e.g., anti-carbohydrate antibody, anti-flagella antibody, anti-FusI antibody, anti-cell surface protein antibodies). Examples of selection markers may include, but are not limited to, kanamycin, phleomycin, bleomycin, hygromycin, or zeocin. Transformation of Host Cells 10071] Transformed cells are produced by introducing homologous and/or heterologous DNA into a population of target cells and selecting the cells which have taken up the DNA. For example, transformants containing exogenous DNA with a selectable marker which confers resistance to kanamycin may be grown in an environment containing kanamycin. f00721 The basic techniques used for transformation and expression in photosynthetic organisms are similar to those commonly used for E. coli, Saccharomyces cerevisiae and other species and include calcium phosphate transfection, 13 DEAE-dextran mediated transfection, Polybrene, protoplast fusion, liposomes, direct microinjection into the nuclei, scrape loading, and electroporation.. Transformation methods customized for an NVPO, e.g., the chloroplast of a strain of algae, are known in the art. These methods have been described in a number of texts for standard molecular biological manipulation (see Packer & Glaser, 1988, "Cyanobacteria", Meth. Enzymol,, Vol. 167; Weissbach & Weissbach, 1988, "Methods for plant molecular biology," Academic Press, New York, Sambrook, Fritsch & Maniatis, 1989, "Molecular Cloning: A laboratory manual," 2nd edition Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.; and Clark M S, 1997, Plant Molecular Biology, Springer, N.Y.). These methods include, for example, biolistic devices (See, for example, Sanford, Trends In Biotech. (1988) 6: 299-302, U.S. Pat. No. 4,945,050; electroporation (Fromm et al., Proc. Nat'l. Acad. Sci. (USA) (1985) 82: 5824-5828); use of a laser beam, electroporation, microinjection or any other method capable of introducing DNA into a host cell (e.g., an NVPO). 100731 Plastid transformation is a routine and well known method for introducing a polynucleotide into a plant cell chloroplast (see U.S. Pat. Nos. 5,451,513, 5,545,817, and 5,545,818; WO 95/16783; McBride et al., Proc. ival. Acad. Sci., USA 91:7301-7305, 1994). In some embodiments, chloroplast transformation involves introducing regions of chloroplast DNA flanking a desired nucleotide sequence, allowing for homologous recombination of the exogenous DNA into the target chloroplast genome. In some instances one to 1.5 kb flanking nucleotide sequences of chloroplast genomic DNA may be used. Using this method, point mutations in the chloroplast 16S rRNA and rps12 genes, which confer resistance to spectinomycin and streptomycin, can be utilized as selectable markers for transformation (Svab et al., Proc. Natl. A cad. Sci., USA 87:8526-8530, 1990), and can result in stable homoplasmic transformants, at a frequency of approximately one per 100 bombardments of target leaves. 100741 Microprojectile mediated transfonnation also can be used to introduce a polynucleotide into a plant cell (Klein et al., Nature 327:70-73, 1987). This method utilizes microprojectiles such as gold or tungsten, which are coated with the desired polynucleotide by precipitation with calcium chloride, spermidine or polyethylene glycol. The microprojectile particles are accelerated at high speed into a plant tissue using a device such as the BIOLISTIC PD 1000 particle gun (BioRad; Hercules Calif. USA). Methods for the transformation using biolistic methods are well known in the art (see, e.g.; Christou, Trends in Plant Science 1:423-431, 1996). Microprojectile mediated transformation has been used, for example, to generate a variety of transgenic plant species, including cotton, tobacco, com, hybrid poplar and papaya. Important cereal crops such as wheat, oat, barley, sorghum and rice also have been transformed using microprojectile mediated delivery (Duan et al., Nature Biotech. 14:494-498, 1996; Shimamoto, Curr. Opin. Biotech. 5:158-162, 1994). The transformation of most dicotyledonous plants is possible with the methods described above. Transformation of monocotyledonous plants also can be transformed using, for example, biolistic methods as described above, protoplast transformation, electroporation of partially permeabilized cells, introduction of DNA using glass fibers, the glass bead agitation method, and the like. Transformation frequency may be increased by replacement of recessive rRNA or r-protein antibiotic resistance genes with a dominant selectable marker, including, but not limited to the bacterial aadA gene (Svab and Maliga, Proc. Nat!. Acad. Sci., USA 90:913-917, 1993). Flocculation Moieties 100751 To harvest a product of interest from a host cell of the present invention (e.g., an NVPO), efficient separation of the host cell from the liquid in which it is grown is often useful. Various methods of separating the organism from the liquid have been used in the past. Centrifugation, for example, has been successfully used in separating cells in small scale culture from liquid media. For large scale applications, however, which usually involve growing an 14 organism in large quantities of water (e.g., a pond, a lake, a bioreactor, etc.), centrifugation can be time-consuming and/or cost-prohibitive. Flocculation is an alternative approach to the separation of cells for large and small scale applications. Certain chemical flocculants, such as heavy metals, pose a challenge as it the metal may need to be removed from the flocculated organism for downstream processes (e.g., enzyme purification, nutriccutical production, transesterification of triglycerides, etc.). Strains of organisms (e.g., NVPOs) engineered to express flocculation moieties, on the other hand, do not present the problem of removing a dangerous, costly, or polluting flocculant from the organisms and/or the liquid environment. Thus, one novel aspect of the present disclosure is the production of an organism engineered to produce one or more flocculation moieties. 100761 The flocculation moiety can be incorporated into an organism, either photosynthetic or non-photosynthetic, by transformation with vectors, such as those described herein. Techniques involved in such processes include, but are not limited to, the development of suitable expression cassette, insertion (i.e. transformation) of the expression cassette into a host cell, and screening the host cell expressing the desired flocculation moiety. Depending on the design of the vector, the flocculation moiety can be of constitutively expressed (e.g., at all times) or can inducibly expressed (e.g., temperature-induced, quorum-induced, etc.). Engineered photosynthetic organisms capable of expressing one or more flocculation moieties can be used for flocculation with or without the addition of other compounds. For example, a non photosynthetic organisms such as E. coli can be transformed so as to produce a carbohydrate-binding protein, for example a lectin, or an antibody fused to a cell surface protein (for example LppOmpA, beta-autotransporter, etc.) such that when expressed, the fusion protein is present on the cell surface and binds to multiple organisms of interest, such as a green algae, to cause flocculation. Alternatively, a green algae such as C. reinhardtii, may be transformed to produce a carbohydrate-binding protein, for example a lectin, or an antibody fused to a cell surface protein, for example GPI, such that the fusion protein is expressed at the cell surface and binds to multiple organisms of interest, such as green algae, to cause flocculation. [00771 Alternately, one host organism (e.g., C. reinhardti) may be transformed so as to produce the FhuA protein from E. coli and a second host organism - the same or different species than the first organism - may be transformed so as to produce the TS phage tail protein, pb5. FhuA and pbS form a very stable 1:1 stoichiometric complex, thus, by combining the two transformed host cells at a desired time, or by controlling expression of the two flocculation moieties in the different strains to only express the flocculation moieties at a desired time, binding between the two rnoieties will cause flocculate via the interaction of the two moieties. [00781 A flocculating moiety will typically be expressed such that it is present on the outer surface of the host cell (e.g., cell wall and/or cell membrane). In some instances, a flocculation moiety is secreted by the host cell into the surrounding environment. Standard molecular biology techniques allow the targeting of a recombinantly expressed protein to various subeellular compartments of a host cell. Examples of such subcellular compartments include Golgi, lysosome, secretion system, cell wall or plasma membrane. Thus, in some instances, the vectors useful in the present disclosure will contain DNA sequences encoding one or more specialized polypeptides (e.g., signal peptides) that are capable of directing recombinant proteins to subcellular compartments if the signal peptide is operably linked to the recombinant protein. [00791 Candidates for genes expressing flocculation moieties can be obtained from a variety of organisms including eukaryotes, prokaryotes, or viruses, In some instances, a flocculation moiety is one member of a protein binding pair. Protein pairs forming strong protein-protein complexes are useful as flocculation moieties. Self-aggregating proteins, 15 proteins capable of forming multimeric complexes are also useful as flocculants. Carbohydrate moieties of glycoproteins (eg., arabinosyl, galactosyl, mannosyl, and rhamnosyl residues), membrane and/or cell wall carbohydrates (e.g., alginic acid, xylanes, mannanes, agarose, carrageenan, porphyran, furcelleran, etc.), proteins increasing the production of certain carbohydrates or glycolipids may also be used to induce flocculation as certain classes of carbohydrates are known components of protein complex formation. 100801 Flocculation moieties can also be recombinantly expressed in host cells and purified to a useful level (e.g., homogeneity). The purified flocculants can be added to a target cell culture to cause flocculation. Such flocculants typically will not pose the same challenges as the use of heavy metal flocculants. For example, a recombinant lectin can be produced by a host cell (e.g. secreted or produced on the surface), collected, and introduced into a culture of an organism to be flocculated. 10081] One of skill in the art will recognize that multiple types of molecules can be utilized in the practice of the present methods. Disclosed herein are various exemplary proteins, carbohydrates, antibodies, and other moieties which may be utilized as a flocculation moiety, either when expressed by a microorganism or by incorporation in the liquid culture media. These examples are meant to provide illustration of the types of molecules which can be utilized and are not intended to be limiting. |00821 Proteins, as a category, are known to bind and/or complex with other macromolecules and compounds. As such, proteins may be utilized as flocculation moieties. Carbohydrate binding proteins (e.g., lectins), for example, are one category of protein which is useful for a flocculation moiety. Carbohydrate binding proteins recognize and bind to a variety of cell surface carbohydrates, carbohydrate moieties, polysaccharide side chains of glycoproteins, glycosylated proteins, glycopeptides, and/or cell surface proteins. Thus, in one embodiment, c-type lectin is expressed on the cell wall of C. reinhardtii, which induces flocculation by binding to a glycoprotein on the surface of C. reinhardili cells. Examples of these flocculation moieties include, but are not limited to, lysophosphatidic acid, c-type lectin, Gal/GaINAc, 0-linked sugars, 0-linked polysaccharides, GlcNAc, phospholipase A2, GaINAc-SO 4 , sialic acid, glycosphingolipids, glucose monomycolate, lipoarabinomannan, phosphatidyl inositols, hexosyl- I -phosphoisoprenoids, mannosyl-phosphodolicols, a-galactosylceramide, or terminal galactoside. Examples of carbohydrate binding proteins include, but are not limited to, CD-SIGN, dectin-1, dectin-2, HECL, langerin, layilin, mincle, MMGL, E-selection, P selectin, L-selectin, DEC-205, Endo 180, mannose receptor, phospholipase A2 receptor, sialoadhesin (siglec-l), siglec 2, siglec-3, siglec-4, siglec-5, siglec-6, siglec-7, siglec-8, siglec-9, siglec-10, siglec-l 1, or galectins. 10083] Another category of proteins that may be utilized as flocculation moieties is antibodies. For example, antibodies against known cell surface antigens expressed on an organism can be used. Expression of such antibodies may lead antigen-antibody complex formation which can subsequently lead to flocculation of an organism expressing the antibody where the antibody specifically binds to a cell-surface antigen on the transformed strain, or a different strain or organism.. For example, C. reinhardtli may be transformed to inducibly express a single chain variable fragment (scFv) of an antibody, which detects an antigen on the external surface of an organism. The surface antigen may be naturally occurring on the surface of C. reinhardili or another organism or may be the result transformation of the organism to produce the cell surface antigen. The antibodies used may be univalent, multivalent, or polyvalent. Other antibodies against various glycoproteins are known in the art (See, e.g., Matsuda et. al., J. Plant, Res., 100:373 384, 1987; Musgrave ct al,, Planta, 170:328-335, 1987). The antibodies can be anchored on tIe cell surface by creating a fusion protein comprising a protein expressed at the cell surface, for example the cell membrane or cell wall, 16 Alternately, the antibody can be engineered to be secreted by the host cell into the surrounding environment to cause flocculation. Antibodies recognizing cell wall components or engineered antibodies of the host cell can be added to the media or other growth environment to induce flocculation. Antibodies known for forming stable complexes with specific epitopes can be utilized as flocculation moieties. In some instances, antibodies may be utilized which target a naturally occurring epitope. 100841 A first organism expressing such antibodies can be paired with another organism expressing the corresponding epitope so as to induce flocculation upon combination. The corresponding epitope may be naturally occurring or may be genetically engineered. Alternately, the corresponding epitope may be added to the media or other growth environment when flocculation is desired. Epitopes may be coupled to solid state supports such as beads, meshes, sieves, etc. to facilitate flocculation, Examples of antibodies useful for the present invention include, but are not limited to, anti-HA tag antibody, anti-His tag antibody, anti-Myc tag antibody, anti-AUl tag antibody, anti-GST tag antibody, anti-KT3 tag antibody, anti-MAT tag antibody, anti-MBP tag antibody, anti-S tag antibody, anti-SI tag antibody, anti SNAP tag antibody, anti-SRT tag antibody, anti-V5 tag antibody, anti-VSV-G tag antibody, anti-TAP tag antibody, and anti-Trx antibody, One of skill in the art will recognize that a single host cell may express more than one flocculation moiety from one or more categories. For example an organism may be transformed to express two different antibodies or an antibody and a carbohydrate-binding protein. [0085] In some embodiments, a flocculation moiety is an antibody to a cell surface epitope of a cell of interest. The particular cell surface epitope may be present on a cell surface protein. Examples of such proteins include, but are not limited to HRP-2, PHC21, ISG-Cl, LMR3, VSP (1, 2, 3, 4), HRP3, GPI, FAS1, FAS2, FAS3, E_GWH.1280.7.1, GAS30, MMP14, ZAP2-2, MIN1, or GOXI from C. reinhardtli and p150 from D. salina. Methods of producing antibodies to a given protein are well known in the art and may comprise culturing a photosynthetic organism; fractionating the membrane and/or cell wall portion of the microorganism; injecting the fraction to an appropriate host animal for immunization; withdrawing sera from the immunized animal; and screening, selecting and purifying one or more antibodies reacting to the fraction. Also, for example where the immunized animal is a mouse, immune cells producing the antibody of interest can be subjected to routine hybridoma formation and culture techniques to produce monoclonal antibodies of interest. In another embodiment, proteins are further purified from the membrane fraction and are utilized in high-throughput screening system as a target of phage display technique whereby DNA sequences expressing a portion of the antibody polypeptide interacting with the target are identified. Phage display techniques are known in the art. See, e.g., U.S. Pat. No. 5,855,885; McCafferty et al., Nature, 348:552-54, 1990. [00861 Another category of proteins which may be utilized as flocculation moieties include proteins which form a binding pair. This category includes, among others, proteins forming multimetic complexes and proteins forming a complex with another class of protein. For example, the E. cali protein FhuA is a monomeric iron transporter channel with a single membrane spanning domain that can be overexpressed; pbS is a T5 phage tail protein that uses FhuA as the phage receptor. The interaction between the two proteins is very stable. Such protein pairs can be utilized as flocculation moieties, For example, in one embodiment, FhuA is expressed in one strain of D. salina and pb5 is expressed in a second strain of D. sal/na. Upon combination of the two strains, flocculation occurs due to interaction of the two proteins. One of skill in the art will recognize that many other protein binding pairs cxist and can be utilized. To allow for interaction between some proteins, it may be necessary to engineer the proteins such that they are inserted into the cell membrane and/or cell wall. 17 Controlling the Timine of Flocculation [0087] Having control over the timing of flocculation may be advantageous in some instance to control flocculation. For example, by controlling the time of flocculation, an operator of a target culture system may ensure efficient use of nutrients, time of harvesting, quantity of harvested organism, and/or maximal product production. One of skill in the art will recognize that optimal conditions may vary according to multiple factors, but such determinations of culture medium preparation are routine. For flocculation moieties expressed by a given host organism, the timing of flocculation can be controlled by incorporating one or more regulatory elements (eg., promoters) into the design of an expression cassette. Such an approach may allow for expression of a flocculation moiety only at a desired time. As is apparent from the present disclosure, multiple routes are available to control timing of flocculation. Although exemplary approaches to controlling the timing of flocculation, this discussion is not meant to limit these approaches to the particular approaches mentioned herein. 100881 For expression of some flocculation moieties, regulatory elements resulting in constitutive expression can be used. Thus, the flocculation moiety under the control of such regulatory elements is expected to be produced throughout the life of the host cell. Examples of regulatory elements are 35S or 19S region of cauliflower mosaic virus (CaMV), the coat promoter of TMV, promoters of nopaline synthase, mannopine synthase, or octopine synthase of Agrobacterium, cell promoter, chalcone synthase promoter, actin promoter, adhi promoter, ubiquitin promoter, or patatin promoter. To induce flocculation, two separate strains constitutively expressing one part of a flocculation pair (e.g., antibody-antigen, protein binding pair, etc.) may be combined when flocculation is desired. In such instances, the flocculation moiety on one strain may be naturally occurring (e.g., the first strain produces a recombinant lectin which recognizes a glycoprotein on the second strain). Alternately, flocculation of a single strain may be induced by adding the second part of a flocculation pair to the culture or environment of the strain when flocculation is desired. In still another approach, host cells containing one part of a flocculation pair which is constitutively expressed may be grown in combination with another strain which expresses the second part of the flocculation pair under inducible conditions. In such instances, inducing expression of the second part of the flocculation pair in the second strain would lead to flocculation. [00891 Inducible regulatory elements may be used to control expression of a flocculation moiety. In such embodiments, the organism, for example a non-vascular photosynthetic organism, may be kept in culture without the expression of the flocculation moiety until flocculation is desired. Induction of expression maybe performed by introducing an extrinsic factor (e.g., exposed to light, where a light-inducible promoter controls expression of the flocculation moiety) or by the occurrence of a factor necessary for expression (e.g., reaching a particular cell density where a quorum-sensing promoter controls expression of a flocculation moiety). Extrinsic factors which may be used to induce expression of a flocculation moiety include, but are not limited to, chemicals, light, culture density, temperature, hormones, or nutrients. Non-limiting examples of inducible promoters responding to cell extrinsic factors which may be utilized for the present invention include: the soybean Gmbsp17.3-B heat shock promoter (Prandl et al., Plant Mol. Physiol. 31:157-62, 2004); chemically inducible promoters (e.g., IPTG/lac promoter); phosphate/phosphate starvation inducible promoter (e.g., U.S. Pat. No. 6,175,060); L-arabinose/ara B promoter; 3-p-indoylacrylic acid/Tip promoter, salicylic acid/PR-I promoter (e.g., U.S. Pat. No. 5,689,044); galactose inducible promoters such as GALl, GAL7, GAL 10 (U.S. Pat. No 5,972,664); metallmetallothionine promoter; FUSI promoter which is inducible by a pheromone (e.g., U.S. Pat. No. 5,063,154); light inducible promoters (e.g., subunit of ribulose bisphosphate carboxylase promoter, 18 see also U.S. Patent No. 6,858,429); quorum sensing promoters, which sense cell density in a liquid environment and can be utilized to automatically induce flocculation as the culture reaches a certain density (e.g., Whiteley et al., Journal ofBacteriology, 183:529-5534, 2001); a temperature sensing promoter system utilizing PL promoter has also been described (see e.g., U.S, Pat, No. 4,711,845.). One of skill in the art will recognize that one or more endogenous regulatory elements may be utilized to control expression of a flocculation moiety by, for example, including an endogenous promoter in an expression cassette or inserting a nucleic acid encoding a flocculation moiety into a target genome such that it will be controlled by a native regulatory element (e.g., homologous recombination). 100901 Another type of promoter includes nitrogen starvation induced promoters. Nitrogen starvation results in the formation of gametes in certain NVPOs, such as C reinhardii. By withdrawing nitrogen or by limiting the amount of available nitrogen, flocculation can be induced by using nitrogen starvation responsive promoters to control expression of a flocculation moiety. Mating type agglutinins, which are naturally expressed by some NVPOs under nitrogen starvation conditions may be utilized, although not normally at levels which would yield flocculation in large culture. Thus, in one embodiment, increased production (e.g., through transformation of a host strain) of one or more agglutinins may yield flocculation. Culture Conditions- Open onds and closed bioreactors 100911 For many organisms, including non-vascular photosynthetic organisms (NVPOs), routine growth can occur at room temperature on 1.5% agar, either on plates or in tubes, while active growth is typically performed in liquid culture. Optimal growth is usually between 20-25*C, though the cells can survive exposure to 35*C and may be grown at lower temperatures. Cell densities of I-5 x 10 6 cells/ml are normal in liquid, with shaking or mixing, and a typical growth rate may yield a tenfold increase in cells per day, depending on growth conditions. Long term storage of cells can be achieved by streaking them onto plates, sealing the plates with PARAFILMTM and placing them in dim light at 10-15*C. Alternatively, cells may be streaked or stabbed into agar tubes, capped and grown as above. Both methods allow storage for several months. For longer storage, the cells can be grown in liquid culture to late log phase and then made to 7% with sterile DMSO and stored at -80*C. Freezing the container in liquid nitrogen in the presence of methanol is also recommended for long term storage. [0092] NVPOs can typically be grown on a simple defined medium with light as the sole energy source. In most cases fluorescent light bulbs at a distance of 1-2 feet are adequate to supply energy for growth. Bubbling with air or 5% CO 2 may improve the growth rate. If the lights are turned on and off at regular intervals (either 12:12 or 14:10 hours of light:dark) the cells of some NVPOs can be synchronized. [00931 Because photosynthetic organisms such as algae require sunlight, CO 2 and water for growth, they can be cultivated in open ponds and lakes. Due to the fact that these are open system, they are much more vulnerable to being contaminated. One challenge with using open systems is that the NVPO of interest may not necessarily be the quickest to reproduce. This creates a problem where other species colonize the liquid environment. In addition, in open systems there is relatively less control over water temperature, CO 2 concentration and lighting conditions. These imply that the growing season is largely dependent on location and, aside from tropical areas, is limited to the warmer months. While the above are the disadvantages with "open systems", some of the benefits of this type of system are that it typically has lower production costs. [00941 Another approach is to use a semi-closed system, such as covering the pond or pool with a greenhouse. While this usually results in a smaller system, it addresses many of the problems associated with an open system. It allows 19 more species to be grown, it allows the species that are being grown to stay dominant, it extends the growing season, and if the greenhouse is heated, production can continue year round. It is also possible to increase the amount of CO 2 in these semi-closed systems, thus again increasing the rate of growth of algae. 10095] A variation of the pond system is an artificial pond e.g., a raceway pond. In these ponds, the algae, water and nutrients circulate around a "racetrack." By providing water movement, for example by the use of paddlewheels, algae are kept suspended in the water, and are circulated back to the surface on a regular frequency. Raceway ponds are usually kept shallow because the algae need to be exposed to sunlight, and sunlight can only penetrate the pond water to a limited depth. However, depth can be varied according to the wavelength(s) utilized by an organism. The ponds can be operated in a continuous manner, with CO 2 and nutrients being constantly fed to the ponds, while algae-containing water is removed at the other end. 100961 Altematively, algae could be grown in closed structures such as photobioreactors, where the environment is under stricter control than in open ponds. While the costs of setting up and operating a photobioreactor would be higher than for those for open ponds, the efficiency and higher yields from these photobioreactors could be significantly higher as well, thus offsetting the initial cost disadvantage in the medium and long run. [00971 A photobioreactor is a bioreactor that incorporates some type of light source. A pond covered with a greenhouse could also be considered a photobioreactor. Because these systems are closed everything that the algae need to grow, (carbon dioxide, water and light) need to be introduced into the system. 10098] Photobioreactors can be set up to be continually harvested (the majority of the larger cultivation systems), or by harvesting a batch at a time (like polyethlyene bag cultivation). A batch photobioreactor is set up with nutrients and algal seed, and allowed to grow until the batch is harvested. A continuous photobioreactor is harvested either continually, as daily, or more frequently. Some types of photobioreactors include glass, plastic tubes, tanks, plastic sleeves or bags. Some sources that can be used to provide the light energy required to sustain photosynthesis include fluorescent bulbs LEDs, or natural sunlight. [00991 Some of the organisms which may be used to practice the present invention are halophilic. For example, D. salina.can grow in ocean water and salt lakes (salinity from 30-300 parts per thousand) and high salinity media (e.g., artificial seawater medium, seawater nutrient agar, brackish water medium, seawater medium, etc.). In some embodiments a host cell comprising a vector described herein can be grown in a liquid environment which is 0.1, 0,2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2,1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 31., 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9, 4.0, 4.1, 4.2, 4.3 molar or higher concentrations of sodium chloride. One of skill in the art will recognize that other salts (sodium salts, calcium salts, potassium salts, etc.) may also be present in the liquid environments. [00100] Where a halophilic organism is utilized, it may be transformed with any of the vectors described herein. For example, D. salina may be transformed with a vector which is capable of insertion into the nuclear genome and which contains nucleic acids which encode a flocculation moiety (e.g., an anti-cell-surface-protein antibody, a carbohydrate binding protein, etc.). Transformed halophilic organisms may then be grown in high-saline environments (e.g., salt lakes, salt ponds, high-saline media, etc.) to produce the products (e.g., isoprenoids, fatty acids, biomass degrading enzymes, etc.) of interest. In some instances, the flocculation moiety may be non-functional under high salinity conditions, In such embodiments, flocculation may be induced by any of the methods described herein and/or by lowering the salinity (e.g, by diluting the liquid environment). Alternately, the flocculation moiety may be functional 20 under high salinity conditions and flocculation may be controlled by any of the methods described herein. Flocculation of the organisms may take place under high salinity conditions, or the liquid environment may be diluted to a lower salinity to allow binding, Isolation of any products of interest produced by the organism may involve removing a transformed organism from a high-saline environment prior to extracting the product from the organism. In instances where the product is secreted into the surrounding environment, it may be necessary to desalinate the liquid environment prior to any further processing of the product. Methods of flocculation 1001011 Provided herein are methods for flocculating a host organism. As discussed herein, flocculation moieties can be either extrinsic or intrinsic to a host organism. Extrinsic flocculation moieties may include recombinantly expressed -and purified proteins, carbohydrates, or other biological molecules capable to binding the cell surface of an NVPO, Intrinsic flocculation moieties may include naturally occurring or recombinant proteins engineered to be expressed in the transformed NVPO, other biological material, such as naturally occurring carbohydrates, lipids, or glycolipids produced at natural levels or that are produced in increased quantity due to genetic modification of the transformed. Thus, any method which allows for interaction of at least two members of a flocculation pair may be utilized. 100102] For example, flocculation may be induced by adding one part of a flocculation pair which binds to an intrinsic flocculation moiety (e.g, a lectin binding to a cell wall glycoprotein). Figure 2 provides an illustration of such an approach using a lectin. Certain steps are not shown on the illustration for simplification. To start the culture, a strain of NVPO, such as C. reinhardili, D. salina, D. tertiolecta, or H. pluvialis is obtained from culture stock. A culture , stock can be an active liquid culture, or from a frozen stockpile. Once the culture stock is introduced into culture media, the culture is expanded in small scale laboratory equipment. At this time, the culture can be monitored for its growth characteristics, health, contamination, or other measurements typically performed for ensuring correct maintenance of NVPOs. Strain phenotyping and/or genotyping can also be done at this time to confirm the identity of the strain. Small scale cultures are used as a seed culture to large scale culture. Large scale culture can be conducted in a photobioreactor, semi-closed ponds, open ponds, or lakes (not shown in figure 2). Multiple batches of small scale culture can be seeded into one large-scale culture vessel. The ratio of seeding volume to receiving volume can be determined at the time of seeding according to parameters such as optical density and growth rate of the small scale culture(s), In preparation of media for the large scale culture, autoclaving, adding nutrients to recycled media, evaluating the condition of recycled media, and measuring the pH, salt, and conductivity of the media can be performed. During the large scale culture, quality control is performed. Quality control criteria may include sampling and screening for contamination, strain divergence, growth kinetics, oxygen level, nitrogen level, salinity of the liquid, pH of the liquid media, sampling of growing cells for oil content measurement, dry weight/wet weight ratio, and optical density of the culture. In one exemplary embodiment, when flocculation is deemed appropriate, lectin is added. Lectin can be purchased, or prepared in-house. Producing recombinant lectin is known in the art. For example, methods and compositions to produce lectin in microorganisms have been described in U.S. Pat. No. 4,870,015. Recombinantly expressed lectin can be purified to homogeneity and then be added to NVPO culture to promote flocculation. In some instances, the NVPO in culture may express a naturally occurring flocculation moiety to which the lectin binds, or may be genetically modified to produce increased levels of a naturally occurring flocculation moiety or may be genetically modified to produce an exogenous flocculation moiety. Flocculants other than lectin (not shown in figure 2) can also be employed as a lone flocculant or in conjunction with lectin. After flocculation, the flocculated cellular mass of the 21 NVPO is harvested. Any of a variety of harvesting methods known in the art can be employed, ranging from sieving with a filter to a sophisticated robotic system to collect, squeeze, and compact the flocculated NVPO mass. 1001031 An alternate approach is shown in Figure 3. Certain steps are not shown on the illustration for simplification. The process presented involves use of a genetically modified organism (e.g, an NVPO) expressing one or more flocculation moieties. In Figure 3, the flocculation moiety is an antibody, for example a single chain variable fragment (scFv) antibody. Antibodies other than an scFv antibody can be applied to the method of flocculation illustrated in Figure 3. Also not shown but applicable to the illustrated steps of Figure 3 are flocculation moieties that can be polymerized. For example, an actin monomer can form an actin polymer. An expression cassette encoding an antibody is constructed and incorporated into a targeting vector appropriate for nuclear genome targeting. The expression cassette contains a regulatory element which allows the expression of the antibody. The regulatory element can be a constitutively active element which allows the antibody transcripts are made constantly in the cell. The regulatory element can be an inducible element which requires an extrinsic signal to start the transcription of the antibody. The organism is transformed using appropriate procedures. Correctly targeted cells are selected by molecular biology techniques known in the art, such as polymerase chain reaction or screening on a selectable antibiotic medium. A portion of selected cells are cryopreserved while the rest are used for starting small scale liquid culture for example as described in figure 2. When flocculation is deemed appropriate, expression of flocculation moiety is induced by providing the extrinsic induction signal. Flocculation can be incremental depending on the amount or intensity of the extrinsic induction signal. Degree of flocculation can be tied to cell density if constitutively active element is employed to express the flocculation moiety. After flocculation, the flocculated mass of NVPO is harvested. Any of a variety of harvesting methods known in the art can be employed, ranging from simple sieving technology with a filter to a sophisticated robotic system to collect, squeeze, and compact the flocculated NVPO mass. 1001041 In other instances, one part of the flocculation pair may be secreted by a genetically modified host cell and induce flocculation upon binding to the second part of the flocculation pair present on that cell or another cell. In still other instances, one member of a flocculation pair may be attached to a solid phase (e.g., a bead, a mesh, a sieve), to induce flocculation of a host strain expressing the other member of the flocculation pair. 100105] Flocculation may be induced by combining, separately grown cultures in any ratio ranging from 1:1 to 1:10 where the different cultures each express one part of a flocculation pair (two-part binding complex) or flocculation complex (three-or-more-part binding complex). A generalized approach is shown in Figure 4. Certain steps are not shown for simplification. In Figure 4, the flocculation pair is FhuA and pb5, expressed on separately grown strains and flocculation is induced by combining the strains. In this scheme, the flocculation moieties are not capable of self recognition or self-polymerization. To flocculate, as illustrated, these flocculation moieties require the presence of each other. Other flocculation moieties that form a pair or a complex can also be applied to the scheme illustrated in figure 4. The construction of expression cassette, introduction of regulatory element, incorporation into a suitable vector, transformation, selection, small to large-scale culture steps or other inventive steps are described, .upra. 1001061 Flocculation may be induced by inducibly regulating expression of one member of a flocculation pair, for example by: 1) exposing a culture from dark to light where a flocculation moiety is controlled by an inducible regulatory element; 2) increasing the culture temperature to about 26"C, 27*C, 28"C, 29*C, 30"C, 31 *C, 32"C, 34*C, 35"C, 36"C, 37*C, 39*C, 40*C, 41"C, 42*C, or 43*C for a brief period of time ranging from several seconds to several minutes to a few hours; 3) increasing the culture density to about 5 x 106, 6 x 106, 7 x 106 , 8 x 106, 9 X 106 , 1 x 101 , 2 22 x 107 ,3 x 107 , 4 x 107 5 x 107 , 6 x 101, 7 x 107, 8 x 10,9 X 107, 1 x 108, 2 x 108, 3 x 10, 4 x 10' , 5 x 10', 6 x 10' , 7 x 10', 8 x 10', 9 x 108 , I x 109 2 x l 9 , 3 x 109 ,4 x 10', 5 x 109 6 x 109, 7 x 10' , 8 x 101 , 9 x 109, 1 x 10'' 2 x 10', 3 x 10'*, 4 x 10", 5 x 10'0, 6 x 1010, 7 x 10'0, 8 x 10'0, 9 x 1010 or more cells/mil; 4) adding nitrogen, for. example in the form of nitrate, to the culture for about 15 min, 30 rmin, 45 min, 60 min, 75 min, 90 min, 105 min, 120 min, 135 min, 150 min, 165 min, 180 min, 195 min, 210 min, 225 min, 240 min, 255 min, 270 min, 285 min, 300 min, 315 min, 330 min, 345 min, 360 min, 375 min, 390 min, 405 min, 420 min, 435 min, 450 min, 465 min, 480 min, 495 min, 510 min, 525 min, 540 min, 555 min, 570 min, 585 min, 600 min, 12 hours, 18 hours, 24 hours 36 hours, 24 hours or more;and/or 5) depriving nitrogen from the culture media for about 15 min, 30 ruin, 45.min, 60 min, 75 min, 90 min, 105 min, 120 min, 135 min, 150 min, 165 min, 180 min, 195 min, 210 min, 225 min, 240 min, 255 min, 270 min, 285 min, 300 min, 315 min, 330 min, 345 ruin, 360 min, 375 min, 390 min, 405 min, 420 min, 435 min, 450 min, 465 min, 480 min, 495 min, 510 min, 525 min, 540 min, 555 min, 570 min, 585 min, 600 min, 12 hours, 18 hours, 24 hours 36 hours, 24 hours or more. [001071 An example of growing two strains in the same culture where both parts of a flocculation pair are inducibly controlled is shown in Figure 5. Certain steps are not shown on the illustration for simplification. In Figure 5, the flocculation pair comprises both mating type agglutinins, In this figure, two strains of C. reinhardti are genetically modified to express increased levels of mating type agglutinin (e.g., each strain produces one member of the flocculation pair), but under the control of the naturally occurring nitrogen-starvation responsive elements. In transformed NVPO, expressed agglutinin is targeted to broader area of cell body than to flagella to promote efficient flocculation. Targeting of agglutinin is achieved by inserting DNA sequences encoding cell wall-targeting signal peptide in the expression cassette. Induction of agglutinin is promoted by depletion of nitrogen in the culture media as the cultures grow. Optimal timing for flocculation can be altered by increasing or decreasing the amount of nitrogen. Upon reaching nitrogen starvation, the two strains will begin to increase production of their individual flocculation moiety and flocculation will occur. Recycling of media [001081 One advantage of the use of engineered and/or naturally expressed flocculation moieties, as disclosed herein, is the recycling of the liquid environment. The recycling of media (e.g., laboratory media, pond water, lake water, bioreactor contents, etc.) is economically advantageous, especially in large scale operations. For example, in a controlled circulating pond system, the liquid environment can be recycled by allowing continuous flow of the liquid while nutrients are continuously added. In another embodiment, in a closed photobioreactor system, media recycling may comprise scooping out flocculated NVPO mass; measuring the pH of the media; measuring the level of each nutrient in the liquid; adjusting nutrients to optimal level; sterilizing the liquid by autoclaving; and/or returning the media for new culture, 100109] It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Although any methods and materials similar or equivalent to those described herein can be used in the practice for testing of the present invention, specific examples of appropriate materials and methods are described herein. [001101 As used in this specification and the appended claims, the singular forms "a", "an" and "the" are to be construed to cover both singular and plural referents unless the content or context clearly dictates otherwise. Thus, for 23 example, reference to "polypeptide" includes two or more such polypeptides. The terms "comprising," "having," "including," and "containing" are to be construed as open-ended terms (i.e., meaning "including, but not limited to,") unless otherwise noted. 1001111 Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value failing within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., "such as") provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention. The headings provided in the description of the invention are included merely for convenience and are not intended to be limiting in the scope of the disclosure. 1001121 Generally, the nomenclature used herein and the laboratory procedures in cell culture, molecular genetics, molecular biology, nucleic acid chemistry, and protein chemistry described below are those well known and commonly employed by those of ordinary skill in the art. In accordance with the present invention, common recombinant DNA techniques, molecular biology techniques, molecular genetics, and microbiology techniques may be used by one of skill in the art. For example, techniques such as those described in Sambrook, Goeddel, supra, and CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, F. M. Ausubel et al., eds., Current Protocols, a joint venture between Greene Publishing Associates, Inc. and John Wiley & Sons, Inc. (1994, supplemented through 1999) (hereinafter "Ausubel"), DNA CLONING: A PRACTICAL APPROACH, Vols. 1-11 (Glover ed. 1985); Animal Cell Culture (Freshney ed. 1986) may be used for recombinant nucleic acid methods, nucleic acid synthesis, cloning methods, cell culture methods, transfection and transformation, and transgene incorporation, e.g., electroporation, injection, gene gun, impressing through the skin, and lipofection. Generally, oligonucleotide synthesis and purification steps are performed according to specifications. The techniques and procedures are generally performed according to conventional methods in the art and various general references that are provided throughout this document. The procedures therein are believed to be well known to those of ordinary skill in the art and are provided for the convenience of the reader, 100113] While certain embodiments have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby. EXAMPLES Example 1. Production of recombinant lectins in E. col |00114) Nucleic acids encoding lectins were introduced into E. coil. Transforming DNA is shown graphically in FIG. IA. In this instance, the segment labeled "Transgene I" is the gene encoding the lectins from H. pomatia, (SEQ ID NO: 1) L. culinaris, T. vu/garis, (SEQ ID NO: 2) or C. ensifonris. The segment labeled "5'UTR" is the T7 promoter and the segment labeled "3'UTR" is the T7 terminator. A metal affinity tag (MAT), Tobacco etch virus (TEV) protease cleavage site, and a Flag epitope are engineered on the 3' end of the gene to facilitate characterization and visualization 24 studies. All DNA manipulations carried out in the construction of this transforming DNA were essentially as described by Sambrook et al., Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press 1989) and Cohen et al,, Meth. Enzymol. 297, 192-208, 1998. [001151 The transforming DNA was introduced into BL21(DE3) pLysS competent cells (Invitrogen) according to the manufacturer's instnctions. Briefly, colonies were lysed by BugBuster Protein Extraction Reagent (Novagen) and MAT-tagged proteins were separated using MagneHis Ni-particles (Promega), according to the manufacturer's instructions. Colonies were cultured in 5 mL of Luria Broth (LB) in the presence of 50 Rg/mL kanamycin. 100 pL of the culture at O.D.w = I was centrifuged and the supernatant was removed, The pellets were lysed by resuspending the cells in 50 pl of IX SDS sample buffer with reducing agent (BioRad). Samples were then boiled and run on a 10% Bis tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent substrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). [001161 To determine the activity of the recombinant lectins, 4 L of each strain were grown and harvested by centrifugation at 5000 x g for 15 minutes. All subsequent manipulations are performed at 4*C and in the presence of protease inhibitors. The pellet was resuspended in 35 mL Ix Tris Buffered Saline (TBS) and sonicated at 30% power using a macrotip for 3 cycles of 30 seconds. The solution was then centrifuged at 30,000 x g for 30 minutes to remove the unlysed cells. The supernatant was transferred and I mL Ni-NTA resin (Qiagen) applied for I hour. The resin was collected, washed with 30 column volumes of Ix Tris Buffered Saline (TBS) and eluted with 5 mL TBS and 400 mM imidazole pH 7.5. The eluate was then concentrated to a final concentration of 5 mg/mL using Amicon Ultra-15 Centrifugal Filter Units (Millipore). Purified protein was then conjugated to FTTC (fluorescein isothiocyanate) using a FITC labeling kit (Thermo Scientific) according to the manufacturer's instructions. Chlamydomonas reinhard/fi and Scenedesmus dimorphus cells were then mixed with the FITC labeled protein to show activity. Results from several representative lectins are shown in FIG 6. Example 2. Production of Scaffold-lectin fusions in E. coli 100117] Nucleic acids encoding lectins from H. pomatia and L. culinaris were fused to scaffold proteins lipoprotein outer membrane protein A hybrid (Lpp-OmpA) or the p-autotransporter from Neisseria gonorrhoea (SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5) and introduced into E. coll. Transforming DNA is shown graphically in FIG. IB. In this instance the segment labeled "Transgene I" is the gene encoding the lectin from H. ponatia. The segment labeled "Transgcne 2" is the gene encoding the lectin from L. culinaris. The segment labeled "5'UTR" is the T7 promoter, the segment labeled "3'UTR" is the T7 terminator, the segment labeled "Scaffold I" is Lpp-OmpA, and the segment labeled "Scaffold 2" is the p-autotransporter. A metal affinity tag (MAT) Tobacco etch virus (TEV) protease cleavage site, and a Flag epitope were engineered between the transgene and the scaffold. All DNA manipulations carried out in the construction of this transforming DNA were essentially as described by Sambrook et al., Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press 1989) and Cohen et al., Meth. Enzymo/. 297, 192-208, 1998. 25 [001181 The transforming DNA was introduced into BL21(DE3) pLysS competent cells (Invitrogen) according to the manufacturer's instructions. Briefly, colonies were lysed by BugBuster Protein Extraction Reagent (Novagen) and MAT-tagged proteins were separated using MagneHis Ni-particles (Promega), according to manufacturer's instructions. Colonies were cultured in 5 mL of Luria Broth (LB) in the presence of 50 pg/mL kanamycin. 100 pL of the culture at 0.D-600 = I was centrifuged and the supernatant was removed. The pellets were lysed by resuspending cells in 50 pl of IX SDS sample buffer with reducing agent (BioRad). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent subrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). 100119] To determine whether the lectin-scaffold fusion is properly inserted in the plasma membrane, membrane isolations were performed. 25 mLs of a culture of at O.D600 = 1 were centrifuged at 5000 x g for 10 minutes. All subsequent manipulations were performed at 4*C and in the presence of protease inhibitors. The pellet was resuspended in 3 mL lx Tris Buffered Saline (TBS) and sonicated at 30% power using a macrotip for 3 cycles of 10 seconds. The solution was then centrifuged at 30,000 x g for 30 minutes to removed the unlysed cells. I mL of the supernatant (mixture of membranes and cytosolic proteins) was carefully removed and centrifuged at 540,000 x g in a TLA100.3 rotor (Beckman) for 20 minutes to separate the insoluble (membranes) from the soluble (cytosolic proteins). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent substrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). Results are shown in FIG 8. 1001201 In order to characterize the activity of the cell surface displayed sugar-binding protein, sedimentation experiments were employed. The E. col transformed to produce a fusion protein composed of the lectin from L. culinaris and the scaffold protein p-autotransporter was grown to an O.D.6= 1.6. The culture was centrifuged and the pellet was resuspended to an O.D.6w = 30 using TAP media. Varying amounts of culture (0 uL, 5 uL, 10 uL, 20 uL, 40 uL, 100 uL, 250 uL, and 500 uL corresponding to a final O.D.
6 oo = 0, 0.02, 0.04, 0.08, 0.160, 0.400, 1.00, 2.00) were added to 7 mL of S. dimorphus grown in TAP media. 500 uL of BL21(DE3) was added to 7 mL of S. dinorphus as a negative control. The mixtures were shaken gently for 30 minutes before settling. Photos (Fig. 8) were taken at time points 0 and 90 minutes to visualize the activity. Example 3. Production of Scaffold-scFv fusions in E. coli 100121] A single chain variable fragment (scFv) antibody to algal surface antigens were fused to scaffold proteins lipoprotein-outer membrane protein A hybrid (Lpp-OmpA) introduced into E. coli (SEQ ID NO. 16). Transforming DNA is shown graphically in FIG. IC. In this instance the segment labeled "Transgene I" is the gene encoding scFv5. The segment labeled "5'UTR" is the T7 promoter, the segment labeled "3'UTR" is the T7 terminator, the segment 26 labeled "Scaffold 1" is Lpp-OmpA. A metal affinity tag (MAT), Tobacco etch virus (TEV) protease cleavage site, and a Flag epitope were engineered between the scaffold and the transgene. All DNA manipulations carried out in the construction of this transforming DNA were essentially as described by Sambrook et al., Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press 1989) and Cohen et al., Meth. Enzymol. 297, 192-208, 1998. 1001221 The transforming DNA was introduced into BL21(DE3) pLysS competent cells (Invitrogen) according to the manufacturer's instructions. Briefly, colonies were lysed by BugBuster Protein Extraction Reagent (Novagen) and MAT-tagged proteins were separated using MagneHis Ni-particles (Promega), according to manufacturer's instructions. Colonies were cultured in 5 mL of Luria Broth (LB) in the presence of 50 pg/mL Kanamycin, 100 L of the culture at
O.D,
6 0 = 1 was centrifuged and the supernatant was removed. The pellets were lysed by resuspending cells in 50 p 1 of IX SDS sample buffer with reducing agent (BioRad). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent substrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). [00123] To determine whether the LppOmpA-scFv fusion is properly inserted in the plasma membrane, membrane isolations were performed. 25 mLs of a culture of at O.D.6 = I were centrifuged at 5000 x g for 10 minutes. All subsequent manipulations were performed at 4*C and in the presence of protease inhibitors. The pellet was resuspended in 3 mL Ix Tris Buffered Saline (TBS) and sonicatcd at 30% power using a macrotip for 3 cycles of 10 seconds. The solution was then centrifuged at 30,000 x g for 30 minutes to remove the unlysed cells. I mL of the supernatant (mixture of membranes and cytosolic proteins) was carefully removed and centrifuged at 540,000 x g in a TLA 100.3 rotor (Beckman) for 20 minutes to separate the insoluble (membranes) from the soluble (cytosolic proteins). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent substrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). Results from a representative fusion construct LppOmpA-scFv5 are shown in FIG 9. Example 4. Production of secreted, recombinant lectins in 'P. pastoris [001241 Nucleic acids encoding lectins such as those from H. pomatia, L. culinaris, T. vulgaris and C. ensiformis can be introduced into P. pastoris, Transforming DNA is shown graphically in FIG, IA. In this instance the segment labeled "Transgene 1" is the gene encoding the lectins from H. pomatia, (SEQ ID NO: 1) L. or vulgaris, (SEQ ID NO: 2). The segment labeled "5'UTR" is the AOXI promoter and the segment labeled "3'UTR" is the AOX I terminator. A metal affinity tag (MAT), Tobacco etch virus (TEV) protease cleavage site, and a Flag epitope are engineered on the 3' end of the gene to facilitate characterization and visualization studies. All DNA manipulations were carried out in the 27 construction of this transforming DNA were essentially as described by Sambrook et al., Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press 1989) and Cohen et al., Meth. Enzymol. 297, 192-208, 1998. [001251 The transforming DNA was cloned into the pPIC9K vector (Invitrogen), thereby introducing the alpha-factor signal peptide at the 5' end to facilitate secretion, and was introduced into GSI 15 competent cells (Invitrogen) according to the manufacturer's instructions. To determine whether the recombinant lectins are expressed, I L of each strain was grown centrifuged at 5000 x g for 15 minutes. All subsequent manipulations were performed at 4"C and in the presence of protease inhibitors. I mL Ni-NTA resin (Qiagen) was applied to the spent media for I hour. The resin was collected, washed with 30 column volumes of Ix Tris Buffered Saline (TBS) and cluted with 5 mL TBS and 400 mM imidazole pH 7.5. The cluate was then concentrated to a final concentration of 5 mg/mL using Amicon Ultra- 15 Centrifugal Filter Units (Millipore). Representative lectins secreted by P. pastoris are labeled and shown in FIG. 10. Example 5. Production of Scaffold-lectin fusions in P. pastoris [00126] Nucleic acids encoding lectins from H, pomatia, L. culinaris, and T. vulgaris were fused to scaffold proteins such as the S. cerevisiae Pirl a, (SEQ ID NO: 6; SEQ ID NO: 7) Pirlb (SEQ ID NO: 8), the flocculin Flo lp, and the agglutinin protein Aga] p. All fusions, except those with Flo Ip, are an N-terminal fusion placing the lectin 5' of the scaffold. A metal affinity tag (MAT), Tobacco etch virus (TEV) protease cleavage site, and a Flag epitope were engineered in the linker between the two genes to facilitate characterization and visualization studies. Transforming DNA is shown graphically in FIG. IB. In this example, the segment labeled "Transgene I" is the gene encoding the lectin from H. pomatia. The segment labeled "Transgene 2" is the gene encoding the lectin from L. culinaris. The segment labeled "5'UTR" is the AOXI promoter, the segment labeled "3'UTR" is the AOXI terminator, the segment labeled "Scaffold I" is Pirla, Pirlb, or Agalp, and the segment labeled "Scaffold 2" is the Flolp. All DNA manipulations carried out in the construction of this transforming DNA were essentially as described by Sambrook et al., Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press 1989) and Cohen et al., Meth. Enzymol. 297, 192-208, 1998. 100127] The transforming DNA was cloned into the pPIC9K vector (Invitrogen), thereby introducing the alpha-factor signal peptide at the 5' end to facilitate secretion, and was introduced into GSI 15 competent cells (Invitrogen) according to the manufacturer's instructions. Colonies were screened for expression according to the manufacturer's instructions. Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent subrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). Representative data showing Pirl b-H. pomitia lectin (1), Pirlb-L. culinaris lectin (2), and Pirla- T. vulgaris lectin (3) from expression studies is shown in FIG 11. 1001281 To determine whether the lectin-scaffold fusion is properly inserted in the plasma membrane, membrane isolations were performed. 25 mLs of a culture of at O.D.No= I were centrifuged at 5000 x g for 10 minutes. All subsequent manipulations were performed at 4*C and in the presence of protease inhibitors. The pellet was resuspended in 3 mL Ix Tris Buffered Saline (TBS) and sonicated at 30% power using a macrotip for 3 cycles of 10 seconds. The solution was then centrifuged at 30,000 x g for 30 minutes to remove the unlysed cells. I mL of the supernatant 28 (mixture of membranes and cytosolic proteins) was carefully removed and centrifuged at 540,000 x g in a TLA100.3 rotor (Beckman) for 20 minutes to separate the insoluble (membranes) from the soluble (cytosolic proteins). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse and-FLAG antibody horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent substrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech), Results from a representative fusion construct, Pirla-T. vulgaris lectin fusion, is shown in FIG 12. Example 6. Nuclear transformation of C reinhardfii with a nucleic acid encoding a fused resistance marker and gene encoding a lectin-Fasl fusion protein. 1001291 A nucleic acid encoding a lectin fromL. culinaris, truncated L cuinaris, and E. cristagalli fused to FasI from C. reinhardili was introduced into C. reinhardili (SEQ ID NO, 9; SEQ ID NO. 10; SEQ ID NO, I1). Transforming DNA is shown graphically in FIG. I D. The segment labeled "Transgene" is lectin-Fas I encoding gene, the segment labeled "5' UTR" is the C. reinhardili HSP70 / rbcS2 5' UTR with introns, the segment labeled "Selection Marker" is a bleomycin resistance gene, the segment labeled CM (cleavage moiety) is the 2A viral protease of foot and mouth disease virus (FMDV), the segment labeled "Targeting Signal" is a signal peptide targeting the protein for cell surface display, the segment labeled "Anchoring Domain" is a glycosylphosphatidylinositol(GPI)-anchoring domain to covalently link the lectin-FasI protein to the cell surface, and the segment labeled 3' UTR is the 3'UTR from C. reinhardili rbcS2. The bleomycin resistance gene, 2A and lectin-Fasi coding regions are physically linked in-frame, resulting in a chimeric single ORE, A Metal Affinity Tag (MAT), Tobacco etch virus (TEV) protease cleavage site, and FLAG epitope were engineered in the junction between the lectin and Fas I using standard techniques. All DNA manipulations carried out in the construction of this transforming DNA were essentially as described by Sambrook et al., Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press 1989) and Cohen et al., Meth. Enzymol, 297, 192-208, 1998. (00130J For these experiments, all transformations were carried out on C. reinhardfil strain 2 lgr. Cells were grown and transformed via electroporation. Cells were grown to mid-log phase (approximately 2-6 x 10' cells/ml). Tween-20 was added into cell cultures to a concentration of 0.05% before harvest to prevent cells from sticking to centrifugation tubes. Cells were spun down gently (between 2000 and 5000 x g) for 5 min. The supernatant was removed and cells resuspended in TAP+40 mM sucrose media. 1 to 2 ug of transforming DNA was mixed with ~ I x 103 cells on ice and transferred to electroporation cuvettes. Electroporation was performed with the capacitance set at 25 uF, the voltage at 800 V to deliver V/cm of 2000 and a time constant for 10-14 ms. Following electroporation, the cuvette was returned to room temperature for 5-20 min. Cells were transferred to 10 ml of TAP+40 mM sucrose and allowed to recover at room temperature for 12-16 hours with continuous shaking. Cells were then harvested by centrifugation at between 2000 x g and 5000 x g and resuspended in 0.5 ml TAP+40 mM sucrose medium. 0.25 ml of cells was plated on TAP + 20 ug/ml bleomycin. All transformations were carried out under bleomycin selection (20 sg/ml) in which resistance was conferred by the gene encoded by the segment in FIG. ID labeled "Selection Marker," Transformed strains are maintained in the presence of bleomycin to prevent loss of the exogenous DNA. 29 1001311 Colonies growing in the presence of bleomycin were screened by dot blot. Briefly, colonies were lysed by BugBuster Protein Extraction Reagent (Novagen) and MAT-tagged proteins were separated using MagneHis Ni particles (Promega), according to the manufacturer's instructions. After exposure to the proteins, the beads were washed three times by 150 pl of IX Tris Buffered Saline with 0.05% Tween-20 (TBST) at room temperature. Proteins were released from beads by 150 pl 20 pM EDTA, 25 mM Tris-HCI pH 7.0,400 mM NaCl, and the 150 pl eluates were dot blotted onto nitrocellulose membranes. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent substrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). Colonies showing positive results in the dot blot analysis were then screened by westem blotting. 1001321 Patches of algae cells growing on TAP agar plates were lysed by resuspending cells in 50 p1 of IX SDS sample buffer with reducing agent (BioRad). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent subrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). Results from three strains are shown in FIG. 13. [00133] To determine whether the lectin-Fasl fusion was properly inserted in the plasma membrane in an orientation where the lectin is externally presented, membrane isolations were performed, 100 mL of a culture of a minimum I x 101 cells/mL were centrifuged at 5000 x g for 10 minutes. All subsequent manipulations were performed at 4*C and in the presence of protease inhibitors. The pellet was resuspended in 3 mL Ix Tris Buffered Saline (TBS) and sonicated at 30% power using a macrotip for 3 cycles of 10 seconds. The solution was then centrifuged at 30,000 x g for 30 minutes to remove the unlysed cells, I mL of the supernatant (mixture of membranes and cytosolic proteins) was carefully removed and centrifuged at 540,000 x g in a TLA 100.3 rotor (Beckman) for 20 minutes to separate the insoluble (membranes) from the soluble (cytosolic proteins). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent subrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech), Results from several fusion constructs arc shown in FIG 14. As expected from the mode of membrane anchoring, there still exists a significant amount of protein in the cytosolic/soluble fraction. However, there is also protein in the membrane fraction. The effect of the presence of the Fasl -E. cristagalli lectin fusion protein construct on settling can be seen in Fig. 15. 30 Example 7. Nuclear transformation of C. reinhardili with a nucleic acid encoding a fused resistance marker and gene encoding a GPI-lectin fusion protein. [001341 A nucleic acid encoding a lectin from H. pomalia and L. culinaris fused to GP I from C. reinhardrii was introduced into C. reinhardii (SEQ ID NO. 12; SEQ ID NO. 13). Transforming DNA is shown graphically in FIG. I E. The segment labeled "Transgene" is lectin-GPI encoding gene, the segment labeled "Promoter/ 5' UTR" is the C. reinhardrii HSP70 / rbcS2 5' UTR with introns, the segment labeled "Selectable Marker" is a bleomycin resistance gene, the segment labeled CM (cleavage moiety) is the 2A viral protease of foot and mouth disease virus (FMDV), the segment labeled "Targeting Signal" is a signal peptide targeting the protein for cell surface display, and the segment labeled 3' UTR is the 3'UTR from C. reinhardiii rbcS2. The bleomycin resistance gene, 2A and GPI-lectin coding regions are physically linked in-frame, resulting in a chimeric single ORF. A Metal Affinity Tag (MAT), Tabbacco etch virus (TEV) protease cleavage site, and FLAG epitope are engineered in the junction between the lectin and GPI using standard techniques. Another Flag epitope is encoded at the 3' end of the transgcne. All DNA manipulations carried out in the construction of this transforming DNA were essentially as described by Sambrook et al., Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press 1989) and Cohen et al., Meth. Enzymol. 297, 192 208, 1998. 100135[ For these experiments, all transformations were carried out on C. reinhardtli strain 21 gr. Cells were grown and transformed via electroporation. Cells were grown to mid-log phase (approximately 2-6 x 1O cells/ml). Tween-20 was added into cell cultures to a concentration of 0.05% before harvest to prevent cells from sticking to centri fugation tubes. Cells were spun down gently (between 2000 and 5000 x g) for 5 min. The supernatant was removed and the cells resuspended in TAP+40 mM sucrose media, I to 2 ug of transforming DNA was mixed with- I x 10 cells on ice and transferred to electroporation cuvettes. Electroporation was performed with the capacitance set at 25 uF, the voltage at 800 V to deliver V/cm of 2000 and a time constant for 10-14 ins, Following electroporation, the cuvette was returned to room temperature for 5-20 min. Cells were transferred to 10 ml of TAP+40 mM sucrose and allowed to recover at room temperature for 12-16 hours with continuous shaking. Cells were then harvested by centrifugation at between 2000g and 5000g and resuspended in 0.5 ml TAP+40 mM sucrose medium. 0.25 ml of cells were plated on TAP + 20 ug/ml bleomycin. All transformations were carried out under bleomycin selection (20 pg/ml) in which resistance was conferred by the gene encoded by the segment in FIG. I E labeled "Selection Marker," Transformed strains are maintained in the presence of bleomycin to prevent loss of the exogenous DNA. 1001361 Colonies growing in the presence of bleomycin were screened by dot blot. Briefly, colonies were lysed by BugBuster Protein Extraction Reagent (Novagen) and MAT-tagged proteins were separated using MagneHis Ni particles (Promega), according to manufacturer's instructions. After exposure to the proteins, the beads were washed three times by 150 pl of IX Tris Buffered Saline with 0.05% Tween-20 (TBST) at room temperature. Proteins were released from beads by 150 pIl 10 pM EDTA, 25 mM Tris-HCI pH 7.0, 400 mM NaCl, and the 150 pl eluates were dot blotted onto nitrocellulose membranes. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent substrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). Colonies showing positive results in the dot blot analysis are then screened by western blotting. 31 [001371 Patches of algae cells growing on TAP agar plates were lysed by resuspending cells in 50 pl of IX SDS sample buffer with reducing agent (BioRad). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent subrate (Thermo Scientific) and imaged using a CCD camera (Alpha innotech). A small amount of intact fusion (Bleomycin resistance marker fused to GPI-lectin) is translated by the cells; as the resistance marker forms a dimcr, these products migrate at a higher molecular weight. FIG. 16. indicates that GPl -lectin fusions involving lectins from H. pomatia and L. culinaris were produced in C. reinhardiii. 1001381 To determine whether the lectin-GPI fusion is properly inserted in the plasma membrane in an orientation where the lectin is externally presented, membrane isolations were performed. 100 mL of a culture of at minimum I x 107 cells/mL were centrifuged at 5000 x g for 10 minutes. All subsequent manipulations were performed at 4*C and in the presence of protease inhibitors. The pellet was resuspended in 3 mL lx Tris Buffered Saline (TBS) 2M urea and sonicated at 30% power using a macrotip for 3 cycles of 10 seconds. The solution was then centrifuged at 30,000 x g for 30 minutes to remove the unlysed cells. I mL of the supernatant (mixture of membranes and cytosolic proteins) was carefully removed and centrifuged at 540,000 x g in a TLA100.3 rotor (Beckman) for 20 minutes to separate the insoluble (membranes) from the soluble (cytosolic proteins). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) in the presence of 2M urea and transferred to PVDF membranes using a Trans-blot semi dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent subrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). The results shown in FIG. 17. demonstrate the presence of OP I-H. polncia lectin in the membrane fraction. The effect of the presence of the GPI- Hpomatia lectin construct on settling can be seen in Fig 18. Example 8. Nuclear transformation of C. reinhardii with a nucleic acid encoding a fused resistance marker and gene encoding a FasI-scFv fusion protein. 1001391 A nucleic acid encoding an antibody/single chain variable fragment (scFv5) fused to Fast was introduced into C. reinhardiii (SEQ ID NO. 14). Transforming DNA is shown graphically in FIG. I D. The segment labeled "Transgene" is scFv5-Fas I encoding gene, the segment labeled "Promoter/ 5' UTR" is the C. reinhardtil HSP70/ rbcS2 5' UTR with introns, the segment labeled "Selectable Marker" is a bleomycin resistance gene, the segment labeled CM (cleavage moiety) is the 2A viral protease of foot and mouth disease virus (FMDV), the segment labeled "Targeting Signal" is a signal peptide targeting the protein for cell surface display, the segment labeled "Anchoring Domain" is a glycosylphosphatidylinositol(GPI)-anchoring domain to covalently link the scFv-Fasl protein to the cell surface, and the segment labeled 3' UTR is the 3'UTR from C. reinhardrii rbcS2. The bleomycin resistance gene, 2A and lectin-FasI coding regions are physically linked in-frame, resulting in a chimeric single ORF. A Metal Affinity Tag (MAT), Tobacco Etch Virus (TEV) protease cleavage site, and a FLAG epitope tag are engineered in the junction between the scFv5 and Fasl using standard techniques. All DNA manipulations carried out in the construction of this 32 transforming DNA were essentially as described by Sambrook et al., Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press 1989) and Cohen et al., Meth. Enzymol. 297, 192-208, 1998. 100140] For these experiments, all transformations were carried out on C reinhardil strain 2lgr. Cells were grown and transformed via electroporation, Cells were grown to mid-log phase (approximately 2-6 x 106cells/ml). Tween-20 was added into cell cultures to a concentration of 0.05% before harvest to prevent cells from sticking to centrifugation tubes. Cells were down gently (between 2000 and 5000 x g) for 5 min. The supernatant was removed and cells resuspended in TAP+40 mM sucrose media, I to 2 ug of transforming DNA was mixed with - I x 10' cells on ice and transferred to electroporation cuvettes. Electroporation was performed with the capacitance set at 25 uF, the voltage at 800 V to deliver V/cm of 2000 and a time constant for 10-14 ms, Following electroporation, the cuvette was returned to room temperature for 5-20 min. Cells were transferred to 10 ml of TAP+40 mM sucrose and allowed to recover at room temperature for 12-16 hours with continuous shaking. Cells were then harvested by centrifugation at between 2000g and 50OOg and resuspended in 0,5 ml TAP+40 mM sucrose medium. 0.25 ml of cells were plated on TAP + 20 ug/ml bleomycin. All transformations were carried out under bleomycin selection (20 pg/ml) in which resistance was conferred by the gene encoded by the segment in FIG. I D labeled "Selection Marker." Transformed strains are maintained in the presence of bleomycin to prevent loss of the exogenous DNA. [001411 Colonies growing in the presence of bleomycin were screened by dot blot. Briefly, colonies were lysed by BugBuster Protein Extraction Reagent (Novagen) and MAT-tagged proteins were separated using MagneHis Ni particles (Promega), according to manufacturer's instructions. After exposure to the proteins, the beads were washed three times by 150 p1 of IX Tris Buffered Saline with 0.05% Tween-20 (TBST) at room temperature. Proteins were released from beads by 150 pl 10 pM EDTA, 25 mM Tris-HCI pH 7.0, 400 mM NaCl, and the 150 pl eluates were dot' blotted onto nitrocellulose membranes. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent subrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). Colonies showing positive results in the dot blot analysis were then screened by western blotting. 1001421 Patches of algae cells growing on TAP agar plates were lysed by resuspending cells in 50 p) of IX SDS sample buffer with reducing agent (BioRad). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to manufacturers instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent subrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). Results from I colony (and wild-type control) are shown in FIG 19. A small amount of intact fusion (Bleomycin resistance marker fused to scFv5-Fasl) is translated by the cells; as the resistance marker forms a dimer, these products migrate at a higher molecular weight. The results indicate that scFv-FasI fusion protein is being produced from the strains. 100143] To determine whether the scFv5-FasI fusion is properly inserted in the plasma membrane in an orientation where it is externally presented, membrane isolations were performed. 100 mL of a culture of at minimum I x 107 cells/mL were centrifuged at 5000 x g for 10 minutes. All subsequent manipulations were performed at 44C and in the presence of protease inhibitors. The pellet was resuspended in 3 mL I x Tris Buffered Saline (TBS) and sonicated at 33 30% power using a macrotip for 3 cycles of 10 seconds. The solution was then centrifuged at 30,000 x g for 30 minutes to remove the unlysed cells. I mL of the supernatant (mixture of membranes and cytosolic proteins) was carefully removed and centrifuged at 540,000 x g in a TLA 100.3 for 20 minutes to separate the insoluble (membranes) from the soluble (cytosolic proteins). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent subrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). Results from a scFv FasI membrane isolation are shown in FIG 20. Example 9. Nitrate-inducible expression of a flocculation moiety in C. reinhardlii. 1001441 In this example, a nucleic acid encoding a lectin from H. pomatia was introduced into C. reinhardii (SEQ ID NO. 15). Transforming DNA is shown graphically in FIG. IF. The segment labeled "Transgene" is lectin-encoding gene, the segment labeled "5' UTR" is the C. reinhardtii nitrate reductase 5' UTR, the segment labeled "Selectable Marker" is the nitrate reductase gene, the segment labeled CM (cleavage moiety) is the 2A viral protease of foot and mouth disease virus (FMDV), and the segment labeled 3' UTR is the 3'UTR from C. reinhardtii nitrate reductase. Nitrate reductase, 2A and H. pomatia lectin coding regions are physically linked in-frame, resulting in a chimeric single ORF. A Metal Affinity Tag (MAT), Tobacco Etch Virus (TEV) protease cleavage site, and FLAG epitope are engineered at the 3' end of the lectin using standard techniques. All DNA manipulations carried out in the construction of this transforming DNA were essentially as. described by Sambrook et al., Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press 1989) and Cohen et al., Meth. Enzymol. 297, 192-208, 1998. [001451 For these experiments, all transformations were carried out on C. reinhardil strain Niti-305, deficient in functional nitrate reductase, from the Chlamydomonas center. Cells were grown and transformed via electroporation. Cells were grown to mid-log phase (approximately 2-6 x 106 cells/ml). Tween-20 was added into cell cultures to a concentration of 0.05% before harvest to prevent cells from sticking to centrifugation tubes. Cells were spun down gently (between 2000 and 5000 x g) for 5 min. The supernatant was removed and cells resuspended in TAP+40 mM sucrose media. I to 2 ug of transforming DNA was mixed with - I x 108 cells on ice and transferred to electroporation cuvettes. Electroporation was performed with the capacitance set at 25 uF, the voltage at 800 V to deliver V/cm of 2000 and a time constant for 10-14 ms. Following electroporation, the cuvette was returned to room temperature for 5 20 min. Cells were transferred to 10 ml of TAP+40 mM sucrose and allowed to recover at room temperature for 12-16 hours with continuous shaking. Cells were then harvested by centrifugation at between 2000g and 50OOg and resuspended in 0.5 ml TAP+40 mM sucrose medium. 0.25 ml of cells were plated on TAP -NH 4 CI, +7.4 mM KNO 3 . All transformations were carried out in the presence of 7.4 mM KNO3 in which the ability to utilize NO 3 as the sole nitrogen source is conferred by nitrate reductase. Transfonned strains are maintained in the presence of KNO 3 to prevent loss of the exogenous DNA. 100146] Colonies growing in TAP-NH 4 CI, + 7.4 mM KNO 3 were screened by dot blot. Briefly, colonies were lysed by BugBuster Protein Extraction Reagent (Novagen) and MAT-tagged proteins were separated using MagneHis Ni particles (Promega), according to manufacturer's instructions. After exposure to the proteins, the beads were washed 34 three times by 150 p of IX Tris Buffered Saline with 0.05% Tween-20 (TBST) at room temperature. Proteins were released from beads by 150 p1 20 pM EDTA, 25 mM Tris-HCI pH 7.0,400 mM NaCl, and the 150 p1 eluates were dot blotted onto nitrocellulose membranes. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent substrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). Colonies showing positive results in the dot blot analysis were then screened by western blotting. 100147] Patches of algae cells growing on TAP agar plates were lysed by resuspending cells in 50 1l of I X SDS sample buffer with reducing agent (BioRad). Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi-dry blotter (BioRad) according to manufacturers instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer. After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent substrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). 1001481 In order to characterize the inducibility of expression, 50 mL of the Nit-2A-H. pomatia lectin strain was grown in TAP media under light. Once the density of the cell culture reached I x 106 cells/mL, the culture was divided into two 25 mL samples. Each was centrifuged at 5000 x g for 10 minutes. The supernatant was removed and one sample was resuspended in 25 mL TAP. The other sample was resuspended in 25 mL TAP -NH4CI + 7.4 mM KNO3. 20 x 106 cells were centrifuged and frozen at time points 0, 12 hrs, and 24 hrs. These samples were processed and MAT tagged proteins were separated using MagneHis Ni-particles (Promega), according to manufacturer's instructions. After exposure to the proteins, the beads were washed three times by 150 p] of I X Tris Buffered Saline with 0.05% Tween-20 (TBST) at room temperature. Proteins were released from beads by 150 III 20 pM EDTA, 25 mM Tris-HCI pH 7.0, 400 mM NaCl. 50 uL of 4X SDS sample buffer with reducing agent (BioRad) was added, Samples were then boiled and run on a 10% Bis-tris polyacrylamide gel (BioRad) and transferred to PVDF membranes using a Trans-blot semi dry blotter (BioRad) according to the manufacturer's instructions. Membranes were blocked by Starting Block (TBS) blocking buffer (Thermo Scientific) and probed for one hour with mouse anti-FLAG antibody-horseradish peroxidase conjugate (Sigma) diluted 1:3000 in Starting Block buffer, After probing, membranes were washed four times with TBST, then developed with Supersignal West Dura chemiluminescent substrate (Thermo Scientific) and imaged using a CCD camera (Alpha Innotech). The induction of H. pomalla lectin expression is very dramatic as shown in FIG. 21. Example 10. Nitrogen deprivation-induced mating ohenotype mediated flocculation of Chlamvdomonas reinhardtii (001491 In this example, the two Ch/amydomonas reinhardili strains 21gr and 6145c, representing the two mating types plus (MT+) and minus (MT-), respectively were grown in Tris-Acetate-Phosphate (TAP) media to 5 x 106 cells/mL. I L of each culture was centrifuged at 5000 x g for 10 minutes. The supernatant was removed and the pellet was resuspended in I L TAP media without ammonium chloride (TAP -NH 4 CI). The culture was centrifuged again to wash away residual ammonium chloride at 5000 x g for 10 minutes. The supernatant was removed and the pellet was resuspended in I L TAP -NH 4 CI. The culture was centrifuged again at 5000 x g for 10 minutes. The pellet was resuspended in I L TAP -NIH 4 C and allowed to shake for 12-16 hours under light. The cultures were combined in a 1:1 ratio and allowed to shake for 12 hours under light before observing the sedimentation. Sedimentation or settling of 35 7.5 mL of the culture was observed in 13 x 100 mm borosilicate disposable culture tubes over time. Results are shown in FIG. 22. 100150] A variation of the method inyolves minimizing the amount of nitrogen in the media so that the culture will naturally begin starvation as it approaches saturation. Strains 21gr and 6145c were grown in TAP until approximately 2-6 x 106 cells/mL. Approximately I x 10" cells were centrifuged and resuspend in I mL of TAP -NH4CIl. These were diluted 10,000 fold in TAP -NH 4 CI + 5 mM NaNO 3 . Saturation was reached after three days of growth under light. Sedimentation of 7.5 mL of the culture was observed in a 13 x 100 mm borosilicate disposable culture tubes over time. Results are sh6wn in FIG. 23. 36 Table 1. Sequence Data SEQ Codon-biased, Synthesized Gene Sequence Sequence ID NO Description I atgacatgtgaattccctaggctcgagcagtgcgccctgaagaccattgctttcagcgccgccatcgaccgcgagcaga H. pomatia cgtttgacgccaaccaggtggtcatetacgacatcgtgattacgaaccacggcaacgcctacgataactecaccggcct lectin gttcaccgcgccggtggacggcatgtacagct tcaactgaacctgctcacgattaaggagaaggagggctggctgga gctcgtgcacaacggtcagctcaaggtgagcgtctacgcgaagcaggacagcacgtacgattcgtcgagcaactoggt catcatcaagatgaaggagggtgatcgggtgaacgtgcgggcccacaagaagtcgggtctgttcggccgcgacgacg agctgtacaacacgtlclccggccacttcctgtccggcctgggcaccggcaccggtgactacaaggacgacgacgaca agtccggcgagaacctgtacttccagggccacaaccaccgccacaagcacaccggtgtcgactag 2 atgacatgtgaattccctaggctcgagcaacggtgcggggagcaggggtccaacatggagtgccccaacaacctgtgc T. vulgaris lectin tgctcgcagtacgggtactgcggcatgggcggcgactactgcggcaagggctgccagaacggcgcctgctggacctc caagcgctgcggttcccaggccggtggcgccacctgcaccaacaaccagtgctgctcccagtatggctactgcggctt cggcgcggagtactgcggtgcgggctgccagggcggcctgccgcgctgacatcaagtgcgggtcgcaggCtggc ggcaagctgtgcccgaacaacctctgctgcagccagtggggcttctgcggtctgggcagcgagttttgcggtggtggtt gccagagcggcgcctgcagcacggacaagccgtgcggcaaggacgctggcggccgggtctgcactaacaactattg ctgctccaagtggggctcctgcggcatcggcccgggctattgggtgcgggctgccagtcgggggctgcgacggeg gcactggcaccggtgactacaaggacgacgacgacaagtcgggcgagaacctgtacttcagggtcacaaccaccge cacaagcacaccggtgtcgaciga 3 ttggttctcgatcccgcgaaattaatacgactcactataggggaattgtgagcggataacaattcccctctagaaataatttt LppOtnpA-H. gtttaactttaagaaggagatatacatatgacatgtgaattcatgaaagtactaaactggtactgggCgCggtaatcctgg pornatia lectin gttctactctgctggcaggttgctccagcaacgctaaaatcgatcagggaattccaggcaacccgtatgttggctttgaaat gggttacgactggttaggtcgtatgccgtacaaaggcagcgttgaaaacggtgcatacaaagctcagggcgttcaaCtg accgctaaactgggttacccaatcactgacgacctagacatctacactcgtctgggtggtatggtatggcgtgcagacact aaatccaacgtttatggtaaaaaccacgacaccggcgtttctccggtcttcgctggggtgttgagtacgcgatactc~t gaaatcgctacccgtctggaataccagtggaccaacaacatcggtgacgcacacaccatcggcactcgtcoggacaac ggtattaactcgagcagcgtgcctggcgatccgcgcgtgcctcgcagctggacggagccctttccgttctgcggtacag gcgactacaaggatgatgacgacaagtcgggcgagaacctctatttccagggtcacaaccaccgccacaagaccCta ggctcgagatgctgtttgtcactattatttccctgggtctgctggctattgtgcacggccagtgcgccctgaagaccattgct ttcagcgccgccatcgaccgcgagcagacgtttgacgccaaccaggtggtcatctacgacatcgtgattacgaaccacg gcaacgcctacgataactccaccggcctgtcaccgcgccggtggacggcatgtacagctttcaactgaactgCtCac gattaaggagaaggagggctggctggagctcgtgcacaacggtagctcaaggtgagcgtctacgcgaagcaggac agcacgtacgattcgtcgagcaactcggtcatcatcaagatgaaggagggtgatcgggtgaacgtgcgggcccacaag aagtcgggctgttcggccgcgacgacgagctgtacaaCacgtttccggccattctgtCCggcctgggcaccggca ccggtgtcgactag 4 atgacatgtgaattcatgaaagctacrtaaactggtactgggcgcggtaatcctgggttctactctgctggcaggttgctcca LppOnipA gcaacgctaaaatcgatcagggaattccaggcaacccgtatgttggctttgaaatgggttacgactggtaggtcgtatgc truncated L. cgtacaaaggcagcgttgaaaacggtgcatacaaagctcagggcgttcaactgaccgctaaactgggttacccaatcac culinaris lectin tgacgacctagacatctacactcgtctgggtggtatggtatggcgtgcagaactaaatccaacgtttatggtaaaaacca cgacaccggcgtttctccggtcttcgctggcggtgttgagtacgcgatcactectgaaatcgctacccgtctggaatacca gtggaccaacaacatcggtgacgcacacaccatcggcactcgtccggacaaeggtattaactcgagcagcgtgcctgg cgatccgcgcgtgcctcgcagctggacggagccctttccgttctgcggtacaggcgactacaaggatgatgacgacaa gtcggcgagaacctctatttccagggtcacaaccaccgccacaagcacctaggtgaggtgacttcctacacgtg aacgaggtggtgccgctgaaggacgtggtgcccgagtgggtgcggatcggcttcagcgccaccacgggCgctgagtt cgccgcccacgaggtgcactcctggtctttcacagcgagctgggtggcaccagcagctcggcacgggCaccggtg tcgactga 5 atgacatgtgaattccctaggctcgagactgagactacgtcgtttagcattaccaagttttcccctgatcagcagaacctga L. cu/mnars tcttccagggcgacggctacaccacgaagggcaagctgaccctgacgaaggccgtcaagagcactgtgggccgggc lectin-p3 gctgtatageaccccc~attcacatttgggacogcgacaccgggaacgtggccaacttcgtgacctccttcaccttcgtgat Autotransporter cgacgccceagctcgtacaacgtggcggacggcttaccttttcatcgcgcctgtggaacgaagccgcagacggg cggcgggtatctgggcgtcttcaactcgaaggagtagacaagacttcgcagaccgtggccgtggagttcgatactttct acaacgcggcctgggaccccagcaacaaggagcgccaCattggcatcgacgtgaactcgatcaagtcggttccac aagagctggaacctgcagaacgggagcgcgcgaaCgtggtcatcgcgttcacgccgccacgaacgtcctgaccgt caccctgacctaccctaccggtgtcgacgattacaaggatgatgatgacaagagcggcgagaacctgtacttcaggg I____ gcacaaccatcgccacaagcacggcatcaacagctcgagcgtgcccggcgacccgcgcgtgcctcggtcgtggac ________ 37 gagccgttccccttctgcggtacaggcgtattcattggatgattatgatgcaaaagacaatagtgaateatcaataggtaa tttagctcgtgtaatacctagaatgggaagggagttaattaatgattatgaagaaatccCttggaggagttggaagatgaa gcggaagaagaacgtcgccaagcaacgcaattccactccaaaagtcgtaaccgtagagctatatcatcggaaccatcat ctgatgaagatgcatctgaatcggtttccacatcagacaaacacctcaagltaataeggaacttcatgaaaaagttgaga cggcgggtttacaaccaagagccgcgcagccgcgaacccaagccgccgCgcaagccgatgcagtcagcaccaatac taacicggctttatctgacgcaatggcaagcacgcaatctatcttgtggatacaggtgcttacttaacacggeacattgca caaaaatcacgcgctgatgccgaaaaaaacagtgttggatgtcaaacactggttatggccgtgattatgcttccgcacaa tatcgccggtttagttcgaaacgcacgcaaacacaaatcggcattgaccgcagcttgtccgaaaAtatgcagataggcg gagtattgactactcgacagtcagcatacttttgatcagggggcggcaaaaatacttttgtgcaagccaacctttatggt oagtattatttaaagatgcttggtatgtggcggcgazttggtgcgggcagttgagaagccggttacaaacgcagcaa aaagcaaactttaaccgaaraagcatccaaaccggccttacttgggcaatacgctgaaatcaatcaattcgagalgtc cct ag tgcggg ta tecg ttac agccgcct gtcatctgc aga tac aagttgggtgacgacagtgtl aaagtaligtt ctat gg cagtgaaaacactaacggccggactggatgcttatcggtttaaagtcggcaacctaccgtaaaaccttgttatctgc agcttacttlgccaattatggcaaaggcggcgtgaatgtgggcggtaaatccttcgcctataaagcagatatCaacagca atatcagcaggcgtcgcgttactgtaccgaatgttaacataacgaatggcagtattacaaaggaaaacaa1ttggaa aaacaaaaatccggacaaattaaaatacagattcgtttctaa 6 atgacatgtgaattccctaggctcgagcaacggtgcggggagcaggggtccaacatggagtgccccaacaacctgtgc Pirl b-If. tgctcgcagtacgggtactgcggcatgggcggcgactactgggcaagggctgccagaaggcgcctgctggacctc pomaiia lectin caagcgctgcggttcccaggccggtggcgccacctgcaccaacaaccagtgctgctcccagtatggctactgcggctt cggcgcggagtactgcggtgcgggctgccagggcggcccctgccgcgctgacatcagtgcgggtcgc1IggctggC ggcaagctgtgcccgaacaacctotgctgcagccagtggggcttctgcggttgggcagcgagttttgcggtggtggtt gccagagcggcgcctgcagcacggcaagccgtgcggcaaggacgctggcggccgggtctgcactaacaactattg ctgctccaagtggggctcctgcggcatcggcggctattgggtggggctgccagtcgggcggtgcgacggcg gcactggcaccggtgtcgacgattaaggacgatgacgacaagagcgggagaacctgtactttagggccacaacc atcggcacaagcacggtacaggcgccgctgctatctctcaaattggtgacggtcaatccaagccataCCaaaccac tgctgctgctgtttctcaaattggtgacggtcaaatccaagccactactaaaaCCaaagctgtgctgtctctcaaattggtg acggccaaatccaagccaccaccagactacctcagctaagactaccgctgagcCgtctcccaaattggtgacggtea aattcaagccactactaaaaccaaagctgctgctgtctctcaaattggtgacggtcaaatccaagccactaccaaaacac tgctgcagctgtctctcaaattggtgacggtcaaatccaagccactataaaaccactgctgctgctgthctcaaatggtg acggtcaaatccaagccaccaccaatactactgttgctccgtctcccaaatcactgatggccaaatcaagccacaactt taacttcttga_________ 7 atgocatgtgaattccctaggotcgagactgagactacgtcgtttagcattaccaagttttcccctgatcagcagaacctga Pirlb-L. tcttccagggcgacggctacaccacgaagggcaagctgaccctgacgaggccgtcaagagcactgtgggccgggc culincaris lectin gctgtatagcaccccattcacattgggaccgcgacaccgggaacgtggccaacttcgtgacctccttcacctlcgtgat cgacgcccccagctcgtacaacgtggcggacggcttcaccttttcatcgcgctgtggacagaagccgcagacggg cggcgggtatctgggcgtctcaactcgaaggagtacgacaagacttcgcagaccgtggccgtggagttcgatacttt acaacgcggcctgggacccagcaacaaggagcgccncattggcatcgaCgtgaactcgatcaagtcggtgtcacC aagagctggaacctgcagaacgggagcgcgcgaacgtggtcatcgcgtcaacgccgccacgaacgtCCtgaccgt caccctgacctaccctaactccctggaggaggagaacgtgacttcctacacgctgaacgaggtggtgccgctgaagga) cgtggtgcccgagtgggtgcggatcggcttagcgccaccagggcgctgagttcgccgcccacgaggtgactcct ggtcctttcacagcgagctgggtggcaccagcagctccggcacgggcaccggtgtcgacgattataaggacgatgac gacaagagcggcgagaacctgtactttcagggccacaaccatcggcacaagcacggtacaggcgccgctgctatCtcI caaattggtgacggtcaaatccaagccactaccaaaacactgctgctgctgtttctcaaattggtgacggtcaaatccaa gccactactaaaaccaaagctgctgctgttctcaaattggtgacggccaaatccaagcaccaccaagactacctcagc taagactaccgctgcagccgtctcccaaattggtgacggtcanattcaagccctactaaaccaagctgctgctgtctc tcaaattggtgacggtcaaatccaagccactaccaaaacaactgctgcagctgtctctcaaattggtgacggtcaaatca agccactactaaaaccactgctgctgctgtttctcaaattggtgacggtcaaatccaagccaccaccaatactaCtgttgct ccagtctcccaaatcactgatggccaaatccaagccacaacttaacttctga 8 atgacatgtgaattccctaggctcgagcaacggtgcggggagaggggtccaacatggagtgcccaacaacctgtgc Pin! a-T. vu/garis tgctcgcagtacgggtactgcggcatgggcggcgactactgcggeagggctgccagaacggcgcctgctggact lectin caagcgctgcggtteccaggccggtggcgccactgcaccaacaaccagtgctgtccagtatggctactgcggctt cggcgcggagtactgcggtgcgggctgccagggcggcccctgccgcgctgacatcaagtgcgggtcgcaggctggc ggcaagctgtgcccgaacaacctctgctgcagccagtggggcttctgcggtctgggcagcgagttttgcggtggtggtt gccagagcggcgcctgcagaggacaagccgtgcggcaaggacgcggcggccgggtctgcactaacaacatg ctgctccaagtggggctcctgcggcatcggcccgggctattgcggtgcgggctgccagtcgggcggctgcgacggcg gcactggcaccggtgtcgacgattacaaggatgatgatgacaagagcggcgagaacctgtacttccagggecacaacc accgccataagcacggtacaggcgccgctgctatctctcaaattggtgacggtcaaatccaagccactaccaaaaccac I________ 38 tgctgctgctgtttctcaaattggtgacggtcaaatccaagccactactaaaaccaaagctgctgctgtctcteaaahtggtg acggccaaatccaagccaccaccaagactacctcagctaagactaccgctgcagccgtctcccaaattggtgacggtca aattcaagccactactna caaagctgctgctgtctctcaaattggtgacggtcaaatccaagccactaccaaacaac tgctgcagctgtctctcaaattggtgacggtcaaatccaagccactactaaaaccactgctgctgctgtttctcaaattggtg acggtcaatccaagccaccaccaatactctgtgctccagtctcccaaatcactgatggccaaatccaagccacaactt taacttctgcaaccattataccatctccagetccagctccaattactaatggcactgacccagtaactgctgaaacatgcaa aagcagtggcactttagaaatgaacttaaagggtggtatcctgactgacggtaaaggtagaattggttctatcgttgccaa cagacaattccaatcgatggtcctcaccacaagctggtgtattatgctgctggttggtcatcaccccagaaggtaa cttggccatcggtgaccaggatactttttaccaatgttgtcaggaaacttctacaactttacgatgagcacattggaactc aatgtaatgcagtccacctacaagctatcgatttgctcaactgttag 9 atggccaagctgaccagcgccgttccgglgctcaccgcgcgcgacgtcgccggagcggtcgagttctggaccgaccg L. culinarlv gctcgggttctcccgggacttcgtggaggacgacttcgccggtgtggtccgggacgacgtgaccctgttcatcagcgcg lectin-Fas I gtceaggaccaggtgagtcgacgagcaagcccggcggatcaggcagegtgcttgcagatttgacttgcaacgcccgc attgtgtcgacgaaggcttftggctcctctgtcgctgtctcaagcagcatctaaccctgcgtcgccgtttccaIgcaggac caggcggtgccggacaacaccctggcctgggtgtgggtgcgcggcctggacgagctgtacgccgagtggtcggaggt cgtgtccacgaacttccgggacgcctccgggccggccatgaccgagatcggcgagcagccgtgggggcgggagttc gccctgcgcgacccggccggcaactgcgtgcacttcgtggccgaggagcaggacgccccggtgaagcagaccctga acttcgacctgctgaagctggcgggcgacgtggagagcaacccgggccccctcgacatggcgtctcatgccgcggcc cagagcgctttcacagctgtggccactgcagcggacccgggcctcgacgactacaaggacgacgacgacaagtccg gcctcgagactgagactacgtcgtttagcattaccaagttttcccctgatcagcagaacctgatcttccagggcgacggct acaccacgaagggcaagctgaccctgacgaaggccgtcaagagcactgtgggccgggcgctgtatagcacccccatt cacatttgggaccgcgacaccgggaacgtggccaacttcgtgacctcctteaccttcgtgatcgacgcccccagctcgta caacgtggcggacggcttcaccttcttcatcgcgcctgtggacacgaagccgcagacgggcggcgggtatctgggcgt cttcaactcgaaggagtacgacaagacttcgcagaccgtggccgtggagttcgatactttctacaacgcggcctgggac cccagcaacaaggagcgccacattggcatcgacgtgaactegatcaagtcggtgtccaccaagagctggaacctgca gaacggcgagcgcgcgaacgtggtcatcgcgttcaacgccgccacgaacgtcctgaccgtcaccctgacctaccctaa ctccctggaggaggagaacgtgacttcctacacgctgaacgaggtggtgccgctgaaggacgtggtgcccgagtggg tgcggatcggcttcagcgccaccacgggcgctgagttcgccgcccacgaggtgcactcctggtcctttacagcgagct gggtggcaccagcagctccggcacgggcaccggtgactataaggacgacgacgacaagtccggtgagaacctgtac tttcagggccacaaccaccgccacaagcacaccggtgtcgacctgttcctttttacctcagccctccaactgagcggcctI graacgttcttcaacgctaccggaaggaacatcacgttattcgcgcccagtgatcaggttggtgettgtacgtagctggag ggcrtctgattatcaactccctcgaaccctccactgaccccaacacgacctcacacccatacgcggcccaccgaag gcgctactagcggcgctgccggccctgaacctgaatcagtccagctggtgactaacgcagtgctcatggcgccagtg ctcavgtaccacgctttcgtg-ccagcgaccaaicaacgcctctgtcctcccggaatttcgtactacaacgcgttgaagtga ggcgggggcgcgagtttagaaggttgacctggagcggccacacggctcgcatgcagccttttcatgttgtgagtacc tcaatgttaggccaaaaaccgcgcaacgtgccaacctacagcacggatggcagcgtcagcggcaaccagctggcga ttacgaggacggtgtcgggcggtctgcgggtcacctccatcggcagcgacgccaacgtgatcaaggtggacctccca actccgggtgagagagcgcgtggctggcggcgccaatgcgctggctcctttcgcctatgtcaggatgagtgtcgtttcgt tgcggactggatcgggtcgcggtgcatggggaagcggcacccggtagaacgtgtatgggcaagtggatgggtacccg aacagtctgcctccgcg-cgtcacacctcaactatctcctctagacatgtggattgtattgtcgctgacaacaggtccacg gtagtgcacgtcgtggacgcggtgcttctcccgttctacccgtcagtgtactccgtgagttgcagtgcaagtgcgggcgc aggcgcaagctgcagaaaccaaaccgggcaaggcgcatgctcggctcctgcagccaaccatatggcgcagacctgc ctttcgcagcgccgacctacatgaggcaggacccaacacgttgcccaacccctgcgccgcacgtgcgcatgagg ctgtggcgcgcacctctgccctgagcacgctggccgcgctggtcggctctgccagcgccagcctggtgtccaagctgc aggtgcgtgtgtgtgttgagcgggtggtgaagatttggtgggcgggctgggcacgccgccgttcttgggttacggcaag tgccgtgttttgctgactggcggcggagttgtgcgcgtgctcgcgcctctctggcgcatcacagcgcccctgatggtgtg cactgaagtggcgattgcgttccgtcctgggcatgttctacaggacactacgggtgtctacaccgtcttgctccctacaat gcgtgagttgtggrtcagcacccactggttgtgccaggccgacaggccgacgttgcgtcaagtcgcgaaccgtgcgcg gctgcaagcattgccctgaccggetttggattgcccagcggctectacgctgaccttccctcgctgtggctccctccctcg tgtgcacagcgcctteacggccgccctggccccctccggcctcaacacgacgattgcgcagctggcggcgcagccg ccctgctgcagtccatcctgtncgtaccacgtcgtgcccggcctgtacaacgcctcctcgttttcaccacacccatcaccg tcaccaccctgacgtatggcttcgctgcaitgcatgcgcacccagcgtgtgtgcgccaccgtgcagaggcaggcctcaa ccttcagatcagtctgatcagtttgaccagttgcattccgacacacgacgatgccctggcatgcctcaatgccccgctccg cagtggccagaagctgacgctggtgaaggacggcacttcgctgtcggtgaagacggccgacggcatgacggccaac ctgctgcaggcgcgcgacctgccgtgcggcttcacggaccagtgagttggtcgcgcgagtgaccagcatagcacggg acaaggactcgtggcatcccgttgttcaggatgggtttgcaccggcgtaggagccccaaatcccaacatgcacagctaa cgcatttcacactacacgtccaacctgtcaggggcacgttccgcgcgaccgtgcacgtgatcgacaaggtactcgtccct I____ ccccctgttacctccgtggctgcggcgctggccctgcgcaccgacgtcaacacactgctggcggccgtcaaggcgga _________ 39 ggggtcctactcggtgcgatcaacaggtgacttgcggcaaccggcgccgttacaaacgctatgCgcttatgccgctt ctcgggcatactgcgtccatttgactgcattacgaaggactggacttacccafgaattgttcccctgctgtgctgcatg ccctgaaaccctcagcaccacattcacggacgcttctggcgcccatcgactggttcacggcgctgctggcggc caatggcagcatcagcgccgcgagctgctgggcaacaccacggcgctgagagatcctggacgtggtgctcgtg ctalgcaggcgcctcaggccacagacctctatgtacagccagcgtgcctgaccttgtggtgcttctggctgtgttcaggc gcacgtggtcacggggtcggtgctgacggtgggggctcaccaacggccagaacattaceaccaggtgggggcatt agccattgggcttgaggtgtcccccacatgggtggttgccgctgggtl~ggtcatttgctgagagaatgctatgct cttggcttgatctttgcgttgcatcatgtatcctgttcgcagtggcggcgctcgatcacggttgtcaagaccggaaccacg acccagctgaagctgggcaacagcgtggcagcgtggtcggggcggaggttgcgattggeageaggtgggtgcacct gacctcttcattgccaccttcctgeagcgctgatgatggcttctttgcgacgttatcgacgtgcttaaaaacgcaacacaa aagtgccatcgccgcgagcctgcatgctgtgttatggtgtcaacgcgcccatacccatgccatgccccctgggtlg cagcgcgacgctcatcgtcatcgacggtgtcctggccgtccggcgttccaccgtgacctcgggaggcggtggcgg cgccgcagcggcaactacgccgtccttcgtgctcatgtgtggagcgttgtggcggcaggtgctgctagcateag cgcctgcagtag 10 atggccaagctgaccagcgccgttccggtgctcaccgcgcgcgacgtcgccggagcggtcgagttCtggaccgaccg L. culinars gctcgggttctccgggactcgtggaggacgacttcgccggtgtggtccgggagacgtgaccctgttcatcagcgcg truncated lectin gtccaggaccaggtgagtcgacgagcaagcccggcggatcaggcagcgtgcttgcagatttgacttgcaacgcccgc Fas I caggtggtgccggacaacaccctggcctgggtgtgggtgcgcggctggacgagctgtaCgCCgagtggtcggaggt cgtgtccacgaacttccgggacgcctccgggccggccatgacgagatcggcgagcagccgtgggggcgggagtc gccctgcgcgacccggccggcaactgcgtgcacttcgtggccgaggagcaggacgccccggtgaagcagaccctga acttcgacctgctgaagctggcgggcgacgtggagagcaacccgggccctCgaatggcgtctcatgccgcggcC cagagcgctttcacagctgtggccactgcagcggacccgggcctgacgactacaaggacgacgacgacaagtceg gcctcgaggtgacttcctacacgctgaacgaggtggtgccgctgaaggaegtggtgcccgagtgggtgcggatcggct tcagcgccaccacgggcgctgagttcgccgcccacgaggtgcactcctggtcctttcacagcgagctgggtggcacca gcagctccggcacgggcaccggtgactataaggacgacgacgacaagtccggtgagaactgtactttcagggccac aaccaccgccacagcacacggtgtcgactgttcctttttacctcagcctCCaactgagcggccttgtaacgtttca acgctaccggaaggaacatcacgttattcgcgcccagtgtcaggttgggcttgtacgtagctggagggcttclgattat caactcccctcgaaccctccactgaccccaacctacgactcacacccatacgcggccacegaaggcgctactagcg gcgcigccggcccgaacctgaatcagtcccagcgggactaacgcgtgctcatggcgccagtgctctgtaccacg ctttcgtgccagcgaccaacaacgcctctgtccctcccggaatttcgtactacaacgCgttgaagtgaggcgggggcgc gagtttagaaggttgacctggatgcggccacacggctcgcattgcagccttttcagtttgtgagtacctcaatgttaggcc auiaaaccgcgccaavgtgccaacctacagCacggatggcagcgtcagcggcaafcagctggcgatuacgaggacgg tgtcgggcggtcgcgggtcacctccatggaggacgccaacgtgatCaaggggaccttccaactccgggtgag agagcgcgtggctggcggcgccaatgcgctggctctltcgcctatgtcaggatgagtgtcgtttcgttgcggactggat cgggtcgcggtgcatggggaagcggcacccggtagaacgtgtatgggcaagtggatgggtacccgaacagtctgcct ccgcgcgtcacacctcaactatctccttagacatgtggcattgtattgtcgctgacaaaggtccacggtagtgcacgtc gtggacgcggtgcttctcccgttctacccgtcagtgtactccgtgagttgcagtgcaagtgcgggCgcaggcgcaagct gcagaaaccaaaccgggcaaggcgcatgctcggctctgCagccaaccatatggcgcagacctgcctttcgcagcgc cgacctacatgaggcagcgacccaacacgttgcccaacccctgCgcctgcacgtgcgccatgcaggctgtggcgCgc acctctgccctgageacgctggccgcgctggtcggtctgccagcgeCagcctggtgtccaagctgcaggtgcgtgtgt gtgttgagcgggtggtgaagatttggtgggcgggctgggcacgccgccgtcttgggttacggcaagtgCcgtgttttgc tgactggcggcggagttgtgcgcgtgctcgcgccttctggcgcatacagcgccctgatggtgtgoactgaagtggc gattgcgttccgtcctgggcatgttctacaggacactacgggtgtctacaccgtctttgctccctacaatgcgtgagttgtg gttcagcacccactggttgtgccaggccgaaggccgacgttgcgtcaagtcgcgaaccgtgcgcggctgcaagcatt gccctgaccggctttggattgcccagcggccctacgctgaccttccctcgctgtggctccctcctcgtgtgcacagcg ccttcacggccgccctggccccctccggcctcaacacgacgattgcgagtggcggcgcagcccgccctgctgcag tccatcctgtcgtacacgtcgtgcccggcctgtacaacgcctcccgttttccaccacaCccatcaccgtcaccacctg acgtatggcttcgctgcatgcatgcgcacccagcggtgtgcgccaccgtgcagaggcaggcCtCaacctcaga tcag tctgatcagttgaccagttgcattccgaacacgacgatgccctggcatgcctcaatgccccgctccgcagtggcaga agctgacgctggtgaaggacggcacttcgctgtcggtgaagacggccgacggCatgacggccaacctgctgCliggc gcgcgacctgccgtgcggcttcacggaccagtgagttggtcgcgcgagtgaccageatagcacgggacaaggaCtcg tggcatcccgtgtcaggatgggtttgcaccggcgtaggagccccaaatCCCacatgcacagtaacgcatttcacac tacacgtccaacctgtcaggggacgttccgcgcgaccgtgcacgtgatcgacaaggtactcgtCcctcccclgttacc tccgtggctgcggcgctggccctgcgcacgacgtCaacacactgctggcggccgCaaggcggaggggtccactC ggctgcgatcaacaggtgacttgcggcaaccggcgccgttacaaacgtatgcgcttactgccgcttctcgggcacata ctgcgtccatttgactgcattacgaaggactggacttaccccagaattgttcccctgcctgtgctgcatgccctgaaaccct _____cagcaccacatcaccggcacgcttctggcgcccatcgactcggccttcacggcgctgctggcggccaatggcagcatI 40 cagcgccgcgcagctgctgggcaacaccacggcgctgaagaagatcctggacgtgagtgctcgtgctatg9caggcgt cctcaggccacagacctctatgtacagccagcgtgcctgaccttgtggtgcttctggctgtgttcaggcgcacgtggtcac ggggtcggtgctgacggtggcgggtctcaccaacggccagaacattaccaccaggtgggggcattagccattgggctt gaggtgtcccccacattgggtggttgccgctgcggctmtggtcattatgctgagtagaatgctatgctottggcttgatcttt gcgttgcatcatgtatcctgttcgcagtggcggcgctacgatcacggttgtcaagaccggaaccacgacccagctgaag ctgggcaacagcgtggtcagcgtggtcggggcggaggttgcgattggcagcaggtgggtgcacctgacctcttcattg ccaccttcctgcagcgctgatgatggcttctttgcgacgttatcgacgtgcttaaaaacgcaacacaacaagtgccatcgc cgcgagcctgcatgctgtgttatggtgtcaacgcgccccatacvccatgccatgccccctggtgtttgcagcgcgacgct catcgrcatcgacggtgtcctggtgccgtccggcgtttccaccgtgacctcgggaggcggtggcggcgccgcagcgg caactacgccgtccttcgtgcatgctgtggagcgttgtggcggcagcgctgctgctagcattccagcgcctgcagtng II atggccaagctgaccagcgccgttccggtgctcaccgcgcgcgacgtcgccggagcggtcgagttctggaccgaccg E. criagalli gctcgggttctcccgggacttcgtggaggacgacttcgccggtgtggtccgggacgacgtgaccctgttcatcagcgcg lectin-Fas I gtccaggaccaggtgagtcgacgagcaagcccggcggatcaggcagcgtgcttgcagatttgacttgcaacgcccgc attgtgtcgacgaaggcttttggctcctctgtcgctgtctcaagcagcatctaaccctgcgtcgccgtttccatttgcaggac caggtggtgccggacaacaccctggcctgggtgtgggtgcgcggcctggacgagctgtacgccgagtggtcggaggt cgtgtccacgaacttccgggacgcctccgggccggccatgaccgagatcggcgagcagccgtgggggcgggagttc gccctgcgcgacccggccggcaactgcgtgcacttcgtggccgaggagcaggacgccccggtgaagcagaccctga acttcgacctgctgaagctggcgggcgacgtggagagcaacccgggccccctcgacatggcgtctcatgccgcggcc cagagcgctttcacagctgtggccactgcagcggacccgggcctcgacgactacaaggacgacgacgacaagtccg gcctcgaggtggagactattagcttttccttttcggagtttgagcctggtaacgataacctgaccctgcaggglgctgccct cattacccagagcggcgtgctgcagctcactaagatcaaccagaacgglatgccggcttgggactcgacgggccgga ccctgtacacgaagcccgtgcacatgtgggacagcaccacggggaccgtggcttccttcgagactcgcttttcgttctcc atcgagcagccctacacccgccctctcccggccgacggcctggtgttctttatgggccccaccaagagcaagccggcc cagggctacggttacctgggcgtgttcaacaactccagaggacaacagctaccagaccctggcggtcagtttgac accttctcgaacccctgggacccgcctcaggtgccccacatcgggatcgacgtgaactcgattcgctcgatcaagaccc agccgtttcagctggacaacggccaagtggcgaacgtggtgattaagtacgacgccccagcaagatcctgcatgtggt cctggtgtacccgagctccggcgccatctacacgatcgccgagattgtggacgtgaagcaggtgctgccggactgggt ggatgtgggtctgtcgggcgccactggcgcgcagcgggatgcggcggagacgcacgacgtgtactcgtggtccttcc aggcttccctgccggaggggaccggcaccggtgactacaaggacgacgatgacaagtcgggcgagaacctgtacttt cagggccacaaccaccgccacaagcacaccggtgtcgacotgttcctttttacctcagccctccaactgagcggccttgt aacgttcttcaacgctaccggaaggaacatcacgttattcgcgcccagtgatcaggttggtgcttgtacgtagctggagg gcttctgattatcaactcccctcgaaccctccactgaccccaacctacgacctcacacccatacgcggcccaccgaagg cgctactagcggcgctgccggccctgaacctgaatcagtcccagctggtgactaacgcagtgctcatggcgccagtgct calgaccacgcttcgtgccagcgaccaacaarcgcctctgtccctcccggaatttcgtactacaacgcgttgaagtgag gcgggggcgcgagtttaganggttgacctggatgcggccacacggctcgcattgcagccttttcatgtttgtgagtacct caatgttaggccaaaaaccgcgccaacgtgccaacctacagcacggatggcagcgtcagcggcaaccagctggcgat tacgaggacggtgtcgggcggtctgcgggtcacctccatcggcagcgacgccaacgtgatcaaggtggaccttcccaa ctccgggtgagagagcgcgtggctggcggcgccaatgcgctggctcctttcgcctatgtcaggatgagtgtcgtttcgtt gcggactggatcgggtcgcggtgcatggggaagcggcacccggtagaacgtgtatgggcaagtggatgggtacccg aacagtctgcctccgcgcgtcacacctcaactatctcctctagacatgtggcattgtattgtcgctgacaacaggtccacg gtagtgcacgtcgtggacgcggtgcttctcccgttctacccgtcagtgtactccgtgagttgcagtgcaagtgcgggcgc aggcgcaagctgcagaaaccaaaccgggcaaggcgcatgctcggctcctgcagccaaccatatggcgcagacctgc ctttcgcagcgccgacctacatgaggcagcgacccaacacgttgcccaacccctgcgcctgcacgtgcgccatgcagg ctgtggcgcgcacctctgccctgagcacgctggccgcgctggtcggctctgccagcgccagcctggtgtccaagctgc aggtgcgtgtgtgtgttgagcgggtggtgaagatttggtgggcgggctgggcacgccgccgtcttgggttacggcaag tgccgtgttttgctgactggcggcggagttgtgcgcgtgctcgcgcctctctggcgcatcacagcgccctgatggtgtg cactgaagtggcgattgcgttccgtcctgggcatgttctacaggacactacgggtgtctacaccgtctttgctccctacaat gcgtgagttgtggttcagcacccactggttgtgccaggccgacaggccgacgttgcgtcaagtcgcgaccgtgcgcg gctgcaagcattgccctgaccggctttggattgcccagoggctcctacgctgaccttccctcgctgtggctccctccctcg tgtgcacagcgccttcacggccgccctggccccctccggcctcaacacgacgattgcgcagctggcggcgcagcccg ccctgctgcagtccatcctgtcgtaccacgtcgtgcccggcctgtcaacgcctcctcgttttccaccacacccotcaccg tcaccaccctgacgtatggcttcgctgcatgcatgcgcacccagcgtgtgtgcgccaccgtgcagaggcaggcctcaa ccttcagatcagtctgatcagtttgaccagttgcattccgacacacgacgatgccctggcatgcctcaatgccccgctccg cagtggccagaagctgacgctggtgaaggacggcacttcgctgtcggtgaagacggccgacggcatgacggccaac ctgctgcaggcgcgcgacctgccgtgcggcttcacggaccagtgagttggtcgcgcgagtgaccagcatagcacggg acaaggactcgtggcatcccgttgttcaggatgggttugcaccggcgtaggagccccaaatcccaacatgcacagctaa cgcntttcacactacacgtccaacctgtcaggggcacgttccgcgcgaccgtgcacgtgatcgacaaggtactcgtccct _____ccccctgttacctccgtggctgcggcgctggccctgcgcaccgacgtcaacacactgctggcggccgtcaaggcggaI 41 ggggtcctactcggctgcgatcaacaggtgacttgcggcaaccggcgccgttacaaacgctatgcgcttactgccgctt cgggcacatactgcgtccatttgactgcattacgaaggactggacttaccccagaatgttcccctgcctgtgctgcatg ccctgaaaccctcagcaccacattcaccggcacgcttctggcgcccatcgactcggccttacggcgctgctggcgge caatggcagcatcagcgccgcgcagctgctgggcaacaccacggcg~ctgaagaagatcctggacgtgagtgctcgtg ctatgcaggcgtcctcaggccacagacctctatgtacagccagcgtgcctgaCcttgtggtgcttctggctglgttcaggc gcacgtggtcacggggtcggtgctgacggtggcgggctcaCCaacggccagaacattaccaccaggtgggggcatt agccattgggcttgaggtgtcccccacattgggtggttgccgctgcggcttttggtcattatgctgagtagaatgctatgt cttggcttgatcutgcgttgcatcatgtCctgttcgcagtggcggcgtacgatcacggttgtcaagaccggaaccacg acccagctgaagctgggcaacagcgtggtagcgtggtcggggcggaggttgcgatggcagcaggtgggtgcaCCt gacctcttcattgccaccttcctgagcgctgatgatggcttctttggaCgttaegacgtgcttaaaaacgcaacacaac aagtgccatcgccgcgagcctgcatgctgtgttatggtgtcaacgcgccvcataccccatgccatgccccctggtgttg cagcgcgacgctcatcgtcatcgacggtgtoctggtgccgtccggcgtttccaccgtgacctcgggaggcggtggcgg cgccgcagcggcaactacgccgtccttcgtgctcatgctgtggagcgttgtggcggcagcgctgctgctagcattccag cgcctgcagtag 12 atggccaagctgaccagcgccgttccggtgctcaccgcgcgcgacgtcgccggagcggtcgagttctggaccgaccg H, pornclia gctcgggttctcccgggacztcgtggaggacgacttcgccggtgtggtccgggacgacgtgaccctgtcatcagcgcg lectin-GP I gtccaggaccagggagtcgacggcaagcccggcggatcaggcagcgtgttgcagatttgacttgcaaCgcccgc attgtgtcgacgaaggcttttggctcctctgtcgctgtctcaagcagcatctaaccctgcgtcgccgtttccatttgcaggac) caggtggtgccggacaacaccctggcctgggtgtgggtgcgcggcctggacgagctgtacgccgagtggtcggaggt cgtgtccacgaacttccgggacgcctccgggccggccatgaccgagatcggcgagagccgtgggggcgggagttc gccctgcgcgacccggccggcaactgcgtgcacttcgggccgaggagcaggacgcccgggagcagaccctga acttcgaicctgctgaagctggcgggcgacgtggagagcacccgggccccctcgacatgatgggcggcaacacgc tgcccccttgtgggggcggtcaacgtcttgatggtggtgctcgccttcgtcgcgagcgctaacgcgcagtgtgtaccg gcggtatcttcaactgcctgagcaggcgccclgaagaccattgcttcagcgccgccatcgaccgcgagcagacgttt gacgcoaaccaggtggtcatctagacatcgtgttacgaaccaggcacgcctacgataactccaccggcctgttea ccgcgccggtggacggcatgtacagcttcaactgaacctgctcacgattaaggagaaggagggctggctggagCtCg tgcacaacggtcagctaaggtgagcgtctacgcgaagcaggacagcacgtcgatcgtgagcaactcggtcatca tcaagatgaaggagggtgatcgggtgaacgtgcgggcccacaagaagtcgggtctgttcggccgcgacgacgagctg tacaacacgttctccggccacttectgtccggcctgggcaccggcacoggtgactacaaggacgacgacgacaagtc ggcgagaacctgtacttcagggccacaaccaccgcacaagcacaccggtgtcgaccctccctctccggccccac gtctcctgcccctccctccccggctcccccgtaccgacccctcgccagcacccgagccagggcccCtc gcccgccccgccgagcccgccgagccctgcgcccccgagccctgcgccgccgagcccggccccgtcccccg cccccccgtotcccgcgccgccatgcctgcgcctccttcccctgcgccaccgtccccgcccaccctcgcccccga gcccggcccctcgtcgcccagccgccggcccccctcgccgtcgccccgtcgccagccccacccctgccacc ctccccaigcgccgcccagcccctccccccggtccgccgtcaccgagcccgcccgtccctcccagCCCCgcccctc cttcgcccacgcctccgtccccagccctcccgtgccgcccagccccgccccgccctctcccgccccgcccgtgcCg ccctcgccggcaccgccctcccctgctcccccggtgcgcctagcctgccccccgtCgcctccctcgcagcgc ccttcccccecccagrocccgccccccctcgccgtcccccccgctccccgagcccgtgccccttctccggcgcc cccagcccgcgcccccctcccctaagccgcccgcgccacccccgcctcccagcccaccgcctcccvcgccgcccc gtcccccattccccgccaacactcccatgcccccatcccctccctccccgcccccctccccggcgccacccacacccC ccacccccccttcaccgtcgccgccgtcgcccgttccgcccagcccagcgcctgtgccgcccagccccgccccgccc tccccagctcccagcccccccctagccccgctccgccgaccccgtcccaagcccctcgccttogccctccccgagc ccctcgccctccccgagcccctcgccctccccgagcceagcccgatcccctetccctcgccgaagcccagcccctca cccgtggccgtcaagctggtttgggctgatgatgccatcgccttcgacgacctgaaggcacctcgaccaggcccggt ocectcgcgcatggtcggcgagccgacatcgccggcaccaagtgcaagggcaacctgaagggctggatgcccaa gcccagcagggtgggtcctaggaagactttgctgtttgctgcgctgcctaggcatcatgacgcctgatgaegttgtctttt gaaggaagttcgaggattgcgctgagttgggaccgcavgcaagcaacttatccacgccacggtcccttccatcttcctc ttcgcagaaccctcgctggggccaggctgtgttctccggtggccgcaccgtgggctccgtcgctaacgtcaccatccgc gtcgcgtgagtcggacttttgagccgcctgtactgtcgtccggtgcttggcctcgttttgtcggatgatetgccgatatccaa ctggagcttgcttgactgaccgcttttctcatccgttgggcgcctcaccttgcctacccgcagtttcgcgacgagaagc cgcgctgatctactccagcatcgagctggtcgtgtacaacactggtgccaccctcatccgcgtgcccatcgccgccaatg tgacccgcagccagatcaggtgccctggttcctgactatggcaccaccvccattgoeggctaccocactggcatcga cgccaccacctggcccaactggaagattgccggcgtgcgcatcaacatgggcgcgggcaacaagaagcccaagacc tcgattgacgcggtcggcetcaacctgaagagcggttccggcgactacaaggacgacgacgacaagtccggcta 13 atggccaagctgaccagcgccgttccggtgctcaccgcgcgcgacgtcgccggagcggtcgagttctggaccgaccg L. culinris gctcgggttvtcccgggacttcgtggaggacgacttcgccggtgtggtccgggaegacgtgaccctgncatcagcgcg tr-uncated lectin _____gtccaggaccaggtgagtcgacgagcaagcccggcggatcaggcagcgtgcttgcagatttgacttgcaacgc.cgc GPI 42 attgtgtcgacgaaggcttttggctcctctgtcgctgtctcaagcagcatctaaccctgcgtcgccgtttccatttgcaggac caggtggtgccggacaacaccctggcctgggtgtgggtgcgcggcctggacgagctgtacgccgagtggtcggaggt cgtgtccacgaacttccgggacgcctccgggccggccatgacgagatcggcgagcagccgrgggggcgggagttc gccctgcgcgacccggccggcaactgcgtgcactcgtggccgaggagcaggacgccccggtgaagcagaccctga acttcgacctgctgaagctggcgggcgacgtggagagcaacccgggccccctcgacatgatgcggcggcaacacgc tgccccccttgtgggggcggtcaacgtc~ttgatggtggtgctcgccttcgtcgcgagcgctaacgcgcagtgtgtacctg gcggtatcttcaactgcctcgaggtgacttcctacacgctgaacgaggtggtgccgctgaaggacgtggtgcccgagtg ggtgcggatcggcttcagcgccaccacgggcgctgagttcgccgcccacgaggtgcactcctggtcctttcacagcga gctgggtggcaccagcagetccggcacgggcaccggtgactataaggacgacgacgacaagtccggtgagaacctg tactttcagggccacaaccaccgcacaagcacaccggtgtcgaccctccctctccggccccaccgtctcctgcccctc cctccccggctcccccgtcacccgcacccccttcgccagcacccccgagcccagggccccctcgcccgccccgce gagcccgccgagccctgcgcccccgagccctgcgccgccgagcccggcccccccgtcccccgcccccccgtctcc cgcgccgccatcgcctgcgcctccttcccctgcgccaccgtcccccgccccaccctcgcccccgagcccggcccctc cgtcgcccagcccgccggcccccccctcgccgtcgcccccgtcgccagccccacccctgccacccccccagcgcc gcccagcccctcccccccggtcccgccgtcaccgagccccccgtccctcccagccccgcccctccttcgcccacgc ctccgtcccccagccctcccgtgccgcccagccccgccccgcctctcccgccccgcccgtgccgccccgccggca ccgccctcccctgctcccccggtgccgcctagccctgccccccgtcgcctccctcgccagcgcccccttcccccccc agccccgcccccccctcgccgtccccccccgctccccgagccccgtgccccecttvtccggcgccccccagccccgc gcccccctcccctaagccgcccgcgccacccccgcctcccagcccaccgcctcccccgccgccecgtcccccattcc ccgccascactcccatgcccccatcccctccctccccgcccccctccccggcgccacccacaccccccacccccctt caccgtcgccgccgtcgcccgttccgcccagcccagcgcctgtgccgcccagccccgccccgccctccccagctccc agccccccccctagccccgctccgccgaccccgtcccaagcccctcgccttcgocctccccgagcccctcgccctcc ccgagcccctcgccctcccgagccccagcccgatcccctctccctcgccgaagcccagcccctcacccgtggccgt caagctggttgggctgatgatgccatcgccttcgacgacctgaacggcacctcgaccaggcccggctccgcccgcg catggtcggcgagcccgacatcgccggcaccaagtgcaagggcaacctgaagggctggatgcccaagcccagcag ggtgggtcctaggaaga~ctttgctgtttgctgcgctgcctaggcatcatgacgcctgtatgacgttgtcttttgaaggaagtt cgaggattgcgctgagttgggaccgcacgcaagcaacttatccacgccacggtccctctccatcttcctcttcgcagaac cctcgctggggccaggctgtgttctccggtggccgcaccgtgggctccgtcgctaacgtcaccatccgcgtcgcgtgag tcggacttttgagccgcctgtactgtcgtccggtgcttggcctcgttttgtcggatgatctgcogatatccaactggagcttg cttgactgaccgcttttctcatccgttgggcgcctcaccttgcctacccgcagtttcgcgaccgagaagcccgcgctgatc tactccagcatcgagctggtcgtgtacaacactggtgccacctcatccgcgtgcccatcgccgccaatgtgaeccgca gccagatcaggtgccctggcttcctgacctatggcaccacccccattgccggctacoccactggcatcgacgceaccac ctggcccaactggaagattgccggcgtgcgcatcaacatgggcgcgggcaacaagaagcccaagacctcgattgacg cggtcggcctcaacctgaagagcggttccggcgactacaaggacgacgacgacaagtccggctaa 14 atggccaagctgaccagcgccgttccggtgctcaccgcgcgcgacgtcgccggagcggtcgagttctggaccgaccg scFvS-Fas I gctcgggttctcccgggacttcgtggaggacgavttcgccggtgtggtccgggacgacgtgaccctgttcatcagcgcg gtccaggaccaggtgagtcgacgagcaagcccggcggatcaggcagcgtgcttgcagatttgacttgcaacgcccgc attgtgtcgacgaaggcttttggctcctctgtcgctgtctcaagcageatctaaccotgcgtcgcegtttccatttgcaggac caggtggtgccggacaacaccctggcctgggtgtgggtgcgcggcctggacgagctgtacgccgagtggtcggaggt cgtgtccacgaacttccgggacgcctccgggccggccatgaccgagatcggcgagcagccgtgggggcgggagttc gccctgcgcgacccggccggcaactgcgtgcacttcgtggccgaggagcaggacgccccggtgaagcagaccctga acttcgacctgctgaagctggcgggcgacgtggagagcaacccgggccccctcgacatggcgtctcatgccgcggc cagagcgctttcacagctgtggccactgeagcggacccgggectcgacgactacaaggacgacgacgacaagtccg gcctcgagatgaaatacctattgcctacggcagccgctggattgttattactcgcggcccagccggccatggccgaggt gcagctgttggagtctgggggaggcttggtacagcctggggggtccctgagactctectgtgcagcctctggattcacct ttagcagctatgccatgagctgggtccgccaggctccagggaaggggctggagtgggtctcoitggatttcggggactg gttcgcggacagactacgcagactccgtgaagggccggttcaccatctccagagacaattecaagaacacgctgtatct gcaaatgaacagcctgagagccgaggacacggccgtatattactgtgcgaaaaaggcgcagaagtttgactactgggg ccagggaaccctggtcaccgtctcgagcggtggaggcggttcaggcggaggtggcagcggcggtggcgggtcgac ggacatccagatgacccagtctccatcctccctgtctgcatctgtaggagacagagtcaccatcacttgccgggcaagtc agagcattagcagctatttaaattggtatcagcagaaaccagggaaagcccctaagctcctgatctatgctgcatccagttt gacaaagtggggtcccatcaaggttcagtggcagtggatctgggacagatttcactctcaccatcagcagtctgcaacctg aagatgcaacttactactgtcaacagagttacagtaccctaatacgttggccaagggaccaaggtggaaatcaaac gggcggccgcacacaaccatcgccacaagcacctcgagctgttcctttuacctcagccctccaactgagcggccttgta acgttcttcaacgctaccggaaggaacatcacgttattcgcgcccagtgatcaggttggtgcttgtacgtagctggaggg ettctgattatcaactcccctcgaaocctccactgacccaacctacgacctcacacccatacgcggcccacgaaggc gctactagcggcgctgcoggccctgaacctgaatcagtcccagctggtgactaiacgcagtgctcatggcgccagtgctc _____atgtaccacgctttcgtgccagcgaccaacaacgcetctgtccctcccggaatttcgtactacaacgcgttgaagtgagg ________ 43 cgggggcgcgagtttagaaggttgacctggatgcggccacacggctcgcattgcagccttttcatgttngtgagtacctca atgttaggccaaaaaccgcgccaacgtgccaacctacagcacggatggcagcgtcagcggcaaccagctggcgatta cgaggacggtgtcgggcggtctgcgggtcacctccatcggcagcgacgccaacgtgatcaaggtggacctcccaact ccgggtgagagagcgcgtggctggcggcgccaatgcgctggctcctntcgcctatgtcaggatgagtgtcgtttcgtgc ggactggatcgggtcgcggtgcatggggaagcggcacccggtagaacgtgtatgggcaagtggatggglacccgaa cagtctgcctccgcgcgtcacacctcaactatctcctctagacatgtggcatgtattgtcgctgacaacaggtccacggta gtgcacgtcgtggacgcggtgcttctcccgttctacccgtcagtgtactccgtgagntgcagtgcaagtgcgggcgcagg cgcaagctgcagaaaccaaaccgggcaaggcgcatgctcggctcctgcagccaaccatatggcgcagacctgcctttc gcagcgccgacctacatgaggcagcgacccaacacgttgcccaacccctgcgcctgcacgtgcgccatgcaggctgt ggcgcgcacctctgccctgagcacgctggccgcgctggtcggctctgccagcgccagcctggtgtccaagctgcagg tgcgtgtglgtgtlgagcgggtggtgaagattggtgggcgggctgggcacgccgccgttcttgggttacggcaagtgc cgtgttttgctgactggcggcggagttgtgcgc-gtgctcgcgcctctctggcgcatcacagcgcccctgatggtgtgcac tgaagtggcgattgcgttccgtcctgggcatgttctacaggacactacgggtgtctacaccgtcmtgctccctacaatgcg tgagttgtggttcagcacccactggttgtgccaggccgacaggccgacgttgcgtcaagtcgcgaaccgtgcgcggct gcaagcattgccctgaocggctttggattgcccagcggctcotacgctgaccttccctcgctgtggctccctccctcgtgt gcacagcgccttcacggccgccclggccccctccggcctcaacacgacgattgcgcagctggcggcgcagcccgcc ctgctgcagtccatcctgtcgtaccacgtcgtgvcccggcctgtacacgvctccgttttccaccacacccatcaccgtc accaccctgacgtatggcttcgctgcatgcatgcgcacecagcgtgtgtgcgccaccgtgcagaggcaggcctcaacc ttcagatcagtctgatcagtttgaccagttgcattccgacacacgacgatgccctggcatgcctcaatgccccgctccgca gtggccagaagctgacgctggtgaaggacggcacttcgctgtcggtgaagacggccgacggcatgacggccaacct gctgcaggcgcgcgacctgccgtgcggcttcacggaccagtgagttggtcgcgcgagtgaccagcatagcacggga caaggactcgtggcatcccgttgttcaggatgggtttgcaccggcgtaggagccccaaatcccaacatgcacagctaac gcattlcacactacar~gtccaacctgtcaggggcacgttccgcgcgaccgtgcacgtgatcgacaaggtictcgtcctc cccctgltacctccgtggctgcggcgctggccctgcgcaccgacgtcaacacactgctggcggccgtcaaggcggag gggtcctacrcggctgcgatcaacaggrgacttgcggeaaccggcgccgttacaaacgctatgcgcttactgccgcttct cgggcacatactgegtccatttgactgcattacgaaggactggacttaccccagaattgttcccctgcctgtgctgcatgc cctgaaaccctcagcaccacattcaccggcacgcttotggcgcccatcgactcggccttcacggcgctgctggcggcc aatggcagcetcagcgccgcgcagctgctgggcaacaccacggcgctgaagaagatcctggacglgagtgctcgtgc tatgcaggcgtcctcaggccacagacctctatgtacagccagcgtgcctgaccttgtggtgcttctggctgtgttcaggcg ca cgtggtcacggggtcggtgc tgacggtggcgggtctcaccaacggccagaacattaccaccaggtgggggcatta gccattgggettgaggtgtcccccacattgggtggttgccgctgcggcttnggtcattatgctgagtagaatgctatgctct tggcttgatctttgcgttgcatcatgtatcctgttcgcagtggcggcgctacgatcacggttgtcaagaccggaaccacga cccagctgaagctgggcaacagcgtggtcagcgtggtcggggcggaggttgcgattggcagcaggtgggtgcacctg acctcttcattgccacettcctgcagcgctgatgatggcttcttgcgacgttatcgacgtgcttaaaaacgcaacacaaca agtgccatcgccgcgagcctgcatgctgtgttatggtgtcaacgcgccccataccccatgccatgcccctggtgtttge agcgcgacgctcategtcatcgacggtgtcctggtgccgtccggcgtttccaccgtgacctcgggaggcggtggcggc gccgcagcggcaactacgccgtccttcgtgctcatgctgtggagcgttgtggcggvagcgctgctgctagcattccagc gcctgcagtag 15 tctagatatgcacgccaggcttgcggttgaaggggcatcaggctcgaggcgagacgtcgagggcgtgggctctgtatg Nit-2A-H. gctgggtaacggtacgtataattccaggtacaagctagagcagacggtggtgagaagcattagaagcattgtcccgagt pomalia lectin gtggtggctagaatcccggcccavgaatcacagtgaatgggtacatgtacaggtgccccgccagcccccgctcctctg ctgcctctgatgcctcatgccaaaagtcctgacgcggcgccctcacatccccgtccgggtaatctatgagttccctatcg agcatgtacgcgatagtggacggggctcagggtggggggtgggtgggtgggaggggcgttccttcagacaccctgga ggggtggctagaaaagcggccgcgcgccagaaatgtctcgctgccctgtgcaataagcaccggctatattgctcagcg ctgttcggcgcaacggggggtcagccttgggaagcgttggactatatggtagggtgcgagtgaccccgcgcgacttg gagctcgatggccccgggttgtttggggcgtccgcctclcgcgctattctgagctggagaccgaggcgcatgaaaatgc ottcgcttccataggacgctgcattgtggettgaaggttcaagggaagggttcaaacgacccgccgtacgaacttttgtc ggggggcgclcccggccccgggctcttgtgcgcgcattagggcttcgggtcgcaagcaagacgatacaggaaccga ccaatcgatagtcttgtgcgaccgtgcacgtglgcagcaatagttaggtegataaccacgttgaacttgogtctctcttcgt ggcgcctcctgcttggrgctccacttcacttgtcgctatatagcacagcgttgaaagcaaaggccacactaatacagccg ggctcgagogtccgtctgcgtttgcattgttggccaagggctgctttgtagccaaagccatacacgaagcttcacttgatta gctttacgaccctcagccgaatcctgccagtatgaccgtlgccgagcagcccgtggcactcgtgeccagcggcaaggt gcaggcgcccgacgctatcgtatcgcaagcggtcgagctcggcgctccgtatgagcctccgctctcgcccgaggatgc cgactggtcgcagcacgtucttccctcagctgtggacaagcgcgaccaggacacgcccgacaactgggtgcggcgcg accccgcatcctgcgcctcaccggccggcacccgctcaactgcgagccgcccatgtccgtgctcatgcaggtgagg gggattgcaggggggaggcgagcttgaggnagguagtgaacaaagagcagaggagggaactgacagccatggct cgaagctggctgggttgataatttagggagaattatgcggcggtggttgggcgtggggtgggggtggcacgggtttgag 1____ gcctggggcctggggcgaggggcggggttaacgggtgacggcaggctgggcgtacgtggagacgcgtcaacccac ________ 44 agtccagctacagcctcgtcctcactgaccatctcccgctctcctcttcccctecaatcccccaaaccaaccaacctaca caaaccaacagtacggtttcatcacgccgccggccgtacacttcgtgcgcaaccacggcgccgcgccgcgctccgct gggatgagcaccgcatcgagatcaacggcctggtcaacaagccgttgactttgaccatggacgagctggtggcgctgc cctccgtcaccttcccggtgacgctggtgtgcgctggcaaccgccgcaaggaggagaacatgctgaagaagagcattg gcttcaactggggcccttgtgccaccagcaccacctactggacgggcgtgcggctgcgcgacctgttgcagcacgccg gcatcaaggtgtgtgtgtgtgtgtgtgtatagctgacagggggttgtaaataccagcccaaactaaaccaaaccagtggg ggggtga~itgggtgatgtgcccgagcccaataagtcvcaagagtcaaggagtcgtcacccaacccagaaatgcagcg cgagctccgcgtataaccgtgggaagaggggggaacgagagagggacgagggatggggagggatggcagggag ggatgggagggaaggaaggaggggaggagggaagcagagcgcgtgtggtggtgatggcgggggcgaggaattgc aagacaggggcttgatgtggcgtggtgtgagtgcatgtatgcctgtgtgggaacgcaagcacatttccctgatccccgcc acccgccttgcttctccccattcccacgcctgctgctgcagacgccggccgagggcgcccgcttcgtgtgcttccgcgg ccccaagggcgagctgccacgtggcgaggacggctcgacggoacctctctgacgtacgccaaggccatggaccc gcctcggacgttatcatcgcatacaagcagaaccacaggtgtgtgcgtgtgcgtatgtgtgtgtgtgtgtgtgtgtgtgtgt gtgtgtgtctctgtgtgtgcgtgtgtgaaagagcgaaaggcaaagaataggctgtgcgtgtgcgtgtgtgttgagcga caaggcaaacactaggctgtgtgtgtttgtgtgcgcgtgtgtcggggggcgggggcgcggggagggcagcgggagg ttggcgctaggctgggcact-ggtcgcacgggtcggaggcctggagctcgtccgaatggcgatggcgacggatgcgc aagattgccgcacagaatagccgtcgtgccgtgctgctcagcttcctcaccccctccctccctccctccccgctcctcccc gcccctccccgcctgctgcctgctgcctgcgcaggtggctgacgcccgaocacggcttcccggtgcgcatcatcatccc gggcttcatcggcggccgcatgglcaagtggctgagcgagatcaccgtcatggacacggagtcgcaggtgcgtgggc gtgtgggtttcgagaatgctttaggctaacaatgcgaagccatoaagccagcgagcacaacgtgtgtgtatgtagttgt ctgggtgtgtgcgggcgaattgattcaggccgatgggctggcatgtagctcccagcctggcatcaaagctgtggggcg taactatgcttacacgcttcggccctaccacgatacccttgtaacctgtgccgccactccctctccatcccccccccaaaac acacacccctacacacacagaacttctaccacttcatggacaaccgcgtgctgcccagccacgtggacgaggagctgg ccaagaa-gagggtgagcgcgggggggaggaccgtggcgtgtgtgtattggagagcacagggtaggaaacaggga aagatttccgcagaatcttgtgtgtgtgcatgtgaccgccatcatcgaacccgtgtcatccccgttccgaagtccccgtc ctgaaactcgccgtgtacacgcgcgcaggctggtggtacaagcccgagttcatcatcaacgacctcaacatcaacagc gcgatggctcggccctggcacgacgagctggtcccgctggacgccaaccggccctacaccatcaagggttacgccta cgccggtgagcagcaacaacagcgataatgacagcaagcgggggcagcgagctgcctagcgagcgagtgagagag ccaacgtcgttggttcgggccgttggtgtggcactggcaggcatcataccgtacatgcgatttaggacgtgtggac gggacacgtgtgagcggctagttaagtaacggcaggactgaagatgaggatgacgaagtatatttaagttgctggc gttggtctgtgtcgtcatcctcatcatgtgcaggcggcggccgcaagatcatccgctgcgaggtctcgctggacgacgg caagacctggcgcctgggcgacatccagcgcttcgaggagcccaacgagtacggcaagcactggtgctgggtgact ggacgctggaggtgaggcgccggagcgaggaggagtgggcgcctgtgggcgaaatgggcgatgtcggttgggatg gcgggatgggcctttgcgtccctccagccecacggacccactgcttcgctctgcccccccccaaaaacacaggt gaacacgtttgacttcctgtccgccaaggaggtgctgtgccgcgcctgggatgagaccatgaacacgcagccggcggt gatcacctggaacctgatgggcatgatgaacaactgctacttccggtgagcgtgtgtgtgtgcgtgtgtggaagggggg gaggcatagagggcgagaggcgcccttttgtgcaatgttcagcatcgcagcgccgctatcgatt cc ccgaacacctgcgtgacagccctggttccacacgtcggcccgcccctcccaccccatcccactaaactaatcatgaat gtccccacgtaacacgcgcagcatcaagatccacccggaggtggacccagccacgggcgtcatgggcctgcgttc cagcacccggcccccgtggagctgggcgacaagggcaacatgggctggcgcgaggaggacaacctggtggcgca ggccgtggcggcggcgcgcgacggcggaggcgcggcggcggcaccgccgccgccgcctccggcggcgctgctg gcgaazggcggccccaagcagtacacgctggaggaggtggcggagcacgcgagcgaggagagctgctggtncgtg cacgagggccgggtgaggagagcggatggcgtggtggctggctggtggctggtctggggctaggggtttgtggttga ggttgtaggaagggcgagaggcgtggttgtgggtacgtgcgtgcccagcagctgcaccccaacccgtgctgacgtge acacgaaaccctgaaccaccvtggaccccagcttctaacccctttcaccccccccctccccgccctccgctcctctc caggtgtacgacgccacgccctacctgaatgaccaaccgggtggcgccgagtccaccctgatcactgcgggcgcgga cgccacagacgagttcaacgccatccacaggtgggtagggggcgagaacgtgtgtgtgcatgtgttgtgcgtgtgtg attggtgttttgggggcgtgtacgagagaggggacgttttgcggggctaggatcagcggcaggcgtgtaaaggggtcc gcgcatggcgtggcatccaacccaccgtcccatacacaccacgcaccaccgtccccatcccatctcacccatctcc ccactgcgccecccacatcccccacacacagctccaaagccaaggccatgctggcccagtactacatcggtgacctcg tggcatcaaaaccagcaaccgccaacggcacggcaaccgccaacggcaacggcacggcaactgccaacggcaccg Gggcggcggcgccgcccgccgaccctctggttgtgctgacgggtcgcgccaaggtgaagctaccgctggtggagcg gattgagctcaaccgcaacacgcgcatattccggttcggcctgccctcgccggagcaccgcatcggtgggtggtgtcg cgcgcgttatgatactaatgatacggtagtacgcacgtcttggctgccctgctgagtgtgtgccttgatttgtgtgggggaa gggggcaagaacaagagcagccagcagaaggggaaggagcgggctgacttcgtgtcggttgcgcgtrCcgCggCaC cactcactggccaccactcactgcactcccaccccctcccctcccccgatgcgcaggcctgccggtgggcaagcacg tgttcgtgtacgcgcaggtgggcggcgagaaogtgatgcgcgcctacacgccatcagcggggacgaggagaaggg I____ ccggctggacatgctcatcaaggtgcgtgtatgtgtgtgtgtgtatgtgtgagggacgtgtgtgcgcctgtgtgtgggggt ________ 45 ggggacgtgtgtgcagtgtgtgtaggtgtttctggtgcgatcatcttttgtaccgtgtgtgccccctgaccgcgcct gccccacaccccacaatccccaccgacccacacaccgggcgagcacgcgtccacccggggcggcaagatga gccagcattucgactcgctcgccatcggcgactgctggagttcaaggggccgCtggggcacttcgtgtacaaggcc gcggaagctacacgctcaacggcaaggtgcgcgcaacaggaacgggcggtCCtgtagccgcgagaatgagtaagCC taccacacaagcacataaatgcacacacatttggtggcttctacggcacattgtcaacac~gctagatagctaa cacacacacccctacctccctgcaggtgaccaagcacgccagtcacatgtcgtttgtgcgggggcacgggeatcac gccctgctacgcggtcatcaaggccgcactgcgcgaccccgaggacaacaccaaggagcagcggcggcggcggg gggaagcgggagaggaagcggcctcattgCCgttggCtgttagCtgatgatgacacgctttgctgccgCCgtatcaca gtgccatagcatagcaaggcagtggatgggcatggctacagccagggactaaagggccacacgcacgtcccggca catacacccgcgcccacacctgtgtccatcatcatacgcacacccactctgacaccaacaccaacacaacac cacaaccccttcccacctgcaggctggcg~tgctgttgcaacc8acagaggacgacttctgctgcgcgaggag ctggacgagctcgvaaaeaaccacccrgaggctccggctgtggtgagcggcgaccgggggccacacgtacgg cgcgcgagccgcagcggccccttccgtceCagcctgagccaaccgtaacgaaccaaccaaaccgaaccc ctcccccaccccctcccgccatctcaggtacacggtgtcagcccaaggacgcggcgacctggaagtacgacgtg gggcgtgtgagcaaggacatgttcacggagcacctttcgccagcacgggcgaggactgcctcagcctattgCgg gccgcacggcatgatcgagcactgctgcgtgcgttcctggaggccatgggctaCagCaaggaccgCCagatcagtt cgccccggtgaagcagaccctgaacttgacctctgagctggcgggcgacgtggagagCaacccgggcccctc gagcagtgcgccctgaagaccattgctttcagcgccgccatgaccgcgagcgacgtttgacgccaaccaggtggtc) atctacgacatcgtgattagaacccggcaacgcctacgataaCtccaccggcctgIcaccgcgccggtggacggc atgtacagctttcaactgaactgctaogattaaggagaaggagggctggctggagctCgtgcacaacggtcgtca aggtgagcgtctacgcgaagcaggacagcacgtacgattcgtegagcaactcggtcatcfltcaagatgaaggagggtg atcgggtgaacgtgcgggcccacaagaagtcgggtctgttcggccgcgacgaCgagctgtacaacacgttccggec acttcctgtccggcctgggcaccggoaccggtgactacaaggacgacgacgacaagtccggcgagaacctgtacttcc agggccacaaccaccgccacaagcacaccggtgtcgactagggactatcgtagagattgtggccacggttggatca tgcgaccagcaggnttggatccgaatccaggctctgggcggatgcagggcaggggcaggggcagcggtcgtgg gagcgtgtgtgagccggaaagggctggcacaggcacggccgcagcggccttttgtgcagtttgacgacggaagtgt gcgtctgtgtggttgtgtgtgagagtaggaggaCcggggtagacagagtgcgcccggcttggctgcggcgca ctgggacgcgttggcagtttaaaacctgcgctgaggggacaaacgagttggCaacagtaggeagttaaaagatagaat gtgtaggcagtttcccagtgggcaaatgagttgtgcaagcctgcaaacggcaggaagcatggcaaggatattactgatt gactgcagcaggggatagcagagggcacagcagagtgcccgagagagtgtgtgcacgtgctagttttggagtcagg caccgccgttgagatgatgtattgatgacgcagcatttcatgtgacatagggaggctttocatgcggttattatattatgtca ggaaagtgcctgacagcgtttagcgcgtggggagaagtacgacccflccgtgggctgaacccacgttagggcgtgggtt ggtcaggagggtgggtgccatgcatgaagcagagggccggggCgttagcccgtttggtgagagettgttgatgcaat gcgatacataatcataagggggttttggcggtgagagtgcgacctgtgtatggCagcflcgccatcggtgccaaccggc gaaggtgcaggaggtgcaggtaaagctacatatagaacVccctgCCgcacagttgtaaattaagcaagcgacttgcat tgtgtccatcactttgtgcagagggcaggcaagggcagggctgccatgggctggcaeggcgtggggcaacaaggg ggctfagactccaggggcgaccagtcgagccagggCCgcaaggaccatggagagCtgctagtgcccagggcgg ccaggccgcaacagcagttgggcggcagatggcagaccgcgaatgggagCCCttggctgtaagtcgggctgcgag aggagtttacctcgactgtggccgggaagagggggcgctgggcaagagteggactagggagtgcgCgactgaaacg cgcggggcactgcgcggggacacaggcgcggtcaaagcacctgtgtacctcgcgagtagatagcagtttagcgcatg) tccttgatoatggtggagcttcagcgaccaaagaaggacttcagaggaccggcccactaaggtcacliccegaac ggccgctccctcgttttcggtgacagccgcatagaagtgcaagtagaaacactaatgttgcttttacagcgacaag tgaaacgggttggttgaagagaattc 16 atgacatgtgaatteatgaaagetactaaactggtactgggcgcggtaatcctgggttctactctgctggcaggttgctcca LppOmpA gcaacgctaaaategatcagggaattccaggcaacccgtatgutggctttgaaatgggttacgactggttaggtcgtatgc scFv5 cgtacaaaggcagcgttgaaaacggtgcatacaaagctcagggcgttcaactgaccgctaaactgggtacccaatcaC tgacgacctagacatctacctcgttgggtggtatggtatggcggcagacactaaatccaacgtttatggtaaaacca egacaccggcgtttctccggtcttcgctggcggtgttgagtacgcgalactCCtgaaatcgctacccgtctggaatacca gtggaccaacaacatcggtgacgcacacaccatcggcactcgtccggacaacggtattaactcgagcagcgtgCCtgg cgatccgcgcgtgcctcgcagctggacggagccctttccgttctgcggtacaggcgactacaaggatgatgacgacaa gtcgggcgagactctattccagggtcaaaccaccgocacaagcliccctaggatgaaatactattgclctggea gccgctggattgttattactogcggcccagccggccatggccgaggtgCagCtgttggagtctgggggaggcttggtac agcctggggggtcctgagatctcctgtgcagcctctggattcacctttagcagctatgccatgagctgggtccgccag gctccagggaaggggctggagtgggtctcatggatttcggggactggttcgcggacagactacgcgatccgtgaag ggccggltcaccatctcgagacaattcaagaacacgcgtatctgcaaatgaacagcctgagagccgaggaeacg gccgtatattactgtgcgaaaaaggcgcagaagtttgactactggggccagggaacctggtcaccgtctegagcggtg gaggcggttcaggcgaggtggcagcggcggtggcgggtcgacggacatcagatgacccflgtctcctcctccctg _____tctgcatctgtaggagacagagtcaccatcacttgccgggcaagtcagagcattagcagctatttaaattggtatcagCag 46 aaaccagggaaagcccctaagctcctgatctatgctgcatccagttgcaaagtggggtcccatcaaggttcagtggcag tggatctgggacagatttcactctcaccatcagcagtctgcaacctgaagattgcaacttactactgtcaaCagagttaca gtaccctaatacgttcggccaagggaccafiggtggaaatcaaacgggcggccgcacatcatcatcaccatcactaa 47
Claims (16)
1. A non-vascular photosynthetic organism comprising an exogenous protein on said organism's external cell surface, said exogenous protein comprising one member of a binding pair.
2. The organism of claim 1, wherein said exogenous protein is an antibody.
3. The organism of claim 2, wherein said antibody is a single chain variable fragment (scFv) antibody.
4. The organism of claim 1, wherein said exogenous protein is a carbohydrate binding protein.
5. The organism of claim 4, wherein said exogenous protein is a lectin.
6. The organism of claim 5, wherein said lectin is a c-type lectin.
7. The organism of claim 1, wherein said exogenous protein is an antigen.
8. The organism of any one of claims 1 to 7, wherein said protein is a fusion protein or a chimeric protein.
9. The organism of any one of claims 1, to 8 wherein said external cell surface is a cell membrane or a cell wall.
10. The organism of any one of claims 1 to 9, wherein said organism is an alga.
11. The organism of claim 10, wherein said alga is a green alga.
12. The organism of claim 11, wherein said alga is member of the genus Chlamydomonas, Dunaliella, Scenedesmus or Hematococcus.
13. The organism of claim 13, wherein said alga C. reinhardtii, D. salina, D. tertiolecta, S. dimorphus or H. pluvialis.
14. The organism of claim 1, wherein said organism is a halophile.
15. The organism of claim 14, wherein said organism is D. salina, D. tertiolecta or D. viridis.
16. The organism of claim 4, wherein said carbohydrate protein is at least one of the group consisting of CD-SIGN, dectin-1, dectin-2, HECL, langerin, layilin, mincle, MMGL, E-selection, P selectin, L-selectin, DEC-205, Endo 180, mannose receptor, phospholipase A2 receptor, sialoadhesin (siglec-1), siglec-2, siglec-3, siglec-4, siglec-5, siglec-6, siglec-7, siglec-8, siglec-9, siglec-10, siglec-1 1, and galectins. 48
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015203662A AU2015203662A1 (en) | 2008-06-27 | 2015-06-30 | Induction of flocculation in photosynthetic organisms |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61/076,430 | 2008-06-27 | ||
| AU2009261966A AU2009261966B2 (en) | 2008-06-27 | 2009-06-26 | Induction of flocculation in photosynthetic organisms |
| AU2015203662A AU2015203662A1 (en) | 2008-06-27 | 2015-06-30 | Induction of flocculation in photosynthetic organisms |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009261966A Division AU2009261966B2 (en) | 2008-06-27 | 2009-06-26 | Induction of flocculation in photosynthetic organisms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2015203662A1 true AU2015203662A1 (en) | 2015-07-23 |
Family
ID=53674389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015203662A Abandoned AU2015203662A1 (en) | 2008-06-27 | 2015-06-30 | Induction of flocculation in photosynthetic organisms |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2015203662A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112342255A (en) * | 2020-11-18 | 2021-02-09 | 五洲丰农业科技有限公司 | Method for inducing bacterial to participate in enzymolysis to produce alginate oligosaccharide and application of product |
-
2015
- 2015-06-30 AU AU2015203662A patent/AU2015203662A1/en not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112342255A (en) * | 2020-11-18 | 2021-02-09 | 五洲丰农业科技有限公司 | Method for inducing bacterial to participate in enzymolysis to produce alginate oligosaccharide and application of product |
| CN112342255B (en) * | 2020-11-18 | 2022-05-13 | 五洲丰农业科技有限公司 | Method for inducing bacterial to participate in enzymolysis to produce alginate oligosaccharide and application of product |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009261966B2 (en) | Induction of flocculation in photosynthetic organisms | |
| AU2010224029B2 (en) | Engineering salt tolerance in photosynthetic microorganisms | |
| PT1276885E (en) | Trophic conversion of obligate phototrophic algae through metabolic engineering | |
| AU2010295660B2 (en) | Salt tolerant organisms | |
| AU2018236915A1 (en) | Lipid and growth trait genes | |
| US20170009250A1 (en) | Production of Therapeutic Proteins in Photosynthetic Organisms | |
| WO2008131359A1 (en) | Genetically modified biological cells | |
| Chai et al. | Expression of soybean Kunitz trypsin inhibitor gene SKTI in Dunaliella salina | |
| Guzmán-Zapata et al. | Production of recombinant proteins in the chloroplast of the green alga Chlamydomonas reinhardtii | |
| CN103288955B (en) | Monoclonal antibody against 26.7kDa protein of Portunus trituberculatus granulosa hemocyte and preparation method thereof | |
| CN110072998A (en) | For making the high production rate method of algal grown | |
| AU2015203662A1 (en) | Induction of flocculation in photosynthetic organisms | |
| CN110804619B (en) | Phosphatidylinositol-specific phospholipase C gene GhPIPLC2-2 of Gossypii and its application | |
| Johanningmeier et al. | Perspective for the use of genetic transformants in order to enhance the synthesis of the desired metabolites: engineering chloroplasts of microalgae for the production of bioactive compounds | |
| EP3544994A1 (en) | Method of purification of recombinant osteopontin from microalgae | |
| CN114196687A (en) | Phosphatidylinositol-specific phospholipase C gene GhPIPLC4-1 of cotton wool and its application | |
| US20190112616A1 (en) | Biomass genes | |
| EP2298923A1 (en) | Method for the production of recombinant proteins by green microalgae | |
| JP2025511877A (en) | Engineered Photosynthetic Organisms | |
| CN121005766A (en) | Application of alkalophilic microalgae transcription factor ChZF in microalgae salt tolerance regulation and control | |
| Marcondes et al. | Monoclonal Antibody Production and Immunolocalization of a Salinity Stress-Related Protein in Rice (Oryza sativa) | |
| JP2019135946A (en) | Microalgal recombinant strains with improved triacylglycerol productivity and methods for producing triacylglycerol | |
| WO2013126512A1 (en) | Artificial biological materials produced by self-assembly of photosynthetic unicells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |